Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - AB Private Credit Investors Corpd29702dex321.htm
EX-31.2 - EXHIBIT 31.2 - AB Private Credit Investors Corpd29702dex312.htm
EX-31.1 - EXHIBIT 31.1 - AB Private Credit Investors Corpd29702dex311.htm
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER: 814-01196

 

 

AB Private Credit Investors Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   47-5049745
(State of incorporation)  

(I.R.S. Employer

Identification No.)

1345 Avenue of the Americas

New York, NY 10105

(Address of principal executive offices)

(212) 969-1000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

   

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, par value $0.01 per share

(Title of Class)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
Emerging Growth Company       

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act).  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

The issuer had 26,819,755 shares of common stock, $0.01 par value per share, outstanding as of May 14, 2021.

 

 

 


Table of Contents

AB PRIVATE CREDIT INVESTORS CORPORATION

FORM 10-Q FOR THE QUARTER ENDED March 31, 2021

Table of Contents

 

    

INDEX

   PAGE
NO.
 

PART I.

   FINANCIAL INFORMATION      3  

Item 1.

  

Consolidated Financial Statements

     3  

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     51  

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk

     71  

Item 4.

  

Controls and Procedures

     71  

PART II.

   OTHER INFORMATION      72  

Item 1.

  

Legal Proceedings

     72  

Item 1A.

  

Risk Factors

     72  

Item 2.

  

Unregistered Sales of Equity Securities and Use of Proceeds

     73  

Item 3.

  

Defaults Upon Senior Securities

     73  

Item 4.

  

Mine Safety Disclosures

     73  

Item 5.

  

Other Information

     73  

Item 6.

  

Exhibits

     73  

SIGNATURES.

     

 

2


Table of Contents
Item 1.

Financial Statements

AB Private Credit Investors Corporation

Consolidated Statements of Assets and Liabilities

 

     As of
March 31, 2021
(Unaudited)
    As of
December 31,
2020
 

Assets

 

Investments, at fair value (amortized cost of $587,129,877 and $539,228,460, respectively)

   $ 582,690,056     $ 533,035,030  

Cash and cash equivalents

     50,890,483       22,410,622  

Interest receivable

     2,342,436       2,264,308  

Deferred financing costs

     2,306,376       1,648,701  

Receivable for fund shares

     153,751       33,298,880  

Prepaid expenses

     146,334       292,668  

Receivable for investments sold

     25,355       80,413  

Other assets

     208       879  
  

 

 

   

 

 

 

Total assets

   $ 638,554,999     $ 593,031,501  
  

 

 

   

 

 

 

Liabilities

 

Notes payable (net of unamortized discount of $25,300 and $26,440, respectively, and debt issuance costs of $1,511,752 and $1,786,062, respectively)

   $ 211,612,948     $ 211,337,498  

Credit facility payable

     149,500,000       130,700,000  

Payable for Fund shares repurchased

     11,061,881       —    

Management fees payable

     3,419,518       1,533,338  

Incentive fee payable

     2,994,136       2,353,074  

Distribution payable

     2,190,454       1,541,994  

Payable to Adviser

     2,150,079       1,568,252  

Interest and borrowing expenses payable

     1,631,217       1,554,186  

Professional fees payable

     664,539       484,248  

Administrator and custodian fees payable

     299,220       136,170  

Transfer agent fees payable

     30,195       13,809  

Accrued expenses and other liabilities

     8,090       —    

Miscellaneous payable

     1,840       1,840  

Accrued organization costs

     —         106,510  

Secured borrowings

     —         18,870,856  

Due to Affiliate

     —         469,453  
  

 

 

   

 

 

 

Total liabilities

   $ 385,564,117     $ 370,671,228  
  

 

 

   

 

 

 

Commitments and Contingencies (Note 6)

 

Net Assets

 

Common stock, par value $0.01 per share (200,000,000 shares authorized, 26,833,819 and 23,775,222 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively)

     268,338       237,752  

Paid-in capital in excess of par value

     256,266,884       227,482,784  

Distributable earnings (accumulated loss)

     (3,547,413     (5,360,904
  

 

 

   

 

 

 

Total net assets of AB Private Credit Investors Corporation

   $ 252,987,809     $ 222,359,632  
  

 

 

   

 

 

 

Non-Controlling Interest in ABPCIC Equity Holdings, LLC

   $ 3,073     $ 641  
  

 

 

   

 

 

 

Total net assets

   $ 252,990,882     $ 222,360,273  
  

 

 

   

 

 

 

Total liabilities and net assets

   $ 638,554,999     $ 593,031,501  
  

 

 

   

 

 

 

Net asset value per share of AB Private Credit Investors Corporation

   $ 9.43     $ 9.35  
  

 

 

   

 

 

 

See Notes to Unaudited Consolidated Financial Statements

 

3


Table of Contents

AB Private Credit Investors Corporation

Unaudited Consolidated Statements of Operations

 

     For the Three Months Ended
March 31,
 
     2021     2020  

Investment Income:

 

Interest income, net of amortization/accretion

   $ 10,377,184     $ 7,052,300  

Payment-in-kind interest

     375,483       206,351  

Other fee income

     107,093       182,600  
  

 

 

   

 

 

 

Total investment income

     10,859,760       7,441,251  
  

 

 

   

 

 

 

Expenses:

 

Interest and borrowing expenses

     2,605,053       2,568,667  

Management fees

     2,069,181       1,352,351  

Income-based incentive fee

     641,062       769,023  

Professional fees

     549,052       547,269  

Collateral management fees

     454,343       459,059  

Administration and custodian fees

     163,051       91,783  

Insurance expenses

     146,334       67,596  

Directors’ fees

     50,000       50,000  

Transfer agent fees

     16,386       10,758  

Other expenses

     163,622       235,122  
  

 

 

   

 

 

 

Total expenses

     6,858,084       6,151,628  

Reimbursement payments to Adviser (See Note 3: Expense Support and Conditional Reimbursement Agreement)

     280,779       —    

Waived collateral management fees

     (454,343     (459,059

Expense reimbursement from Adviser

     —         (89,757

Waived management fees

     (183,001     (1,227,046

Waived incentive fees

     —         (486,784
  

 

 

   

 

 

 

Net expenses

     6,501,519       3,888,982  
  

 

 

   

 

 

 

Net investment income before taxes

     4,358,241       3,552,269  
  

 

 

   

 

 

 

Net investment income

     4,358,241       3,552,269  
  

 

 

   

 

 

 

Net realized and change in unrealized gains (losses) on investment transactions:

 

Net realized gain (loss) from investments

     59,470       (13,369

Net change in unrealized appreciation (depreciation) on investments

     1,753,609       (19,036,228
  

 

 

   

 

 

 

Net realized and change in unrealized gains (losses) on investment transactions

     1,813,079       (19,049,597
  

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

   $ 6,171,320     $ (15,497,328
  

 

 

   

 

 

 

Less: Net increase (decrease) in net assets resulting from operations related to Non-Controlling Interest in ABPCIC Equity Holdings, LLC

   $ (193   $ —    
  

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations related to AB Private Credit Investors Corporation

   $ 6,171,513     $ (15,497,328
  

 

 

   

 

 

 

Net investment income per share (basic and diluted):

 

Net investment income per share (basic and diluted):

   $ 0.16     $ 0.24  

Earnings per share (basic and diluted):

   $ 0.23     $ (1.06

Weighted average shares outstanding:

     26,432,156       14,683,464  

See Notes to Unaudited Consolidated Financial Statements

 

4


Table of Contents

AB Private Credit Investors Corporation

Unaudited Consolidated Statements of Changes in Net Assets

 

     Common Stock                          
     Shares     Par
Amount
    Paid in
Capital in
Excess of Par
    Distributable
Earnings
    Non-Controlling
Interest –
ABPCIC
Equity
Holdings,
LLC
    Total
Net Assets
 

Net assets at December 31, 2020

     23,775,222     $ 237,752     $ 227,482,784     $ (5,360,904   $ 641     $ 222,360,273  

Increase (decrease) in net assets resulting from operations:

 

Net investment income

     —         —         —         4,358,498       (257     4,358,241  

Net realized gain (loss) on investments

     —         —         —         59,470       —         59,470  

Net change in unrealized appreciation (depreciation) on investments

     —         —         —         1,753,545       64       1,753,609  

Capital transactions:

 

Issuance of common stock

     4,001,981       40,020       37,668,979       —         —         37,708,999  

Contribution of non-controlling interest into ABPCIC Equity Holdings, LLC

     —         —         —         —         2,625       2,625  

Issuance of common shares pursuant to distribution reinvestment plan

     229,904       2,299       2,165,269       —         —         2,167,568  

Repurchase of common stock

     (1,173,288     (11,733     (11,050,148     —         —         (11,061,881

Distributions to stockholders

     —         —         —         (4,358,022     —         (4,358,022
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) for the three months ended March 31, 2021

     3,058,597       30,586       28,784,100       1,813,491       2,432       30,630,609  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net assets at March 31, 2021

     26,833,819     $ 268,338     $ 256,266,884     $ (3,547,413   $ 3,073     $ 252,990,882  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions declared per share

     —       $ —       $ —       $ 0.16     $ —       $ 0.16  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

See Notes to Unaudited Consolidated Financial Statements

 

5


Table of Contents

AB Private Credit Investors Corporation

Unaudited Consolidated Statements of Changes in Net Assets

 

     Common Stock                             
     Shares      Par
Amount
     Paid in
Capital in
Excess of Par
     Distributable
Earnings
    Non-Controlling
Interest –
ABPCIC
Equity
Holdings,
LLC
     Total
Net Assets
 

Net assets at December 31, 2019

     14,627,401      $ 146,274      $ 146,096,298      $ (1,680,177   $      $ 144,562,395  

Increase (decrease) in net assets resulting from operations:

 

Net investment income

     —          —          —          3,552,269       —          3,552,269  

Net realized gain (loss) on investments

     —          —          —          (13,369     —          (13,369

Net change in unrealized appreciation (depreciation) on investments

     —          —          —          (19,036,228     —          (19,036,228

Capital transactions:

 

Issuance of common stock

     4,876,625        48,766        41,796,086        —         —          41,844,852  

Issuance of common shares pursuant to distribution reinvestment plan

     225,117        2,251        1,929,415        —         —          1,931,666  

Repurchase of common stock

     —          —          —          —         —          —    

Distributions to stockholders

     —          —          —          (3,551,533     —          (3,551,533
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Total increase (decrease) for the three months ended March 31, 2020

     5,101,742        51,017        43,725,501        (19,048,861     —          24,727,657  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Net assets at March 31, 2020

     19,729,143      $ 197,291      $ 189,821,799      $ (20,729,038   $ —        $ 169,290,052  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Distributions declared per share

     —        $ —        $ —        $ 0.24     $ —        $ 0.24  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

See Notes to Unaudited Consolidated Financial Statements

 

6


Table of Contents

AB Private Credit Investors Corporation

Unaudited Consolidated Statements of Cash Flows

 

     Three Months
Ended

March 31, 2021
    Three Months
Ended

March 31, 2020
 

Cash flows from operating activities

 

Net increase (decrease) in net assets resulting from operations

   $ 6,171,320     $ (15,497,328

Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used for) operating activities:

 

Purchases of investments

     (70,237,468     (57,511,820

Payment-in-kind investments

     (375,483     (206,351

Proceeds from sales of investments and principal repayments

     23,559,275       13,458,168  

Net realized (gain) loss on investments

     (59,470     13,369  

Net change in unrealized (appreciation) depreciation on investments

     (1,753,609     19,036,228  

Amortization of premium and accretion of discount, net

     (788,271     (452,560

Amortization of discount, debt issuance and deferred financing costs

     492,785       396,314  

Increase (decrease) in operating assets and liabilities:

 

(Increase) decrease in receivable for investments sold

     55,058       212,441  

(Increase) decrease in interest receivable

     (78,128     240,380  

(Increase) decrease in other assets

     671       —    

(Increase) decrease in prepaid expenses

     146,334       67,598  

Increase (decrease) in Due to affiliate

     (469,453     —    

Increase (decrease) in management fees payable

     1,886,180       93,430  

Increase (decrease) in payable to Adviser

     581,827       121,330  

Increase (decrease) in administrator and custodian fees payable

     163,050       (127,657

Increase (decrease) in professional fees payable

     180,291       266,172  

Increase (decrease) in incentive fees payable

     641,062       282,239  

Increase (decrease) in directors’ fees payable

     —         50,000  

Increase (decrease) in transfer agent fees payable

     16,386       10,758  

Increase (decrease) in interest and borrowing expenses payable

     77,031       (1,647,346

Increase (decrease) in accrued organization and offering costs

     (106,510     —    

Increase (decrease) in accrued expenses and other liabilities

     8,090       98,774  
  

 

 

   

 

 

 

Net cash provided by (used for) operating activities

     (39,889,032     (41,095,861
  

 

 

   

 

 

 

Cash flows from financing activities

 

Issuance of common stock

     70,854,128       19,880,528  

Contribution of Non-Controlling Interest into ABPCIC Equity Holdings, LLC

     2,625       —    

Distributions paid

     (1,541,994     (964,833

Financing costs paid

     (875,010     —    

Borrowings on credit facility

     98,800,000       56,000,000  

Repayments of credit facility

     (80,000,000     (32,500,000

Repayments on secured borrowings

     (18,870,856     —    
  

 

 

   

 

 

 

Net cash provided by (used for) financing activities

     68,368,893       42,415,695  
  

 

 

   

 

 

 

Net increase (decrease) in cash

     28,479,861       1,319,834  

Cash and cash equivalents, beginning of period

     22,410,622       14,931,791  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $     50,890,483     $     16,251,625  
  

 

 

   

 

 

 

Supplemental and non-cash financing activities

 

Cash paid during the period for interest

   $ 1,951,874     $ 3,787,866  

Issuance of common shares pursuant to distribution reinvestment plan

   $ 2,167,568     $ 1,931,666  

See Notes to Unaudited Consolidated Financial Statements

 

7


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of March 31, 2021

(Unaudited)

 

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair
Value
 
Investments at Fair Value —230.32% + * # ^  
U.S. Corporate Debt —221.04%  
1st Lien/Senior Secured Debt —216.53%  

AmerCareRoyal, LLC(1) (2)

  Business Services   Delayed Draw Term Loan   6.00% (L + 5.00%; 1.00% Floor)     11/25/2025     $ —       $ (5,932   $ —    

AmerCareRoyal, LLC

  Business Services   Incremental Term Loan   6.00% (L + 5.00%; 1.00% Floor)     11/25/2025       542,188       536,954       542,188  

AmerCareRoyal, LLC(3)

  Business Services   Term Loan   6.00% (L + 5.00%; 1.00% Floor)     11/25/2025       4,520,669       4,484,110       4,520,669  

BEP Borrower Holdco,
LLC(1) (2)

  Business Services   Delayed Draw Term Loan
A
  5.25% (L + 4.25%; 1.00% Floor)     06/12/2024       —         (8,290     (12,883

BEP Borrower Holdco,
LLC(1) (2)

  Business Services   Revolver   5.25% (L + 4.25%; 1.00% Floor)     06/12/2024       —         (4,159     (6,441

BEP Borrower Holdco,
LLC(3)

  Business Services   Term Loan A   5.25% (L + 4.25%; 1.00% Floor)     06/12/2024       3,435,477       3,400,525       3,383,945  

Engage2Excel, Inc.(1) (3)

  Business Services   Revolver   9.00% (L + 6.00%; 2.00% PIK; 1.00% Floor)     03/07/2023       260,459       257,325       245,266  

Engage2Excel, Inc.(3)

  Business Services   Term Loan   9.00% (L + 6.00%; 2.00% PIK; 1.00% Floor)     03/07/2023       1,033,197       1,022,185       991,869  

Engage2Excel, Inc.(3)

  Business Services   Term Loan   9.00% (L + 6.00%; 2.00% PIK; 1.00% Floor)     03/07/2023       2,977,672       2,950,751       2,858,565  

Foundation Risk Partners, Corp.(1) (2)

  Business Services   First Lien Delayed Draw
Term Loan
  5.75% (L + 4.75%; 1.00% Floor)     11/10/2023       —         (26,765     (29,328

Foundation Risk Partners, Corp.(4)

  Business Services   First Lien Term Loan   5.75% (L + 4.75%; 1.00% Floor)     11/10/2023       1,950,284       1,912,629       1,911,279  

Global Radar Holdings,
LLC(1) (2)

  Business Services   Revolver   8.00% (L + 7.00%; 1.00% Floor)     12/31/2025       —         (11,071     (11,638

Global Radar Holdings, LLC(4) (5)

  Business Services   Term Loan   8.00% (L + 7.00%; 1.00% Floor)     12/31/2025       6,384,859       6,262,365       6,257,162  

Higginbotham Insurance Agency, Inc.(1) (2)

  Business Services   Delayed Draw Term Loan   6.50% (L + 5.75%; 0.75% Floor)     11/25/2026       —         (11,824     (12,534

Higginbotham Insurance Agency, Inc.(4) (5)

  Business Services   Term Loan   6.50% (L + 5.75%; 0.75% Floor)     11/25/2026       5,937,344       5,851,406       5,848,284  

Metametrics, Inc.(1) (2)

  Business Services   Revolver   6.00% (L + 5.00%; 1.00% Floor)     09/10/2025       —         (9,700     (6,512

Metametrics, Inc.(3) (5)

  Business Services   Term Loan   6.00% (L + 5.00%; 1.00% Floor)     09/10/2025       5,425,654       5,340,543       5,371,397  

MSM Acquisitions, Inc.(1)

  Business Services   Delayed Draw Term Loan   7.00% (L + 6.00%, 1.00% Floor)     12/09/2026       1,545,808       1,508,318       1,507,298  

MSM Acquisitions, Inc.(1) (2)

  Business Services   Revolver   7.00% (L + 6.00%, 1.00% Floor)     12/09/2026       —         (23,262     (24,501

MSM Acquisitions, Inc.(3) (4)

  Business Services   Term Loan   7.00% (L + 6.00%, 1.00% Floor)     12/09/2026       7,331,895       7,191,419       7,185,258  

Rep Tec Intermediate Holdings, Inc.(5)

  Business Services   Delayed Draw Term Loan   7.50% (L + 6.50%; 1.00% Floor)     06/19/2025       294,741       289,743       294,741  

Rep Tec Intermediate Holdings, Inc.(1) (2)

  Business Services   Revolver   7.50% (L + 6.50%; 1.00% Floor)     06/19/2025       —         (7,498     —    

Rep Tec Intermediate Holdings, Inc.(3) (4)

  Business Services   Term Loan   7.50% (L + 6.50%; 1.00% Floor)     06/19/2025       5,071,636       4,991,008       5,071,636  

Valcourt Holdings II,
LLC(1) (2)

  Business Services   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)     01/07/2027       —         (33,215     (34,501

Valcourt Holdings II, LLC

  Business Services   Incremental Term Loan   6.50% (L + 5.50%; 1.00% Floor)     01/07/2027       2,688,362       2,635,013       2,634,594  

Valcourt Holdings II,
LLC(3) (5)

  Business Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)     01/07/2027       6,391,221       6,264,420       6,263,397  

AEG Holding Company,
Inc.(3)

  Consumer Discretionary   Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)     11/20/2023       1,064,666       1,054,682       1,043,372  

AEG Holding Company,
Inc.(4)

  Consumer Discretionary   First Amendment Term
Loan
  6.50% (L + 5.50%; 1.00% Floor)     11/20/2023       1,852,684       1,829,492       1,815,631  

AEG Holding Company,
Inc.(1) (2)

  Consumer Discretionary   Revolver   6.50% (L + 5.50%; 1.00% Floor)     11/20/2023       —         (11,619     (22,337

AEG Holding Company,
Inc.(3)

  Consumer Discretionary   Term Loan   6.50% (L + 5.50%; 1.00% Floor)     11/20/2023       6,028,365       5,969,721       5,907,797  

Blink Holdings, Inc.(3)

  Consumer Non-Cyclical   Delayed Draw Term Loan   4.50% (L + 3.50%; 1.00% Floor)     11/08/2024       1,178,697       1,169,989       1,090,295  

Blink Holdings, Inc.

  Consumer Non-Cyclical   Fifth Amendment
Delayed Draw Term Loan
  4.50% (L + 3.50%; 1.00% Floor)     11/08/2024       945,093       940,579       874,211  

Blink Holdings, Inc.(3)

  Consumer Non-Cyclical   Term Loan   4.50% (L + 3.50%; 1.00% Floor)     11/08/2024       1,647,736       1,635,558       1,524,155  

Captain D’s, Inc.(1) (2)

  Consumer Non-Cyclical   Revolver   5.50% (L + 4.50%; 1.00% Floor)     12/15/2023       —         (968     (1,950

Captain D’s, Inc.(3)

  Consumer Non-Cyclical   Term Loan   5.50% (L + 4.50%; 1.00% Floor)     12/15/2023       1,929,660       1,919,994       1,910,364  

Freddy’s Frozen Custard, L.L.C(1)

  Consumer Non-Cyclical   Revolver   7.00% (L + 6.00%; 1.00% Floor)     03/03/2027       82,454       77,366       77,301  

Freddy’s Frozen Custard, L.L.C(4) (5)

  Consumer Non-Cyclical   Term Loan   7.00% (L + 6.00%; 1.00% Floor)     03/03/2027       5,153,306       5,089,404       5,088,890  

GPS Hospitality Holding Company LLC(3)

  Consumer Non-Cyclical   Term Loan B   4.45% (L + 4.25%)     12/08/2025       2,319,940       2,295,014       2,285,141  

PF Growth Partners, LLC(1)

  Consumer Non-Cyclical   Delayed Draw Term Loan   8.00% (L + 7.00%, 1.00% Floor)     07/11/2025       119,241       116,629       112,051  

PF Growth Partners, LLC(3)

  Consumer Non-Cyclical   Term Loan   8.00% (L + 7.00%, 1.00% Floor)     07/11/2025       2,006,681       1,991,509       1,966,547  

5 Bars, LLC(1) (2)

  Digital Infrastructure &
Services
  Delayed Draw Term Loan   6.00% (L + 4.00%; 2.00% Floor)     09/27/2024       —         (36,288     —    

5 Bars, LLC(1) (2)

  Digital Infrastructure &
Services
  Revolver   6.00% (L + 4.00%; 2.00% Floor)     09/27/2024       —         (6,804     —    

 

8


Table of Contents

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair Value  

5 Bars, LLC(4)

  Digital Infrastructure &
Services
  Term Loan   6.00% (L + 4.00%; 2.00% Floor)     09/27/2024     $ 4,742,121     $ 4,690,592     $ 4,742,121  

EvolveIP, LLC(1)

  Digital Infrastructure &
Services
  Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)     06/07/2023       113,090       106,013       111,201  

EvolveIP, LLC(1) (2)

  Digital Infrastructure &
Services
  Revolver   6.75% (L + 5.75%; 1.00% Floor)     06/07/2023       —         (5,293     (1,417

EvolveIP, LLC(3)

  Digital Infrastructure &
Services
  Term Loan A   6.75% (L + 5.75%; 1.00% Floor)     06/07/2023       6,550,691       6,486,773       6,534,315  

Fatbeam, LLC(1) (2)

  Digital Infrastructure &
Services
  Delayed Draw Term Loan
1
  6.75% (L + 5.75%; 1.00% Floor)     02/22/2026       —         (35,481     (36,216

Fatbeam, LLC(1) (2)

  Digital Infrastructure &
Services
  Delayed Draw Term Loan
2
  6.75% (L + 5.75%; 1.00% Floor)     02/22/2026       —         (35,481     (36,216

Fatbeam, LLC(1) (2)

  Digital Infrastructure &
Services
  Revolver   6.75% (L + 5.75%; 1.00% Floor)     02/22/2026       —         (14,192     (14,487

Fatbeam, LLC(4) (5)

  Digital Infrastructure &
Services
  Term Loan   6.75% (L + 5.75%; 1.00% Floor)     02/22/2026       6,438,490       6,295,475       6,293,624  

Fuze, Inc.(1) (4)

  Digital Infrastructure &
Services
  Delayed Draw Term Loan   8.50% (L + 6.50%; 2.00% Floor)     09/20/2024       777,531       311,594       766,905  

Fuze, Inc.(1) (2)

  Digital Infrastructure &
Services
  Revolver   8.50% (L + 6.50%; 2.00% Floor)     09/20/2024       —         (4,514     (18,531

Fuze, Inc.(3) (4)

  Digital Infrastructure &
Services
  Term Loan   8.50% (L + 6.50%; 2.00% Floor)     09/20/2024       11,015,029       10,976,516       10,857,514  

Single Digits, Inc.(5)

  Digital Infrastructure &
Services
  Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/21/2023       606,056       602,483       557,572  

Single Digits, Inc.(1) (2)

  Digital Infrastructure &
Services
  Revolver   7.00% (L + 6.00%; 1.00% Floor)     12/21/2023       —         (2,283     (33,292

Single Digits, Inc.(3)

  Digital Infrastructure &
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/21/2023       3,254,274       3,234,007       2,993,932  

Thrive Buyer, Inc(1) (5)

  Digital Infrastructure &
Services
  Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)     01/22/2027       300,334       257,956       256,785  

Thrive Buyer, Inc(1) (2)

  Digital Infrastructure &
Services
  Revolver   7.00% (L + 6.00%; 1.00% Floor)     01/22/2027       —         (14,557     (15,017

Thrive Buyer, Inc(4) (5)

  Digital Infrastructure &
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     01/22/2027       8,709,676       8,538,949       8,535,483  

Accelerate Resources Operating, LLC(1) (2)

  Energy   Delayed Draw Term Loan   8.50% (L + 7.50%; 1.00% Floor)     02/24/2026       —         (27,298     (49,772

Accelerate Resources Operating, LLC(1) (2)

  Energy   Revolver   8.50% (L + 7.50%; 1.00% Floor)     02/24/2026       —         (6,824     (12,443

Accelerate Resources Operating, LLC(3)

  Energy   Term Loan   8.50% (L + 7.50%; 1.00% Floor)     02/24/2026       4,687,793       4,610,863       4,547,159  

BCP Raptor II, LLC(3)

  Energy   1st Lien Term Loan   4.86% (L + 4.75%)     11/03/2025       5,640,020       5,639,270       5,294,569  

Brazos Delaware II, LLC(3)

  Energy   Term Loan B   4.11% (L + 4.00%)     05/21/2025       3,992,756       3,917,625       3,703,282  

Nine Point Energy, LLC(1)

  Energy   DIP Delayed Draw Term
Loan
  9.00% (L + 8.00%, 1.00% Floor)     06/13/2021       292,250       292,250       292,250  

Nine Point Energy, LLC(3)

  Energy   Term Loan   9.00% (L + 5.50%; 2.50% PIK; 1.00% Floor)     06/07/2024       5,655,715       5,574,508       4,773,424  

Edgewood Partners Holdings LLC(3)

  Financials   Term Loan   5.25% (L + 4.25%; 1.00% Floor)     09/06/2024       5,551,259       5,513,038       5,495,746  

Purchasing Power, LLC(3)

  Financials   Term Loan   8.25% (L + 7.25%; 1.00% Floor)     02/06/2024       2,585,412       2,556,252       2,540,167  

American Physician Partners, LLC(3) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   7.75% (L + 6.75%; 1.00% Floor)     12/21/2021       993,358       989,531       953,623  

American Physician Partners, LLC(1)

  Healthcare & HCIT   Revolver   7.75% (L + 6.75%; 1.00% Floor)     12/21/2021       346,322       344,670       328,562  

American Physician Partners, LLC(3)

  Healthcare & HCIT   Term Loan A   7.75% (L + 6.75%; 1.00% Floor)     12/21/2021       5,263,276       5,241,760       5,052,745  

American Physician Partners, LLC(5)

  Healthcare & HCIT   Term Loan C   7.75% (L + 6.75%; 1.00% Floor)     12/21/2021       1,138,888       1,134,881       1,093,333  

American Physician Partners, LLC(3) (5)

  Healthcare & HCIT   Term Loan D   7.75% (L + 6.75%; 1.00% Floor)     12/21/2021       2,113,991       2,018,913       2,029,432  

Analogic Corporation(1) (2)

  Healthcare & HCIT   Revolver   6.25% (L + 5.25%; 1.00% Floor)     06/22/2023       —         (1,825     (7,486

Analogic Corporation(3) (4)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)     06/24/2024       2,112,153       2,088,675       2,038,227  

Azurity Pharmaceuticals, Inc.(1) (2)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)     03/21/2023       —         (4,367     —    

Azurity Pharmaceuticals, Inc.(1) (2)

  Healthcare & HCIT   Revolver   6.75% (L + 5.75%; 1.00% Floor)     03/21/2023       —         (4,367     —    

Azurity Pharmaceuticals, Inc.(3) (5)

  Healthcare & HCIT   Term Loan   6.75% (L + 5.75%; 1.00% Floor)     03/21/2023       7,146,422       7,077,714       7,146,422  

BK Medical Holding Company, Inc.(1) (2)

  Healthcare & HCIT   Revolver   6.25% (L + 5.25%; 1.00% Floor)     06/22/2023       —         (2,110     (8,848

BK Medical Holding Company, Inc.(4)

  Healthcare & HCIT   Term Loan A   6.25% (L + 5.25%; 1.00% Floor)     06/22/2024       2,972,809       2,950,956       2,891,057  

Caregiver 2, Inc.(5)

  Healthcare & HCIT   Third Amendment Term
Loan
  8.00% (L + 6.50%; 1.50% Floor)     07/24/2025       658,127       645,005       658,127  

Caregiver 2, Inc.(4)

  Healthcare & HCIT   Term Loan   8.00% (L + 6.50%; 1.50% Floor)     07/24/2025       4,807,610       4,721,766       4,807,610  

Caregiver 2, Inc.(4)

  Healthcare & HCIT   Term Loan   8.00% (L + 6.50%; 1.50% Floor)     07/24/2025       690,047       677,726       690,047  

 

9


Table of Contents

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair Value  

Coding Solutions Acquisition, Inc(1) (2)

  Healthcare & HCIT   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/31/2026     $ —       $ (23,448   $ (24,440

Coding Solutions Acquisition, Inc(1)

  Healthcare & HCIT   Revolver   7.00% (L + 6.00%; 1.00% Floor)     12/31/2025       19,397       17,182       17,069  

Coding Solutions Acquisition, Inc(4) (5)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/31/2026       7,894,007       7,740,552       7,736,127  

Delaware Valley Management Holdings, Inc.(1) (2)

  Healthcare & HCIT   Delayed Draw Term Loan   7.25% (L + 4.00%; 2.25% PIK; 1.00% Floor)     03/21/2024       —         (28,153     (150,161

Delaware Valley Management Holdings, Inc.

  Healthcare & HCIT   Revolver   7.25% (L + 4.00%; 2.25% PIK; 1.00% Floor)     03/21/2024       532,453       525,929       456,579  

Delaware Valley Management Holdings, Inc.

  Healthcare & HCIT   Term Loan   7.25% (L + 4.00%; 2.25% PIK; 1.00% Floor)     03/21/2024       3,475,353       3,431,607       2,980,115  

Ethos Veterinary Health LLC(1) (3)

  Healthcare & HCIT   Delayed Draw Term Loan   4.86% (L + 4.75%)     05/15/2026       1,067,934       1,052,328       1,067,934  

Ethos Veterinary Health LLC(3)

  Healthcare & HCIT   Term Loan   4.86% (L + 4.75%)     05/15/2026       2,285,855       2,267,909       2,285,855  

FH MD Buyer, Inc(3) (4)

  Healthcare & HCIT   Term Loan   6.75% (L + 5.75%; 1.00% Floor)     10/31/2026       5,411,071       5,292,727       5,356,961  

GHA Buyer, Inc.(3)

  Healthcare & HCIT   3rd Amendment Term
Loan
  8.00% (L + 6.00%; 2.00% Floor)     06/24/2025       563,779       554,537       563,779  

GHA Buyer, Inc.(3) (4)

  Healthcare & HCIT   4th Amendment Term
Loan
  8.00% (L + 6.00%; 2.00% Floor)     06/24/2025       5,394,557       5,301,354       5,394,557  

GHA Buyer, Inc.(1) (5)

  Healthcare & HCIT   Fifth Amendment
Delayed Draw Term loan
  8.00% (L + 6.00%; 2.00% Floor)     06/24/2025       817,339       801,407       817,339  

GHA Buyer, Inc.(4)

  Healthcare & HCIT   Fifth Amendment Term
Loan
  8.00% (L + 6.00%; 2.00% Floor)     06/24/2025       4,670,508       4,582,248       4,670,508  

GHA Buyer, Inc.(1) (2)

  Healthcare & HCIT   Revolver   8.00% (L + 6.00%; 2.00% Floor)     06/24/2025       —         (15,120     —    

GHA Buyer, Inc.(3)

  Healthcare & HCIT   Term Loan   8.00% (L + 6.00%; 2.00% Floor)     06/24/2025       1,972,817       1,950,906       1,972,817  

INH Buyer, Inc.(1) (2)

  Healthcare & HCIT   Revolver   7.00% (L + 6.00%, 1.00% Floor)     01/31/2024       —         (1,815     (3,088

INH Buyer, Inc.(3)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%, 1.00% Floor)     01/31/2025       8,571,697       8,481,168       8,443,122  

Kindeva Drug Delivery L.P.(1)

  Healthcare & HCIT   Revolver   7.00% (L + 6.00%; 1.00% Floor)     05/01/2025       433,597       403,956       397,464  

Kindeva Drug Delivery L.P.(3) (4)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)     05/01/2026       15,779,302       15,434,604       15,384,819  

Medbridge Holdings, LLC(3) (5)

  Healthcare & HCIT   Initial Term Loan   8.00% (L + 7.00%, 1.00% Floor)     12/23/2026       15,367,872       15,072,562       15,060,514  

Medbridge Holdings, LLC(1) (2)

  Healthcare & HCIT   Revolver   8.00% (L + 7.00%, 1.00% Floor)     12/23/2026       —         (26,306     (27,525

OMH-HealthEdge Holdings, LLC

  Healthcare & HCIT   1st Amendment
Incremental Term Loan
  6.25% (L + 5.25%; 1.00% Floor)     10/24/2025       2,159,743       2,111,615       2,138,146  

OMH-HealthEdge Holdings, LLC(1) (2)

  Healthcare & HCIT   Revolver   6.25% (L + 5.25%; 1.00% Floor)     10/24/2024       —         (7,405     (4,587

OMH-HealthEdge Holdings, LLC(3)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)     10/24/2025       3,727,679       3,660,623       3,690,402  

Pace Health Companies, LLC(1) (2)

  Healthcare & HCIT   Revolver   5.50% (L + 4.50%; 1.00% Floor)     08/02/2024       —         (4,256     (6,167

Pace Health Companies, LLC(3)

  Healthcare & HCIT   Term Loan   5.50% (L + 4.50%; 1.00% Floor)     08/02/2024       5,312,561       5,274,544       5,259,435  

Pinnacle Dermatology Management, LLC(1) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   5.25% (L + 4.25%; 1.00% Floor)     05/18/2023       2,280,367       2,243,059       2,199,409  

Pinnacle Dermatology Management, LLC(1) (2)

  Healthcare & HCIT   Revolver   5.25% (L + 4.25%; 1.00% Floor)     05/18/2023       —         (2,785     (6,455

Pinnacle Dermatology Management, LLC(3)

  Healthcare & HCIT   Term Loan   5.25% (L + 4.25%; 1.00% Floor)     05/18/2023       5,367,287       5,304,004       5,259,941  

Pinnacle Treatment Centers, Inc.(5)

  Healthcare & HCIT   Delayed Draw Term Loan
2
  6.75% (L + 5.75%; 1.00% Floor)     12/31/2022       349,787       347,335       349,787  

Pinnacle Treatment Centers, Inc.(1) (2)

  Healthcare & HCIT   Seventh Amendment
Delayed Draw Term Loan
  6.75% (L + 5.75%; 1.00% Floor)     12/31/2022       —         (2,135     —    

Pinnacle Treatment Centers, Inc.(1) (2)

  Healthcare & HCIT   Seventh Amendment
Revolver
  6.75% (L + 5.75%; 1.00% Floor)     12/31/2022       —         (2,244     —    

Pinnacle Treatment Centers, Inc.(4) (5)

  Healthcare & HCIT   Seventh Amendment
Term Loan
  6.75% (L + 5.75%; 1.00% Floor)     12/31/2022       4,128,092       4,102,827       4,128,092  

Platinum Dermatology Partners, LLC(6)

  Healthcare & HCIT   General Delayed Draw
Term Loan
  10.25% (L + 3.00%; 6.25% PIK; 1.00% Floor)     01/03/2023       1,499,536       1,475,854       1,197,229  

Platinum Dermatology Partners, LLC(7)

  Healthcare & HCIT   Revolver   11.50% (P + 2.00%; 6.25% PIK; 1.00% Floor)     01/03/2023       525,149       515,735       419,279  

Platinum Dermatology Partners, LLC

  Healthcare & HCIT   Specified Delayed Draw
Term Loan
  11.50% (P + 2.00%; 6.25% PIK; 1.00% Floor)     01/03/2023       2,064,214       2,030,958       1,648,069  

Platinum Dermatology Partners, LLC

  Healthcare & HCIT   Term Loan   10.25% (L + 3.00%; 6.25% PIK; 1.00% Floor)     01/03/2023       3,281,991       3,219,373       2,620,342  

RCP Encore Acquisition, Inc.(3)

  Healthcare & HCIT   Term Loan   6.00% (L + 5.00%; 1.00% Floor)     06/09/2025       3,468,095       3,442,458       3,320,701  

Salisbury House, LLC(1) (2)

  Healthcare & HCIT   Revolver   6.00% (L + 5.00%; 1.00% Floor)     08/30/2025       —         (10,030     (11,209

Salisbury House, LLC(3) (4)

  Healthcare & HCIT   Term Loan A1   6.50% (L + 5.50%; 1.00% Floor)     08/30/2025       3,934,410       3,839,706       3,836,049  

SCA Buyer, LLC(5)

  Healthcare & HCIT   Term Loan   7.50% (L + 6.50%; 1.00% Floor)     01/20/2026       3,863,094       3,805,406       3,805,148  

SCA Buyer, LLC(1)

  Healthcare & HCIT   Revolver   7.50% (L + 6.50%; 1.00% Floor)     01/20/2026       128,770       119,470       119,112  

SIS Purchaser, Inc.(1) (2)

  Healthcare & HCIT   Revolver   7.00% (L + 6.00%; 1.00% Floor)     10/15/2026       —         (18,869     (20,404

SIS Purchaser, Inc.(3) (4) (5)

  Healthcare & HCIT   Term Loan   7.00% (L + 6.00%; 1.00% Floor)     10/15/2026       12,793,392       12,582,878       12,569,508  

Smile Brands, Inc.(4)

  Healthcare & HCIT   Delayed Draw Term Loan   5.39% (L + 5.17%; 0.21% Floor)     10/12/2024       491,690       488,725       483,085  

Smile Brands, Inc.(1) (2)

  Healthcare & HCIT   Revolver   6.17% (L + 5.17%; 1.00% Floor)     09/30/2024       —         (1,314     (4,459

Smile Brands, Inc.(3)

  Healthcare & HCIT   Term Loan   5.39% (L + 5.17%; 0.21% Floor)     10/12/2024       1,618,985       1,608,892       1,590,652  

 

10


Table of Contents

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair
Value
 

The Center for Orthopedic and Research Excellence,
Inc.(1) (5)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (L + 5.75%, 1.00% Floor)     08/15/2025     $ 576,594     $ 561,024     $ 556,416  

The Center for Orthopedic and Research Excellence,
Inc.(1) (2)

  Healthcare & HCIT   Revolver   6.75% (L + 5.75%, 1.00% Floor)     08/15/2025       —         (8,988     (12,084

The Center for Orthopedic and Research Excellence,
Inc.(3) (4)

  Healthcare & HCIT   Term Loan   6.75% (L + 5.75%, 1.00% Floor)     08/15/2025       4,931,262       4,864,888       4,844,965  

Theranest, LLC(3) (4)

  Healthcare & HCIT   Delayed Draw Term Loan   6.00% (L + 5.00%; 1.00% Floor)     07/24/2023       2,736,748       2,707,861       2,736,748  

Theranest, LLC(1) (2)

  Healthcare & HCIT   Revolver   6.00% (L + 5.00%; 1.00% Floor)     07/24/2023       —         (4,013     —    

Theranest, LLC(3)

  Healthcare & HCIT   Term Loan   6.00% (L + 5.00%; 1.00% Floor)     07/24/2023       2,962,500       2,932,714       2,962,500  

Women’s Health USA,
Inc.(3) (4)

  Healthcare & HCIT   Desert Term Loan   8.75% (L + 7.75%; 1.00% Floor)     10/09/2023       4,106,492       4,051,968       4,047,358  

Women’s Health USA, Inc.(1)

  Healthcare & HCIT   Revolver   8.75% (L + 7.75%; 1.00% Floor)     10/09/2023       122,908       120,947       120,713  

ZBS Alliance Animal Health, LLC(3) (4)

  Healthcare & HCIT   Delayed Draw Term Loan   6.75% (L + 5.75%, 1.00% Floor)     11/08/2025       3,056,995       3,009,756       2,995,855  

ZBS Alliance Animal Health, LLC(1)

  Healthcare & HCIT   First Amendment
Delayed Draw Term Loan
  6.75% (L + 5.75%, 1.00% Floor)     11/08/2025       860,483       846,321       815,407  

ZBS Alliance Animal Health, LLC(1) (2)

  Healthcare & HCIT   Revolver   6.75% (L + 5.75%, 1.00% Floor)     11/08/2025       —         (10,776     (13,607

ZBS Alliance Animal Health, LLC(3)

  Healthcare & HCIT   Term Loan   6.75% (L + 5.75%, 1.00% Floor)     11/08/2025       2,687,343       2,644,393       2,633,596  

Alphasense, Inc.(1) (2) (8)

  Software & Tech
Services
  Delayed Draw Term Loan   8.00% (L + 7.00%; 1.00% Floor)     05/29/2024       —         (17,828     —    

Alphasense, Inc.(1) (2) (8)

  Software & Tech
Services
  Revolver   8.00% (L + 7.00%; 1.00% Floor)     05/29/2024       —         (9,952     —    

Alphasense, Inc.(4) (8)

  Software & Tech
Services
  Term Loan   8.00% (L + 7.00%; 1.00% Floor)     05/29/2024       7,269,628       7,186,713       7,269,628  

AMI US Holdings, Inc.(1)

  Software & Tech
Services
  Revolver   5.61% (L + 5.50%)     04/01/2024       788,116       774,423       771,696  

AMI US Holdings, Inc.(3)

  Software & Tech
Services
  Term Loan   6.50% (L + 5.50%; 1.00% Floor)     04/01/2025       8,152,617       8,035,998       8,030,328  

Arrowstream Acquisition Co., Inc.(1) (2)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     12/15/2025       —         (7,281     (7,726

Arrowstream Acquisition Co., Inc.(4)

  Software & Tech
Services
  Term Loan   7.50% (L + 6.50%; 1.00% Floor)     12/15/2025       3,863,094       3,790,334       3,785,832  

Avetta, LLC(1) (2)

  Software & Tech
Services
  Revolver   6.25% (L + 5.25%; 1.00% Floor)     04/10/2024       —         (5,046     (9,888

Avetta, LLC(3) (4)

  Software & Tech
Services
  Term Loan   6.25% (L + 5.25%; 1.00% Floor)     04/10/2024       3,245,403       3,186,642       3,180,495  

Avetta, LLC(3)

  Software & Tech
Services
  Term Loan B   6.25% (L + 5.25%; 1.00% Floor)     04/10/2024       4,272,320       4,215,731       4,186,874  

Businesssolver.com, Inc.(3)

  Software & Tech
Services
  Delayed Draw Term Loan   8.50% (L + 7.50%; 1.00% Floor)     05/15/2023       388,235       386,124       388,235  

Businesssolver.com, Inc.(4)

  Software & Tech
Services
  First Amendment Term
Loan
  8.50% (L + 7.50%; 1.00% Floor)     05/15/2023       1,390,037       1,371,333       1,390,037  

Businesssolver.com, Inc.(1) (2)

  Software & Tech
Services
  Revolver   8.50% (L + 7.50%; 1.00% Floor)     05/15/2023       —         (2,863     —    

Businesssolver.com,
Inc.(3) (4) (5)

  Software & Tech
Services
  Term Loan   8.50% (L + 7.50%; 1.00% Floor)     05/15/2023       9,703,535       9,617,947       9,703,535  

Datacor Holdings, Inc.(1) (2)

  Software & Tech
Services
  First Lien Delayed Draw
Term Loan
  6.25% (L + 5.25%; 1.00% Floor)     12/26/2025       —         (24,814     (25,754

Datacor Holdings, Inc.(1) (2)

  Software & Tech
Services
  Revolver   6.25% (L + 5.25%; 1.00% Floor)     12/26/2025       —         (12,215     (12,877

Datacor Holdings, Inc.(3) (4)

  Software & Tech
Services
  Term Loan   6.25% (L + 5.25%; 1.00% Floor)     12/26/2025       6,180,951       6,045,939       6,041,879  

Degreed, Inc.

  Software & Tech
Services
  3rd Amendment Term
Loan
  6.50% (L + 5.50%; 1.00% Floor)     05/31/2025       2,782,788       2,755,103       2,754,960  

Degreed, Inc.(1) (2)

  Software & Tech
Services
  Delayed Draw Term Loan   6.50% (L + 5.50%; 1.00% Floor)     05/31/2025       —         (6,921     (6,957

Degreed, Inc.(4)

  Software & Tech
Services
  Revolver   6.50% (L + 5.50%; 1.00% Floor)     05/31/2025       417,813       415,146       413,635  

Degreed, Inc.(3) (4)

  Software & Tech
Services
  Term Loan   6.50% (L + 5.50%; 1.00% Floor)     05/31/2025       5,153,024       5,137,680       5,101,494  

Dispatch Track, LLC(1) (2)

  Software & Tech
Services
  Revolver   5.50% (L + 4.50%; 1.00% Floor)     12/17/2024       —         (3,390     (3,019

Dispatch Track, LLC(3)

  Software & Tech
Services
  Term Loan   5.50% (L + 4.50%; 1.00% Floor)     12/17/2024       6,038,593       5,970,800       5,978,207  

Drilling Info Holdings, Inc.(3)

  Software & Tech
Services
  Term Loan   4.36% (L + 4.25%)     07/30/2025       3,352,272       3,342,068       3,301,988  

Dude Solutions Holdings,
Inc.(4)

  Software & Tech
Services
  2nd Amendment
Incremental Term Loan
  8.50% (L + 7.50%; 1.00% Floor)     06/13/2025       3,878,023       3,794,464       3,790,768  

EnterpriseDB Corporation(1) (2)

  Software & Tech
Services
  Revolver   8.25% (L + 6.00%; 0.50% PIK; 1.75% Floor)     06/21/2024       —         (9,046     (3,482

EnterpriseDB Corporation(3) (4) (5)

  Software & Tech
Services
  Term Loan   8.25% (L + 6.00%; 0.50% PIK; 1.75% Floor)     06/21/2024       7,894,336       7,787,539       7,854,864  

EnterpriseDB Corporation(3) (4)

  Software & Tech
Services
  Third Amendment Term
Loan
  8.25% (L + 6.00%; 0.50% PIK; 1.75% Floor)     06/21/2024       4,523,533       4,439,168       4,500,916  

Exterro, Inc.(3) (5)

  Software & Tech
Services
  1st Amendment Term
Loan
  6.50% (L + 5.50%; 1.00% Floor)     05/31/2024       5,809,123       5,717,873       5,780,077  

Exterro, Inc.(4) (5)

  Software & Tech
Services
  2nd Amendment Term
Loan
  6.50% (L + 5.50%; 1.00% Floor)     05/31/2024       6,567,902       6,447,685       6,535,062  

Exterro, Inc.(1) (2)

  Software & Tech
Services
  Revolver   6.50% (L + 5.50%; 1.00% Floor)     05/31/2024       —         (2,658     (1,237

Exterro, Inc.(3)

  Software & Tech
Services
  Term Loan   6.50% (L + 5.50%; 1.00% Floor)     05/31/2024       2,793,450       2,763,276       2,779,483  

Faithlife, LLC(1) (3) (5)

  Software & Tech
Services
  Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)     09/18/2025       1,705,713       1,651,413       1,705,713  

Faithlife, LLC(1) (2)

  Software & Tech
Services
  Revolver   7.00% (L + 6.00%; 1.00% Floor)     09/18/2025       —         (4,992     —    

Faithlife, LLC(3) (5)

  Software & Tech
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     09/18/2025       732,515       719,392       732,515  

Finalsite Holdings, Inc.(1) (2)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     09/25/2024       —         (2,595     (4,430

Finalsite Holdings, Inc.(3)

  Software & Tech
Services
  Term Loan   7.50% (L + 6.50%; 1.00% Floor)     09/25/2024       4,001,842       3,953,314       3,931,809  

Genesis Acquisition Co.(5)

  Software & Tech
Services
  Delayed Draw Term Loan   4.20% (L + 4.00%)     07/31/2024       40,091       39,865       36,784  

 

11


Table of Contents

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair
Value
 

Genesis Acquisition Co.(4)

  Software & Tech
Services
  Revolver   4.20% (L + 4.00%)     07/31/2024     $ 202,400     $ 200,096     $ 185,702  

Genesis Acquisition Co.(3)

  Software & Tech
Services
  Term Loan   4.20% (L + 4.00%)     07/31/2024       1,345,495       1,329,398       1,234,492  

Greenhouse Software, Inc.(1) (2)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     03/01/2027       —         (27,351     (27,726

Greenhouse Software, Inc.(4) (5)

  Software & Tech
Services
  Term Loan   7.50% (L + 6.50%; 1.00% Floor)     03/01/2027       12,376,845       12,100,398       12,098,366  

GS AcquisitionCo, Inc.(4)

  Software & Tech
Services
  Delayed Draw Term
Loan 4
  6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       1,426,452       1,426,452       1,405,055  

GS AcquisitionCo, Inc.(3)

  Software & Tech
Services
  Fifth Supplemental
Term Loan
  6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       820,965       809,527       808,651  

GS AcquisitionCo, Inc.(1) (2)

  Software & Tech
Services
  Fourth
Supplemental
Delayed Draw Term
Loan
  6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       —         (3,446     (3,741

GS AcquisitionCo, Inc.(1)

  Software & Tech
Services
  Revolver   6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       170,185       166,870       164,441  

GS AcquisitionCo, Inc.(4)

  Software & Tech
Services
  Second
Supplemental
Delayed Draw Term
Loan
  6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       695,326       688,559       684,896  

GS AcquisitionCo, Inc.(3) (4)

  Software & Tech
Services
  Term Loan   6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       3,517,738       3,486,769       3,464,972  

Kaseya Inc.(1)

  Software & Tech
Services
  Delayed Draw Term
Loan
  8.00% (L + 4.00%; 3.00% PIK; 1.00% Floor)     05/02/2025       192,480       187,882       186,946  

Kaseya Inc.(5)

  Software & Tech
Services
  Delayed Draw Term
Loan
  8.00% (L + 4.00%; 3.00% PIK; 1.00% Floor)     05/02/2025       541,577       537,073       536,161  

Kaseya Inc.(1)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     05/02/2025       184,235       181,613       180,475  

Kaseya Inc.(3) (4) (5)

  Software & Tech
Services
  Term Loan   8.00% (L + 4.00%; 3.00% PIK; 1.00% Floor)     05/02/2025       5,127,396       5,088,162       5,076,122  

Lexipol, LLC(1)

  Software & Tech
Services
  Delayed Draw Term
Loan
  6.75% (L + 5.75%; 1.00% Floor)     10/08/2025       1,379,476       1,355,497       1,354,058  

Lexipol, LLC(3)

  Software & Tech
Services
  Term Loan A   6.75% (L + 5.75%; 1.00% Floor)     10/08/2025       6,243,945       6,143,391       6,134,676  

Ministry Brands, LLC(3) (5)

  Software & Tech
Services
  Delayed Draw Term
Loan
  5.00% (L + 4.00%; 1.00% Floor)     12/02/2022       649,331       647,916       634,721  

Ministry Brands, LLC(5)

  Software & Tech
Services
  Term Loan   5.00% (L + 4.00%; 1.00% Floor)     12/02/2022       3,104,742       3,098,780       3,034,885  

Netwrix Corporation And Concept Searching Inc.(5)

  Software & Tech
Services
  First Amendment
Last Out Term Loan
  9.08% (L + 8.08%; 1.00% Floor)     09/30/2026       6,702,674       6,552,806       6,544,491  

Netwrix Corporation And Concept Searching Inc.(3)

  Software & Tech
Services
  Last Out Term Loan   10.00% (L + 9.00%; 1.00% Floor)     09/30/2026       1,661,346       1,620,377       1,622,138  

Netwrix Corporation And Concept Searching Inc.(5)

  Software & Tech
Services
  Primary Delayed
Draw Term Loan
  7.25% (L + 6.25%; 1.00% Floor)     09/30/2026       500,905       491,696       490,887  

Netwrix Corporation And Concept Searching Inc.(1) (2)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     09/30/2026       —         (4,102     (5,413

Netwrix Corporation And Concept Searching Inc.

  Software & Tech
Services
  Supplemental
Delayed Draw Term
Loan
  7.50% (L + 6.50%; 1.00% Floor)     09/30/2026       1,001,811       983,392       981,774  

Netwrix Corporation And Concept Searching Inc.(1) (2)

  Software & Tech
Services
  Tranche 2 Delayed
Draw Term Loan
  7.50% (L + 6.50%; 1.00% Floor)     09/30/2026       —         (24,255     (49,721

PerimeterX, Inc.(1) (2)

  Software & Tech
Services
  Delayed Draw Term
Loan
  6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)     11/22/2024       —         (6,634     (6,988

PerimeterX, Inc.(4)

  Software & Tech
Services
  Initial Term Loan   6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)     11/22/2024       2,809,451       2,782,699       2,781,356  

PerimeterX, Inc.(1) (2)

  Software & Tech
Services
  Revolver   6.50% (L + 4.00%; 1.50% PIK; 1.00% Floor)     11/22/2024       —         (2,598     (2,795

Real Capital Analytics, Inc.(3) (4)

  Software & Tech
Services
  First Supplemental
Term Loan
  5.00% (L + 4.00%, 1.00% Floor)     10/02/2024       3,019,297       3,008,069       3,019,297  

Real Capital Analytics, Inc.(1) (2)

  Software & Tech
Services
  Revolver   5.00% (L + 4.00%, 1.00% Floor)     10/02/2024       —         (2,524     —    

Real Capital Analytics, Inc.(3)

  Software & Tech
Services
  Term Loan   5.00% (L + 4.00%, 1.00% Floor)     10/02/2024       4,863,178       4,845,283       4,863,178  

SecureLink, Inc(3)

  Software & Tech
Services
  Initial Term Loan   6.50% (L + 5.50%; 1.00% Floor)     10/01/2025       4,910,348       4,842,992       4,836,693  

SecureLink, Inc(1) (2)

  Software & Tech
Services
  Revolver   6.50% (L + 5.50%; 1.00% Floor)     10/01/2025       —         (5,938     (6,593

Sirsi Corporation(1) (2)

  Software & Tech
Services
  Revolver   5.75% (L + 4.75%; 1.00% Floor)     03/15/2024       —         (5,100     (6,922

Sirsi Corporation(3) (5)

  Software & Tech
Services
  Term Loan   5.75% (L + 4.75%; 1.00% Floor)     03/15/2024       8,345,047       8,264,064       8,240,734  

Smartlinx Solutions, LLC(1) (2)

  Software & Tech
Services
  Revolver   7.00% (L + 6.00%; 1.00% Floor)     03/04/2026       —         (4,289     (9,974

Smartlinx Solutions, LLC(3) (4) (5)

  Software & Tech
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     03/04/2026       5,721,464       5,623,170       5,611,612  

Streamsets, Inc.(1) (2)

  Software & Tech
Services
  Revolver   6.75% (L + 5.00%; 0.75% PIK; 1.00% Floor)     11/25/2024       —         (8,546     (9,349

Streamsets, Inc.(4)

  Software & Tech
Services
  Term Loan   6.75% (L + 5.00%; 0.75% PIK; 1.00% Floor)     11/25/2024       2,108,406       2,056,621       2,052,173  

SugarCRM, Inc.(1) (2)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     07/31/2024       —         (3,262     —    

SugarCRM, Inc.(3) (4)

  Software & Tech
Services
  Term Loan   7.50% (L + 6.50%; 1.00% Floor)     07/31/2024       4,268,824       4,218,610       4,268,824  

Swiftpage, Inc.(1) (2)

  Software & Tech
Services
  Revolver   6.50% (L + 5.50%; 1.00% Floor)     06/13/2023       —         (2,170     (7,886

Swiftpage, Inc.(5)

  Software & Tech
Services
  Term Loan   6.50% (L + 5.50%; 1.00% Floor)     06/13/2023       2,465,104       2,445,381       2,378,825  

Swiftpage, Inc.(4) (5)

  Software & Tech
Services
  Term Loan A   6.50% (L + 5.50%; 1.00% Floor)     06/13/2023       226,895       224,724       218,954  

Sysnet North America, Inc(1) (2)

  Software & Tech
Services
  Delayed Draw Term
Loan B1
  6.50% (L + 5.50%; 1.00% Floor)     12/01/2026       —         (27,774     (57,946

Sysnet North America, Inc(3) (4) (5)

  Software & Tech
Services
  Term Loan B 1   6.50% (L + 5.50%; 1.00% Floor)     12/01/2026       5,137,915       5,063,186       5,060,847  

Telesoft Holdings, LLC(1) (2)

  Software & Tech
Services
  Revolver   6.75% (L + 5.75%, 1.00% Floor)     12/16/2025       —         (10,605     (8,953

Telesoft Holdings, LLC(4) (5)

  Software & Tech
Services
  Term Loan   6.75% (L + 5.75%, 1.00% Floor)     12/16/2025       5,908,978       5,801,892       5,820,343  

TRGRP, Inc.(5)

  Software & Tech
Services
  Incremental Term
Loan
  8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)     11/01/2023       2,306,732       2,261,130       2,260,597  

TRGRP, Inc.(3)

  Software & Tech
Services
  Incremental Term
Loan
  8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)     11/01/2023       1,097,763       1,084,555       1,075,808  

 

12


Table of Contents

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair
Value
 

TRGRP, Inc.(1) (2)

  Software & Tech
Services
  Revolver   8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)     11/01/2023     $ —       $ (3,460   $ (6,667

TRGRP, Inc.(3) (4) (5)

  Software & Tech
Services
  Term Loan   8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)     11/01/2023       4,913,243       4,858,712       4,814,978  

Vectra AI, Inc(1) (2)

  Software & Tech
Services
  Delayed Draw Term
Loan
  6.75% (L + 5.75%, 1.00% Floor)     03/18/2026       —         (58,190     (58,190

Vectra AI, Inc(4)

  Software & Tech
Services
  Initial Term Loan   6.75% (L + 5.75%, 1.00% Floor)     03/18/2026       3,258,620       3,177,155       3,177,155  

Vectra AI, Inc(1) (2)

  Software & Tech
Services
  Revolver   6.75% (L + 5.75%, 1.00% Floor)     03/18/2026       —         (5,819     (5,819

Velocity Purchaser Corporation(1) (2)

  Software & Tech
Services
  Revolver   7.00% (L + 6.00%; 1.00% Floor)     12/01/2022       —         (1,323     —    

Velocity Purchaser Corporation(3)

  Software & Tech
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/01/2022       2,655,701       2,636,543       2,655,701  

Velocity Purchaser Corporation(3)

  Software & Tech
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/01/2022       660,247       654,363       660,247  

Velocity Purchaser Corporation(3) (5)

  Software & Tech
Services
  Third Amendment
Term Loan
  7.00% (L + 6.00%; 1.00% Floor)     12/01/2022       5,154,853       5,066,117       5,154,853  

Watermark Insights,
LLC(3)

  Software & Tech
Services
  Delayed Draw Term
Loan
  5.75% (L + 4.75%, 1.00% Floor)     06/07/2024       323,727       322,384       316,443  

Watermark Insights,
LLC(3)

  Software & Tech
Services
  Term Loan   5.75% (L + 4.75%, 1.00% Floor)     06/07/2024       2,579,549       2,564,670       2,521,509  

Dillon Logistics,
Inc.(1)(9)

  Transport &
Logistics
  Revolver   8.00% (L + 7.00%; 1.00% Floor)     12/11/2023       350,149       346,551       127,314  

Dillon Logistics, Inc.(9)

  Transport &
Logistics
  Term Loan A   8.00% (L + 7.00%; 1.00% Floor)     12/11/2023       2,851,148       2,737,165       1,288,719  

Dillon Logistics, Inc.(9)

  Transport &
Logistics
  Term Loan B   8.00% (L + 7.00%; 1.00% Floor)     12/11/2023       838,554       793,183       379,027  

OSG Bulk Ships, Inc.(3)

  Transport &
Logistics
  Term Loan   5.12% (L + 5.00%)     12/21/2023       5,044,073       5,007,192       4,943,192  
           

 

 

   

 

 

 

Total U.S. 1st Lien/Senior Secured Debt

      553,797,126       547,790,553  

2nd Lien/Junior Secured Debt —4.51%

 

Foundation Risk Partners, Corp.(1) (2)

  Business
Services
  2nd Lien Delayed
Draw Term Loan
  9.50% (L + 8.50%; 1.00% Floor)     11/10/2024       —         (14,700     (14,140

Foundation Risk Partners, Corp.(3)

  Business
Services
  2nd Lien Term
Loan
  9.50% (L + 8.50%; 1.00% Floor)     11/10/2024       837,931       817,613       819,078  

Conterra Ultra Broadband Holdings, Inc.(3) (5)

  Digital
Infrastructure &
Services
  2nd Lien Term
Loan
  9.00% (L + 8.00%; 1.00% Floor)     04/30/2027       6,537,710       6,456,768       6,537,710  

Brave Parent Holdings, Inc.(3)

  Software & Tech
Services
  2nd Lien Term
Loan
  7.61% (L + 7.50%)     04/17/2026       1,230,107       1,209,554       1,202,429  

Symplr Software, Inc.(3)

  Software & Tech
Services
  2nd Lien Term
Loan
  8.63% (L + 7.875%; 0.75% Floor)     12/22/2028       2,909,482       2,852,797       2,851,293  
           

 

 

   

 

 

 

Total U.S. 2nd Lien/Junior Secured Debt

      11,322,032       11,396,370  
           

 

 

   

 

 

 

Total U.S. Corporate Debt

      565,119,158       559,186,923  

Canadian Corporate Debt —2.32%

 

1st Lien/Senior Secured Debt —2.32%

 

McNairn Holdings
Ltd.(3) (8)

  Business
Services
  Term Loan   6.00% (L + 5.00%; 1.00% Floor)     11/25/2025       837,736       830,961       837,736  

Banneker V Acquisition, Inc.(4) (8)

  Software & Tech
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/04/2025       5,160,060       5,062,322       5,056,859  

Banneker V Acquisition, Inc.(1) (2) (8)

  Software & Tech
Services
  Revolver   7.00% (L + 6.00%; 1.00% Floor)     12/04/2025       —         (4,865     (5,186

Banneker V Acquisition, Inc.(1) (2) (8)

  Software & Tech
Services
  Delayed Draw Term
Loan
  7.00% (L + 6.00%; 1.00% Floor)     12/04/2025       —         (19,458     (20,744
           

 

 

   

 

 

 

Total Canadian 1st Lien/Senior Secured Debt

      5,868,960       5,868,665  
           

 

 

   

 

 

 

Total Canadian Corporate Debt

      5,868,960       5,868,665  

United Kingdom Corporate Debt —2.08%

 

1st Lien/Senior Secured Debt —2.08%

 

GlobalWebIndex
Inc.(1) (2)

  Software & Tech
Services
  Delayed Draw Term
Loan
  7.00% (L + 6.00%; 1.00% Floor)     12/30/2024       —         (34,560     (36,837

GlobalWebIndex
Inc.(4) (5)

  Software & Tech
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/30/2024       5,525,580       5,321,429       5,307,319  
           

 

 

   

 

 

 

Total United Kingdom 1st Lien/Senior Secured Debt

      5,286,869       5,270,482  
           

 

 

   

 

 

 

Total United Kingdom Corporate Debt

      5,286,869       5,270,482  

Portfolio Company

      Industry     Shares     Cost     Fair
Value
 

U.S. Preferred Stock —3.23%

 

Global Radar Holdings, LLC(10) (11)

    Business Services       125     $ 367,615     $ 367,618  

SBS Ultimate Holdings, LP(10)

    Healthcare & HCIT     217,710       861,879       620,472  

Concerto, LLC(10) (12)

   
Software & Tech
Services
 
    65,614       349,977       392,372  

Datarobot, Inc.(10)

   
Software & Tech
Services
 
 
    38,190       289,278       501,892  

Datarobot, Inc.(10)

   
Software & Tech
Services
 
 
    6,715       88,248       88,248  

Degreed, Inc.(10)

   
Software & Tech
Services
 
 
    43,819       278,541       518,379  

Heap(10)

   
Software & Tech
Services
 
 
    189,617       696,351       696,351  

Netskope, Inc.(10)

   
Software & Tech
Services
 
 
    36,144       302,536       332,886  

PerimeterX, Inc.(10)

   
Software & Tech
Services
 
 
    282,034       838,601       838,600  

 

13


Table of Contents

Portfolio Company

  Industry   Shares     Cost     Fair
Value
 

Phenom People, Inc.(10)

  Software & Tech Services     35,055     $ 220,610     $ 704,606  

Protoscale Rubrik(10)

  Software & Tech Services     25,397       598,212       598,201  

Punchh(10)

  Software & Tech Services     24,262       275,337       275,337  

Samsara Networks, Inc.(10)

  Software & Tech Services     33,451       369,998       369,999  

Streamsets, Inc.(10)

  Software & Tech Services     109,518       295,512       295,512  

Symplr Software Intermediate Holdings, Inc.(10)

  Software & Tech Services     1,196       1,160,532       1,573,848  
     

 

 

   

 

 

 

Total U.S. Preferred Stock

 

    6,993,227       8,174,321  

U.S. Common Stock - 1.44%

 

Leeds FEG Investors, LLC(10)

  Consumer Discretionary     320       321,309       350,846  

Freddy’s Acquisition, LP(10)

  Consumer Non-Cyclical     72,483       72,483       72,483  

Nestle Waters(10) (13)

  Consumer Non-Cyclical     341,592       341,592       341,592  

Neutral Connect, LLC(10) (14)

  Digital Infrastructure &
Services
    396,513       439,931       406,704  

Thrive Buyer, Inc(10)

  Digital Infrastructure &
Services
    88,980       222,450       222,450  

Nine Point Energy, LLC(10)

  Energy     3,567,059       —         —    

Health Platforms Group(10)

  Healthcare & HCIT     16,502       —         —    

Healthcare Services Acquisition(8) (10)

  Healthcare & HCIT     15,183       46       46  

Healthcare Services Acquisition(8) (10) (15)

  Healthcare & HCIT     28,158       281,580       282,143  

INH Group Holdings(10)

  Healthcare & HCIT     484,552       484,552       775,283  

Aggregator, LLC(10)

  Software & Tech Services     417,813       417,813       852,338  

American Safety Holdings Corp.(10) (16)

  Software & Tech Services     130,824       130,824       143,906  

Omni Logistics, LLC(10) (17)

  Transport & Logistics     193,770       193,770       193,770  
     

 

 

   

 

 

 

Total U.S. Common Stock

 

    2,906,350       3,641,561  

U.S. Warrants —0.15%

 

Fuze, Inc., expire 09/20/2029(10)

  Digital Infrastructure &
Services
    196,328       615,168       —    

Healthcare Services Acquisition, expire 12/31/2027(8) (10)

  Healthcare & HCIT     14,079       —         —    

Healthcare Services Acquisition, expire 12/31/2027(8) (10)

  Healthcare & HCIT     23,721       23,721       14,944  

SBS Ultimate Holdings, LP, expire 09/18/2030(10)

  Healthcare & HCIT     17,419       —         —    

Alphasense, LLC, expire 05/29/2027(8) (10)

  Software & Tech Services     38,346       35,185       154,916  

Degreed, Inc., expire 05/31/2026(10)

  Software & Tech Services     26,294       46,823       143,828  

Streamsets, Inc., expire 11/25/2027(10)

  Software & Tech Services     23,382       16,367       16,367  

Vectra AI, Inc., expire 03/18/2031(10)

  Software & Tech Services     35,156       58,190       58,190  
     

 

 

   

 

 

 

Total U.S. Warrants

 

    795,454       388,245  

United Kingdom Warrants —0.06%

 

GlobalWebIndex, Inc., expire 12/30/2027(10)

  Software & Tech Services     8,832       159,859       159,859  
     

 

 

   

 

 

 

Total United Kingdom Warrants

 

    159,859       159,859  

TOTAL INVESTMENTS - 230.32%(18)

 

  $  587,129,877     $ 582,690,056  
     

 

 

   

 

 

 

Cash Equivalents —1.92%

 

U.S. Investment Companies —1.92%

 

Blackrock T Fund I(15) (19)

  Money Market Portfolio
0.01% (20)
    4,854,867       4,854,867       4,854,867  
     

 

 

   

 

 

 

Total U.S. Investment Companies

 

    4,854,867       4,854,867  
     

 

 

   

 

 

 

Total Cash Equivalents

 

    4,854,867       4,854,867  

LIABILITIES IN EXCESS OF OTHER ASSETS —(132.24%)

 

  $  (334,554,041
       

 

 

 

NET ASSETS—100.00%

 

  $  252,990,882  
       

 

 

 

 

+ 

As of March 31, 2021, qualifying assets represented 97.12% of total assets. Under the 1940 Act we may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of our total assets.

* 

Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of Financial Accounting Standards Board’s Accounting Standards Codification 820 fair value hierarchy.

# 

Percentages are based on net assets.

^ 

Generally, the interest rate on floating interest rate investments is at benchmark rate plus spread. The borrower has an option to choose the benchmark rate, such as the London Interbank Offered Rate (“LIBOR”) or the U.S. Prime rate. The spread may change based on the type of rate used. The terms in the Consolidated Schedule of Investments disclose the actual interest rate in effect as of the reporting period. LIBOR loans are typically indexed to 30-day, 60-day, 90-day or 180-day LIBOR rates (1M L, 2M L, 3M L or 6M L, respectively) at the borrower’s option. LIBOR loans may be subject to interest floors. As of March 31, 2021, rates for weekly 1M L, 2M L, 3M L and 6M L are 0.11%, 0.13%, 0.19% and 0.21%, respectively. As of March 31, 2021, the U.S. Prime rate was 3.25%.

(1) 

Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date, that may expire prior to the maturity date stated. See Note 6 “Commitments and Contingencies”.

(2) 

The negative cost is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value is the result of the capitalized discount on the loan.

(3) 

Position, or a portion thereof, has been segregated to collateralize ABPCI Direct Lending Fund CLO VI Ltd.

(4) 

Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding II, LLC.

(5) 

Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding III, LLC.

(6) 

$309,132 of the funded par amount accrues interest at 11.50% (P + 2.00%; 6.25% PIK; 1.00% Floor).

(7) 

$130,216 of the funded par amount accrues interest at 10.25% (L + 3.00%; 6.25% PIK; 1.00% Floor).

(8) 

Positions considered non-qualified assets therefore excluded from the qualifying assets calculation as noted in footnote + above.

(9) 

The investment is on non-accrual status. See Note 2 “Significant Accounting Policies.”

(10) 

Non-income producing investment.

(11) 

Position or portion thereof is held by Global Radar Acquisition Holdings, LLC which is held by ABPCIC Global Radar LLC

(12) 

Concerto, LLC is held through ABPCIC Concerto Holdings LLC.

(13) 

Position or portion thereof is held by ORCP III Triton Co-Investors, L.P. which is held by ABPCIC Equity Holdings, LLC.

 

14


Table of Contents
(14) 

Neutral Connect, LLC is held through ABPCIC NC Holdings LLC.

(15) 

Categorized as Level 1 assets under the definition of ASC 820 fair value hierarchy.

(16) 

Position or portion thereof is held by REP Coinvest II Tec, LP which is held by ABPCIC Equity Holdings, LLC.

(17) 

Position or portion thereof is held by REP Coinvest III-A Omni, L.P. which is held by ABPCIC Equity Holdings, LLC.

(18) 

Aggregate gross unrealized appreciation for federal income tax purposes is $4,797,558; aggregate gross unrealized depreciation for federal income tax purposes is $9,237,379. Net unrealized depreciation is $4,439,821 based upon a tax cost basis of $587,129,877.

(19) 

Included within ‘Cash and cash equivalents’ on the Consolidated Statements of Assets and Liabilities.

(20) 

The rate shown is the annualized seven-day yield as of March 31, 2021.

 

L   -   LIBOR
P   -   Prime
PIK   -   Payment-In-Kind

 

15


Table of Contents

AB Private Credit Investors Corporation

Consolidated Schedule of Investments as of December 31, 2020

 

Portfolio Company

   Industry    Facility Type   

Interest

   Maturity      Funded
Par Amount
     Cost     Fair Value  
Investments at Fair Value —239.72% + * # ^  
U.S. Corporate Debt —229.94%  
1st Lien/Senior Secured Debt —224.81%  

Amercareroyal, LLC(1)

   Business Services    Term Loan    6.00% (L + 5.00%; 1.00% Floor)      11/25/2025      $ 4,532,375      $ 4,494,065     $ 4,487,051  

BEP Borrower Holdco, LLC(2) (3)

   Business Services    Delayed Draw Term
Loan A
   5.25% (L + 4.25%; 1.00% Floor)      06/12/2024        —          (8,923     (19,325

BEP Borrower Holdco, LLC(2) (3)

   Business Services    Revolver    5.25% (L + 4.25%; 1.00% Floor)      06/12/2024        —          (4,477     (4,295

BEP Borrower Holdco, LLC(1)

   Business Services    Term Loan A    5.25% (L + 4.25%; 1.00% Floor)      06/12/2024        3,435,477        3,398,119       3,383,945  

Edgewood Partners Holdings LLC(1)

   Business Services    Term Loan    5.25% (L + 4.25%; 1.00% Floor)      09/06/2024        5,565,603        5,524,826       5,509,947  

Global Radar Holdings, LLC(2) (3)

   Business Services    Revolver    8.00% (L + 7.00%; 1.00% Floor)      12/31/2025        —          (11,637     (11,637

Global Radar Holdings, LLC(4)

   Business Services    Term Loan    8.00% (L + 7.00%; 1.00% Floor)      12/31/2025        6,400,861        6,272,844       6,272,844  

Metametrics, Inc.(2) (3)

   Business Services    Revolver    6.25% (L + 5.25%; 1.00% Floor)      09/10/2025        —          (10,230     (13,024

Metametrics, Inc.(1)

   Business Services    Term Loan    6.25% (L + 5.25%; 1.00% Floor)      09/10/2025        5,425,654        5,336,647       5,317,140  

MSM Acquisitions, Inc.(2) (3)

   Business Services    Delayed Draw Term
Loan
   7.00% (L + 6.00%, 1.00% Floor)      12/09/2026        —          (15,154     (15,313

MSM Acquisitions, Inc.(2) (3)

   Business Services    Revolver    7.00% (L + 6.00%, 1.00% Floor)      12/09/2026        —          (24,249     (24,501

MSM Acquisitions, Inc.(1) (4)

   Business Services    Term Loan    7.00% (L + 6.00%, 1.00% Floor)      12/09/2026        7,350,271        7,204,523       7,203,266  

Single Digits, Inc.

   Business Services    Delayed Draw Term
Loan
   7.00% (L + 6.00%; 1.00% Floor)      12/21/2023        607,575        603,967       558,969  

Single Digits, Inc.(2) (3)

   Business Services    Revolver    7.00% (L + 6.00%; 1.00% Floor)      12/21/2023        —          (2,489     (33,292

Single Digits, Inc.(1)

   Business Services    Term Loan    7.00% (L + 6.00%; 1.00% Floor)      12/21/2023        3,262,597        3,240,552       3,001,589  

Smile Brands, Inc.(4)

   Business Services    Delayed Draw Term
Loan
   5.42% (L + 5.17%; 0.21% Floor)      10/12/2024        493,072        489,895       484,443  

Smile Brands, Inc.(2) (3)

   Business Services    Revolver    6.17% (L + 5.17%; 1.00% Floor)      10/12/2023        —          (1,439     (4,459

Smile Brands, Inc.(1)

   Business Services    Term Loan    5.42% (L + 5.17%; 0.21% Floor)      10/12/2024        1,623,125        1,612,386       1,594,721  

Blink Holdings, Inc.(1)

   Consumer Non-Cyclical    Delayed Draw Term
Loan
   4.50% (L + 3.50%; 1.00% Floor)      11/08/2024        1,178,697        1,169,455       1,090,295  

Blink Holdings, Inc.

   Consumer Non-Cyclical    Delayed Draw Term
Loan
   4.50% (L + 3.50%; 1.00% Floor)      11/08/2024        945,093        939,402       874,211  

Blink Holdings, Inc.(1)

   Consumer Non-Cyclical    Term Loan    4.50% (L + 3.50%; 1.00% Floor)      11/08/2024        1,647,736        1,634,821       1,524,155  

Captain D’s, Inc.(2)

   Consumer Non-Cyclical    Revolver    5.50% (L + 4.50%; 1.00% Floor)      12/15/2023        144,787        143,730       142,826  

Captain D’s, Inc.(1)

   Consumer Non-Cyclical    Term Loan    5.50% (L + 4.50%; 1.00% Floor)      12/15/2023        1,929,660        1,919,188       1,910,364  

GPS Hospitality Holding Company LLC(1)

   Consumer Non-Cyclical    Term Loan B    4.47% (L + 4.25%)      12/08/2025        2,322,145        2,296,073       2,240,870  

PF Growth Partners, LLC(2)

   Consumer Non-Cyclical    Delayed Draw Term
Loan
   8.00% (L + 7.00%, 1.00% Floor)      07/11/2025        119,542        116,781       112,345  

PF Growth Partners, LLC(1)

   Consumer Non-Cyclical    Term Loan    8.00% (L + 7.00%, 1.00% Floor)      07/11/2025        2,011,787        1,995,817       1,971,551  

5 Bars, LLC(2) (3)

   Digital Infrastructure &
Services
   Delayed Draw Term
Loan
   6.00% (L + 4.00%; 2.00% Floor)      09/27/2024        —          (38,832     —    

5 Bars, LLC(2) (3)

   Digital Infrastructure &
Services
   Revolver    6.00% (L + 4.00%; 2.00% Floor)      09/27/2024        —          (7,281     —    

5 Bars, LLC(4)

   Digital Infrastructure &
Services
   Term Loan    6.00% (L + 4.00%; 2.00% Floor)      09/27/2024        4,742,121        4,687,586       4,742,121  

EvolveIP, LLC(2)

   Digital Infrastructure &
Services
   Delayed Draw Term
Loan
   6.75% (L + 5.75%; 1.00% Floor)      06/07/2023        113,373        105,505       102,036  

EvolveIP, LLC(2) (3)

   Digital Infrastructure &
Services
   Revolver    6.75% (L + 5.75%; 1.00% Floor)      06/07/2023        —          (5,886     (8,503

EvolveIP, LLC(1)

   Digital Infrastructure &
Services
   Term Loan A    6.75% (L + 5.75%; 1.00% Floor)      06/07/2023        6,567,317        6,496,610       6,468,808  

Fuze, Inc.(2) (4)

   Digital Infrastructure &
Services
   Delayed Draw Term
Loan
   8.50% (L + 6.50%; 2.00% Floor)      09/20/2024        777,532        280,941       766,905  

Fuze, Inc.(2) (3)

   Digital Infrastructure &
Services
   Revolver    8.50% (L + 6.50%; 2.00% Floor)      09/20/2024        —          (4,833     (18,531

Fuze, Inc.(1) (4)

   Digital Infrastructure &
Services
   Term Loan    8.50% (L + 6.50%; 2.00% Floor)      09/20/2024        11,015,029        10,973,819       10,857,514  

Star2star Communications, LLC(2) (3)

   Digital Infrastructure &
Services
   Delayed Draw Term
Loan
   6.50% (L + 5.50%; 1.00% Floor)      03/13/2025        —          (10,811     —    

Star2star Communications, LLC(2) (3)

   Digital Infrastructure &
Services
   Revolver    6.50% (L + 5.50%; 1.00% Floor)      03/13/2025        —          (16,217     —    

Star2star Communications, LLC(1) (4)

   Digital Infrastructure &
Services
   Term Loan    6.50% (L + 5.50%; 1.00% Floor)      03/13/2025        5,404,057        5,312,392       5,404,057  

AEG Holding Company, Inc.(1)

   Education    Delayed Draw Term
Loan
   6.50% (L + 5.50%; 1.00% Floor)      11/20/2023        1,067,375        1,056,524       1,046,027  

AEG Holding Company, Inc.(2) (3)

   Education    Revolver    6.50% (L + 5.50%; 1.00% Floor)      11/20/2023        —          (12,646     (22,337

AEG Holding Company, Inc.(4)

   Education    Term Loan    6.50% (L + 5.50%; 1.00% Floor)      11/20/2023        1,857,399        1,832,000       1,820,251  

AEG Holding Company, Inc.(1)

   Education    Term Loan    6.50% (L + 5.50%; 1.00% Floor)      11/20/2023        6,043,942        5,980,204       5,923,063  

Accelerate Resources Operating, LLC(2) (3)

   Energy    Delayed Draw Term
Loan
   8.50% (L + 7.50%; 1.00% Floor)      02/24/2026        —          (28,622     (49,772

Accelerate Resources Operating, LLC(2) (3)

   Energy    Revolver    8.50% (L + 7.50%; 1.00% Floor)      02/24/2026        —          (7,155     (12,443

 

16


Table of Contents

Portfolio Company

   Industry    Facility Type   

Interest

   Maturity      Funded
Par Amount
     Cost     Fair Value  

Accelerate Resources Operating, LLC(1)

   Energy    Term Loan    8.50% (L + 7.50%; 1.00% Floor)      02/24/2026      $ 4,989,614      $ 4,903,754     $ 4,839,925  

BCP Raptor II, LLC(1)

   Energy    Term Loan    4.90% (L + 4.75%)      11/03/2025        5,654,641        5,653,854       4,891,264  

Brazos Delaware II, LLC(1)

   Energy    Term Loan B    4.16% (L + 4.00%)      05/21/2025        4,003,380        3,924,100       3,462,923  

Nine Point Energy, LLC(2) (3)

   Energy    Delayed Draw Term Loan    9.00% (L + 5.50%; 2.50% PIK; 1.00% Floor)      06/07/2024        —          (4,707     (42,656

Nine Point Energy, LLC

   Energy    Term Loan    9.00% (L + 5.50%; 2.50% PIK; 1.00% Floor)      06/07/2024        5,737,924        5,651,856       4,991,994  

Foundation Risk Partners, Corp.(2) (3)

   Financials    First Lien
Delayed Draw Term Loan
   5.75% (L + 4.75%; 1.00% Floor)      11/10/2023        —          (29,327     (29,327

Foundation Risk Partners, Corp.(4)

   Financials    First Lien Term Loan    5.75% (L + 4.75%; 1.00% Floor)      11/10/2023        1,955,172        1,916,069       1,916,069  

Higginbotham Insurance Agency, Inc.(2) (3)

   Financials    Delayed Draw Term Loan    6.50% (L + 5.75%; 0.75% Floor)      11/25/2026        —          (12,328     (12,535

Higginbotham Insurance Agency, Inc.(5)

   Financials    Term Loan    6.50% (L + 5.75%; 0.75% Floor)      11/25/2026        5,937,344        5,849,538       5,848,284  

American Physician Partners, LLC(1)

   Healthcare & HCIT    Delayed Draw Term Loan    7.75% (L + 6.75%; 1.00% Floor)      12/21/2021        1,004,457        999,314       964,278  

American Physician Partners, LLC(2)

   Healthcare & HCIT    Revolver    7.75% (L + 6.75%; 1.00% Floor)      12/21/2021        346,322        344,112       328,562  

American Physician Partners, LLC(1)

   Healthcare & HCIT    Term Loan A    7.75% (L + 6.75%; 1.00% Floor)      12/21/2021        5,322,083        5,293,112       5,109,200  

American Physician Partners, LLC

   Healthcare & HCIT    Term Loan C    7.75% (L + 6.75%; 1.00% Floor)      12/21/2021        1,151,613        1,146,211       1,105,549  

American Physician Partners, LLC(1)

   Healthcare & HCIT    Term Loan D    7.75% (L + 6.75%; 1.00% Floor)      12/21/2021        2,137,611        2,009,807       2,052,107  

Analogic Corporation(2) (3)

   Healthcare & HCIT    Revolver    6.25% (L + 5.25%; 1.00% Floor)      06/22/2023        —          (2,024     (7,486

Analogic Corporation(1) (4)

   Healthcare & HCIT    Term Loan    6.25% (L + 5.25%; 1.00% Floor)      06/24/2024        2,117,500        2,092,383       2,043,387  

Azurity Pharmaceuticals, Inc.(2) (3) (4) (6)

   Healthcare & HCIT    Delayed Draw Term Loan    6.75% (L + 5.75%; 1.00% Floor)      03/21/2023        —          (4,912     (9,659

Azurity Pharmaceuticals, Inc.(2) (3) (4) (6)

   Healthcare & HCIT    Revolver    6.75% (L + 5.75%; 1.00% Floor)      03/21/2023        —          (4,912     (9,659

Azurity Pharmaceuticals, Inc.(1) (4) (6)

   Healthcare & HCIT    Term Loan    6.75% (L + 5.75%; 1.00% Floor)      03/21/2023        7,182,884        7,105,941       7,039,226  

BK Medical Holding Company, Inc.(2) (3)

   Healthcare & HCIT    Revolver    6.25% (L + 5.25%; 1.00% Floor)      06/22/2023        —          (2,342     (12,870

BK Medical Holding Company, Inc.(4)

   Healthcare & HCIT    Term Loan A    6.25% (L + 5.25%; 1.00% Floor)      06/22/2024        2,980,316        2,956,762       2,861,104  

Caregiver 2, Inc.(4)

   Healthcare & HCIT    Term Loan    8.50% (L + 6.50%; 2.00% Floor)      07/24/2025        4,869,246        4,777,466       4,771,861  

Caregiver 2, Inc.(4)

   Healthcare & HCIT    Term Loan    8.50% (L + 6.50%; 2.00% Floor)      07/24/2025        698,894        685,721       684,916  

Coding Solutions Acquisition, Inc(2) (3)

   Healthcare & HCIT    Delayed Draw Term Loan    7.00% (L + 6.00%; 1.00% Floor)      12/31/2026        —          (24,440     (24,440

Coding Solutions Acquisition, Inc(2)

   Healthcare & HCIT    Revolver    7.00% (L + 6.00%; 1.00% Floor)      12/31/2025        19,396        17,069       17,069  

Coding Solutions Acquisition, Inc(4)

   Healthcare & HCIT    Term Loan    7.00% (L + 6.00%; 1.00% Floor)      12/31/2026        7,913,792        7,755,516       7,755,516  

Delaware Valley Management Holdings, Inc.(2) (3)

   Healthcare & HCIT    Delayed Draw Term Loan    7.25% (L + 4.00%; 2.25% PIK; 1.00% Floor)      03/21/2024        —          (30,445     (160,698

Delaware Valley Management Holdings, Inc.

   Healthcare & HCIT    Revolver    7.25% (L + 4.00%; 2.25% PIK; 1.00% Floor)      03/21/2024        529,343        522,326       448,618  

Delaware Valley Management Holdings, Inc.

   Healthcare & HCIT    Term Loan    7.25% (L + 4.00%; 2.25% PIK; 1.00% Floor)      03/21/2024        3,455,055        3,409,119       2,928,159  

Ethos Veterinary Health LLC(1) (2)

   Healthcare & HCIT    Delayed Draw Term Loan    4.90% (L + 4.75%)      05/15/2026        1,067,933        1,051,553       1,058,398  

Ethos Veterinary Health LLC(1)

   Healthcare & HCIT    Term Loan    4.90% (L + 4.75%)      05/15/2026        2,291,671        2,272,956       2,280,213  

FH MD Buyer, Inc(1) (4)

   Healthcare & HCIT    Term Loan    6.75% (L + 5.75%; 1.00% Floor)      10/31/2026        4,758,403        4,642,290       4,639,443  

 

17


Table of Contents

Portfolio Company

   Industry    Facility Type   

Interest

   Maturity      Funded
Par Amount
     Cost     Fair Value  

GHA Buyer, Inc.(2)

   Healthcare & HCIT    Fifth Amendment
Delayed Draw Term
loan
   8.00% (L + 6.00%; 2.00% Floor)      06/24/2025      $ 819,387      $ 802,507     $ 819,387  

GHA Buyer, Inc.(2) (3)

   Healthcare & HCIT    Revolver    8.00% (L + 6.00%; 2.00% Floor)      06/24/2025        —          (16,560     —    

GHA Buyer, Inc.(4)

   Healthcare & HCIT    Term Loan    8.00% (L + 6.00%; 2.00% Floor)      06/24/2025        4,682,214        4,589,427       4,682,214  

GHA Buyer, Inc.(1)

   Healthcare & HCIT    Term Loan    8.00% (L + 6.00%; 2.00% Floor)      06/24/2025        1,977,880        1,954,014       1,977,880  

GHA Buyer, Inc.(1) (4)

   Healthcare & HCIT    Term Loan    8.00% (L + 6.00%; 2.00% Floor)      06/24/2025        5,408,146        5,310,809       5,408,146  

GHA Buyer, Inc.(1)

   Healthcare & HCIT    Term Loan    8.00% (L + 6.00%; 2.00% Floor)      06/24/2025        565,207        555,552       565,207  

INH Buyer, Inc.(2) (3)

   Healthcare & HCIT    Revolver    7.00% (L + 6.00%, 1.00% Floor)      01/31/2024        —          (1,962     (3,088

INH Buyer, Inc.(1)

   Healthcare & HCIT    Term Loan    7.00% (L + 6.00%, 1.00% Floor)      01/31/2025        8,593,414        8,497,744       8,464,513  

Kindeva Drug Delivery L.P.(2) (3)

   Healthcare & HCIT    Revolver    7.00% (L + 6.00%; 1.00% Floor)      05/01/2025        —          (31,405     (36,133

Kindeva Drug Delivery L.P.(1) (4)

   Healthcare & HCIT    Term Loan    7.00% (L + 6.00%; 1.00% Floor)      05/01/2026        15,819,048        15,463,256       15,423,572  

OMH-HealthEdge Holdings, LLC(2) (3)

   Healthcare & HCIT    Revolver    6.25% (L + 5.25%; 1.00% Floor)      10/24/2024        —          (7,910     (10,322

OMH-HealthEdge Holdings, LLC(1)

   Healthcare & HCIT    Term Loan    6.25% (L + 5.25%; 1.00% Floor)      10/24/2025        3,737,140        3,666,904       3,653,054  

Pace Health Companies, LLC(2) (3)

   Healthcare & HCIT    Revolver    5.50% (L + 4.50%; 1.00% Floor)      08/02/2024        —          (4,542     (6,167

Pace Health Companies, LLC(1)

   Healthcare & HCIT    Term Loan    5.50% (L + 4.50%; 1.00% Floor)      08/02/2024        5,358,969        5,318,091       5,305,379  

Pinnacle Dermatology Management, LLC(2)

   Healthcare & HCIT    Delayed Draw Term
Loan
   5.25% (L + 4.25%; 1.00% Floor)      05/18/2023        2,280,367        2,238,882       2,199,409  

Pinnacle Dermatology Management, LLC(2) (3)

   Healthcare & HCIT    Revolver    5.25% (L + 4.25%; 1.00% Floor)      05/18/2023        —          (3,106     (6,455

Pinnacle Dermatology Management, LLC(1)

   Healthcare & HCIT    Term Loan    5.25% (L + 4.25%; 1.00% Floor)      05/18/2023        5,380,911        5,310,665       5,273,293  

Pinnacle Treatment Centers, Inc.(2) (3)

   Healthcare & HCIT    Delayed Draw Term
Loan
   7.25% (L + 6.25%; 1.00% Floor)      12/31/2022        —          (2,434     (2,343

Pinnacle Treatment Centers, Inc.

   Healthcare & HCIT    Delayed Draw Term
Loan 2
   7.25% (L + 6.25%; 1.00% Floor)      12/31/2022        350,666        348,199       347,160  

Pinnacle Treatment Centers, Inc.(2) (3)

   Healthcare & HCIT    Revolver    7.25% (L + 6.25%; 1.00% Floor)      12/31/2022        —          (2,387     (2,929

Pinnacle Treatment Centers, Inc.(4)

   Healthcare & HCIT    Term Loan    7.25% (L + 6.25%; 1.00% Floor)      12/31/2022        4,128,092        4,099,904       4,086,812  

Platinum Dermatology Partners, LLC(7)

   Healthcare & HCIT    General Delayed
Draw Term Loan
   9.25% (L + 3.00%; 5.25% PIK; 1.00% Floor)      01/03/2023        1,478,951        1,453,814       1,196,915  

Platinum Dermatology Partners, LLC(8)

   Healthcare & HCIT    Revolver    10.50% (P + 2.00%; 5.25% PIK; 1.00% Floor)      01/03/2023        518,062        508,152       419,267  

Platinum Dermatology Partners, LLC

   Healthcare & HCIT    Specified Delayed
Draw Term Loan
   10.50% (P + 2.00%; 5.25% PIK; 1.00% Floor)      01/03/2023        2,036,183        2,000,944       1,647,883  

Platinum Dermatology Partners, LLC

   Healthcare & HCIT    Term Loan    9.25% (L + 3.00%; 5.25% PIK; 1.00% Floor)      01/03/2023        3,238,540        3,172,757       2,620,951  

RCP Encore Acquisition, Inc.(1)

   Healthcare & HCIT    Term Loan    5.75% (L + 4.75%; 1.00% Floor)      06/09/2025        3,934,668        3,904,130       3,767,444  

Salisbury House, LLC(2) (3)

   Healthcare & HCIT    Revolver    6.00% (L + 5.00%; 1.00% Floor)      08/30/2025        —          (10,572     (11,209

Salisbury House, LLC(1) (4)

   Healthcare & HCIT    Term Loan A1    6.50% (L + 5.50%; 1.00% Floor)      08/30/2025        5,366,661        5,239,533       5,232,494  

SIS Purchaser, Inc.(2) (3)

   Healthcare & HCIT    Revolver    7.00% (L + 6.00%; 1.00% Floor)      10/15/2026        —          (19,692     (20,405

SIS Purchaser, Inc.(1) (4)

   Healthcare & HCIT    Term Loan    7.00% (L + 6.00%; 1.00% Floor)      10/15/2026        12,825,456        12,606,394       12,601,010  

The Center for Orthopedic and Research Excellence, Inc.(2) (9)

   Healthcare & HCIT    Delayed Draw Term
Loan
   6.25% (L + 5.25%; 1.00% Floor)      08/15/2025        577,458        561,028       557,270  

The Center for Orthopedic and Research Excellence, Inc.(2) (3)

   Healthcare & HCIT    Revolver    6.25% (L + 5.25%; 1.00% Floor)      08/15/2025        —          (9,474     (12,084

 

18


Table of Contents

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair
Value
 

The Center for Orthopedic and Research Excellence, Inc.(1) (4)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)     08/15/2025     $ 4,943,778     $ 4,873,997     $ 4,857,261  

Theranest, LLC(1) (4)

  Healthcare & HCIT   Delayed
Draw Term Loan
  6.00% (L + 5.00%; 1.00% Floor)     07/24/2023       2,743,641       2,711,689       2,675,050  

Theranest, LLC(2) (3)

  Healthcare & HCIT   Revolver   6.00% (L + 5.00%; 1.00% Floor)     07/24/2023       —         (4,438     (10,714

Theranest, LLC(1)

  Healthcare & HCIT   Term Loan   6.00% (L + 5.00%; 1.00% Floor)     07/24/2023       2,970,000       2,937,217       2,895,750  

Women’s Health USA, Inc.(2) (3)

  Healthcare & HCIT   Revolver   8.75% (L + 7.75%; 1.00% Floor)     10/09/2023       —         (2,150     (2,195

Women’s Health USA, Inc.(1) (4)

  Healthcare & HCIT   Term Loan   8.75% (L + 7.75%; 1.00% Floor)     10/09/2023       4,116,949       4,057,490       4,056,430  

ZBS Alliance Animal Health,
LLC(1) (4)

  Healthcare & HCIT   Delayed Draw
Term Loan
  6.25% (L + 5.25%; 1.00% Floor)     11/08/2025       3,056,995       3,007,287       2,995,855  

ZBS Alliance Animal Health,
LLC(2) (3)

  Healthcare & HCIT   First Amendment
Delayed Draw
Term Loan
  6.25% (L + 5.25%; 1.00% Floor)     11/08/2025       —         (14,900     (45,076

ZBS Alliance Animal Health,
LLC(2)

  Healthcare & HCIT   Revolver   6.25% (L + 5.25%; 1.00% Floor)     11/08/2025       453,560       442,268       439,953  

ZBS Alliance Animal Health,
LLC(1)

  Healthcare & HCIT   Term Loan   6.25% (L + 5.25%; 1.00% Floor)     11/08/2025       2,694,147       2,649,100       2,640,264  

Alphasense, Inc.(2) (3) (11)

  Software & Tech
Services
  Delayed Draw
Term Loan
  8.00% (L + 7.00%; 1.00% Floor)     05/29/2024       —         (19,224     —    

Alphasense, Inc.(2) (3) (11)

  Software & Tech
Services
  Revolver   8.00% (L + 7.00%; 1.00% Floor)     05/29/2024       —         (10,717     —    

Alphasense, Inc.(4) (11)

  Software & Tech
Services
  Term Loan   8.00% (L + 7.00%; 1.00% Floor)     05/29/2024       7,269,628       7,180,336       7,269,628  

AMI US Holdings, Inc.(2)

  Software & Tech
Services
  Revolver   5.65% (L + 5.50%)     04/01/2024       788,116       773,369       771,697  

AMI US Holdings, Inc.(1)

  Software & Tech
Services
  Term Loan   6.50% (L + 5.50%; 1.00% Floor)     04/01/2025       8,173,415       8,050,411       8,050,814  

Arrowstream Acquisition Co.,
Inc.(2) (3)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     12/15/2025       —         (7,655     (7,726

Arrowstream Acquisition Co.,
Inc.(4)

  Software & Tech
Services
  Term Loan   7.50% (L + 6.50%; 1.00% Floor)     12/15/2025       3,863,094       3,786,548       3,785,832  

Avetta, LLC(2) (3)

  Software & Tech
Services
  Revolver   6.25% (L + 5.25%; 1.00% Floor)     04/10/2024       —         (5,453     (9,888

Avetta, LLC(1) (4)

  Software & Tech
Services
  Term Loan   6.25% (L + 5.25%; 1.00% Floor)     04/10/2024       3,253,746       3,190,633       3,188,671  

Avetta, LLC(1)

  Software & Tech
Services
  Term Loan B   6.25% (L + 5.25%; 1.00% Floor)     04/10/2024       4,283,219       4,222,444       4,197,555  

Businesssolver.com, Inc.(1)

  Software & Tech
Services
  Delayed Draw
Term Loan
  8.50% (L + 7.50%; 1.00% Floor)     05/15/2023       388,235       385,900       388,235  

Businesssolver.com, Inc.(2) (3)

  Software & Tech
Services
  Revolver   8.50% (L + 7.50%; 1.00% Floor)     05/15/2023       —         (3,180     —    

Businesssolver.com, Inc.(1) (4) (5)

  Software & Tech
Services
  Term Loan   8.50% (L + 7.50%; 1.00% Floor)     05/15/2023       9,703,535       9,608,867       9,703,535  

Businesssolver.com, Inc.(4)

  Software & Tech
Services
  Term Loan   8.50% (L + 7.50%; 1.00% Floor)     05/15/2023       1,390,037       1,369,183       1,390,037  

Datacor Holdings, Inc.(2) (3)

  Software & Tech
Services
  First Lien
Delayed Draw
Term Loan
  6.25% (L + 5.25%; 1.00% Floor)     12/26/2025       —         (25,714     (25,754

Datacor Holdings, Inc.(2) (3)

  Software & Tech
Services
  Revolver   6.25% (L + 5.25%; 1.00% Floor)     12/26/2025       —         (12,849     (12,877

Datacor Holdings, Inc.(1) (4)

  Software & Tech
Services
  Term Loan   6.25% (L + 5.25%; 1.00% Floor)     12/26/2025       6,180,951       6,042,052       6,041,879  

Degreed, Inc.(4)

  Software & Tech
Services
  Delayed Draw
Term Loan
  7.35% (L + 6.35%; 1.00% Floor)     05/31/2024       2,924,689       2,865,519       2,924,689  

Degreed, Inc.(4)

  Software & Tech
Services
  Revolver   7.35% (L + 6.35%; 1.00% Floor)     05/31/2024       417,813       414,941       417,813  

Degreed, Inc.(1) (4)

  Software & Tech
Services
  Term Loan   7.35% (L + 6.35%; 1.00% Floor)     05/31/2024       2,228,335       2,211,944       2,228,335  

Dispatch Track, LLC(2) (3)

  Software & Tech
Services
  Revolver   5.50% (L + 4.50%; 1.00% Floor)     12/17/2024       —         (3,610     (3,020

Dispatch Track, LLC(1)

  Software & Tech
Services
  Term Loan   5.50% (L + 4.50%; 1.00% Floor)     12/17/2024       6,038,593       5,966,394       5,978,207  

Drilling Info Holdings, Inc.(1)

  Software & Tech
Services
  Term Loan   4.40% (L + 4.25%)     07/30/2025       3,360,865       3,350,124       3,310,452  

 

19


Table of Contents

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair
Value
 

Dude Solutions Holdings, Inc.(4)

  Software & Tech
Services
  Term Loan   8.50% (L + 7.50%; 1.00% Floor)     06/13/2025     $ 3,882,883     $ 3,796,420     $ 3,795,518  

E2open LLC(2)

  Software & Tech
Services
  Revolver   6.75% (L + 5.75%; 1.00% Floor)     11/26/2024       238,713       235,653       238,713  

E2open LLC(1)

  Software & Tech
Services
  Term Loan   6.75% (L + 5.75%; 1.00% Floor)     11/26/2024       4,895,325       4,843,685       4,895,325  

Engage2Excel, Inc.(1) (2)

  Software & Tech
Services
  Revolver   9.00% (L + 6.00%; 2.00% PIK; 1.00% Floor)     03/07/2023       259,141       255,648       244,002  

Engage2Excel, Inc.(1)

  Software & Tech
Services
  Term Loan   9.00% (L + 6.00%; 2.00% PIK; 1.00% Floor)     03/07/2023       1,030,639       1,018,322       989,413  

Engage2Excel, Inc.(1)

  Software & Tech
Services
  Term Loan   9.00% (L + 6.00%; 2.00% PIK; 1.00% Floor)     03/07/2023       2,970,378       2,940,272       2,851,562  

EnterpriseDB Corporation(2) (3)

  Software & Tech
Services
  Revolver   7.75% (L + 5.50%; 0.50% PIK; 1.75% Floor)     06/21/2024       —         (9,730     (6,964

EnterpriseDB Corporation(1) (4)

  Software & Tech
Services
  Term Loan   7.75% (L + 5.50%; 0.50% PIK; 1.75% Floor)     06/21/2024       7,884,480       7,770,371       7,805,636  

EnterpriseDB Corporation(1) (4)

  Software & Tech
Services
  Term Loan   7.75% (L + 5.50%; 0.50% PIK; 1.75% Floor)     06/21/2024       4,517,886       4,430,433       4,472,707  

Exterro, Inc.(2) (3)

  Software & Tech
Services
  Revolver   6.50% (L + 5.50%; 1.00% Floor)     05/31/2024       —         (2,863     (1,238

Exterro, Inc.(4)

  Software & Tech
Services
  Term Loan   6.50% (L + 5.50%; 1.00% Floor)     05/31/2024       6,584,363       6,455,464       6,551,441  

Exterro, Inc.(1)

  Software & Tech
Services
  Term Loan   6.50% (L + 5.50%; 1.00% Floor)     05/31/2024       5,809,123       5,714,227       5,780,077  

Exterro, Inc.(1)

  Software & Tech
Services
  Term Loan   6.50% (L + 5.50%; 1.00% Floor)     05/31/2024       2,793,450       2,761,205       2,779,483  

Faithlife, LLC(1) (2)

  Software & Tech
Services
  Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)     09/18/2025       1,705,713       1,649,597       1,645,019  

Faithlife, LLC(2) (3)

  Software & Tech
Services
  Revolver   7.00% (L + 6.00%; 1.00% Floor)     09/18/2025       —         (5,267     (5,581

Faithlife, LLC(1)

  Software & Tech
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     09/18/2025       732,515       718,688       717,865  

Finalsite Holdings, Inc.(2) (3)

  Software & Tech
Services
  Revolver   6.00% (L + 5.00%; 1.00% Floor)     09/25/2024       —         (2,778     (4,430

Finalsite Holdings, Inc.(1)

  Software & Tech
Services
  Term Loan   6.00% (L + 5.00%; 1.00% Floor)     09/25/2024       3,299,280       3,260,625       3,241,542  

Genesis Acquisition Co.

  Software & Tech
Services
  Delayed Draw Term Loan   4.22% (L + 4.00%)     07/31/2024       40,193       39,949       36,877  

Genesis Acquisition Co.(4)

  Software & Tech
Services
  Revolver   4.22% (L + 4.00%)     07/31/2024       202,400       199,929       185,702  

Genesis Acquisition Co.(1)

  Software & Tech
Services
  Term Loan   4.22% (L + 4.00%)     07/31/2024       1,348,936       1,331,729       1,237,649  

GS AcquisitionCo, Inc.(4)

  Software & Tech
Services
  Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       697,073       689,765       686,617  

GS AcquisitionCo, Inc.(4)

  Software & Tech
Services
  Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       1,430,055       1,430,055       1,408,604  

GS AcquisitionCo, Inc.(1)

  Software & Tech
Services
  Fifth Supplemental Term
Loan
  6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       823,023       810,749       810,677  

GS AcquisitionCo, Inc.(2) (3)

  Software & Tech
Services
  Fourth Supplemental
Delayed Draw Term Loan
  6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       —         (3,717     (3,741

GS AcquisitionCo, Inc.(2) (3)

  Software & Tech
Services
  Revolver   6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       —         (3,559     (5,743

GS AcquisitionCo, Inc.(1) (4)

  Software & Tech
Services
  Term Loan   6.75% (L + 5.75%; 1.00% Floor)     05/24/2024       3,526,700       3,493,436       3,473,799  

Kaseya Inc.(2) (3) (10)

  Software & Tech
Services
  Delayed Draw Term Loan   8.00% (L + 4.00%; 3.00% PIK; 1.00% Floor)     05/02/2025       —         (4,197     (6,015

Kaseya Inc.(10)

  Software & Tech
Services
  Delayed Draw Term Loan   8.00% (L + 4.00%; 3.00% PIK; 1.00% Floor)     05/02/2025       539,265       534,498       528,480  

Kaseya Inc.(2) (10)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     05/02/2025       184,235       181,464       176,716  

Kaseya Inc.(1) (4) (10)

  Software & Tech
Services
  Term Loan   8.00% (L + 4.00%; 3.00% PIK; 1.00% Floor)     05/02/2025       5,087,721       5,046,461       4,985,967  

Lexipol, LLC(1)

  Software & Tech
Services
  Delayed Draw Term Loan   6.75% (L + 5.75%; 1.00% Floor)     10/08/2025       1,382,942       1,357,778       1,357,464  

Lexipol, LLC(1)

  Software & Tech
Services
  Term Loan A   6.75% (L + 5.75%; 1.00% Floor)     10/08/2025       6,259,633       6,154,275       6,150,089  

Medbridge Holdings, LLC(1) (5)

  Software & Tech
Services
  Initial Term Loan   8.00% (L + 7.00%, 1.00% Floor)     12/23/2026       15,367,872       15,061,604       15,060,514  

Medbridge Holdings, LLC(2) (3)

  Software & Tech
Services
  Revolver   8.00% (L + 7.00%, 1.00% Floor)     12/23/2026       —         (27,413     (27,524

 

20


Table of Contents

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair
Value
 

Ministry Brands, LLC(1)

  Software & Tech
Services
  Delayed Draw Term Loan   5.00% (L + 4.00%; 1.00% Floor)     12/02/2022     $ 650,993     $ 649,558     $ 636,346  

Ministry Brands, LLC(1)

  Software & Tech
Services
  Term Loan   5.00% (L + 4.00%; 1.00% Floor)     12/02/2022       3,112,742       3,105,923       3,042,705  

Netwrix Corporation And Concept Searching Inc.(2) (3)

  Software & Tech
Services
  Delayed Draw Term Loan   7.25% (L + 6.25%; 1.00% Floor)     09/30/2026       —         (19,215     (23,794

Netwrix Corporation And Concept Searching Inc.

  Software & Tech
Services
  First Amendment First
Out Term Loan
  4.50% (L + 3.50%; 1.00% Floor)     09/30/2026       2,807,645       2,769,039       2,769,039  

Netwrix Corporation And Concept Searching Inc.

  Software & Tech
Services
  First Amendment Last
Out Term Loan
  9.08% (L + 8.08%; 1.00% Floor)     09/30/2026       7,175,092       7,014,042       7,014,042  

Netwrix Corporation And Concept Searching Inc.(1)

  Software & Tech
Services
  Last Out Term Loan   10.00% (L + 9.00%; 1.00% Floor)     09/30/2026       1,665,510       1,622,670       1,625,954  

Netwrix Corporation And Concept Searching Inc.

  Software & Tech
Services
  Primary Delayed Draw
Term Loan
  7.25% (L + 6.25%; 1.00% Floor)     09/30/2026       500,905       491,298       489,009  

Netwrix Corporation And Concept Searching Inc.(2) (3)

  Software & Tech
Services
  Revolver   7.25% (L + 6.25%; 1.00% Floor)     09/30/2026       —         (4,284     (3,956

PerimeterX, Inc.(2) (3)

  Software & Tech
Services
  Delayed Draw Term Loan   5.00% (L + 4.00%; 1.00% Floor)     11/22/2024       —         (6,883     (6,989

PerimeterX, Inc.(2) (3)

  Software & Tech
Services
  Revolver   5.00% (L + 4.00%; 1.00% Floor)     11/22/2024       —         (2,737     (2,795

PerimeterX, Inc.(4)

  Software & Tech
Services
  Term Loan   5.00% (L + 4.00%; 1.00% Floor)     11/22/2024       2,798,825       2,771,229       2,770,837  

Purchasing Power, LLC(1)

  Software & Tech
Services
  Term Loan   8.25% (L + 7.25%; 1.00% Floor)     02/06/2024       2,624,201       2,592,378       2,571,717  

Real Capital Analytics, Inc.(2) (3)

  Software & Tech
Services
  Revolver   6.00% (L + 5.00%, 1.00% Floor)     10/02/2024       —         (2,683     —    

Real Capital Analytics, Inc.(1) (4)

  Software & Tech
Services
  Term Loan   6.00% (L + 5.00%; 1.00% Floor)     10/02/2024       3,019,297       3,007,315       3,019,297  

Real Capital Analytics, Inc.(1)

  Software & Tech
Services
  Term Loan   6.00% (L + 5.00%, 1.00% Floor)     10/02/2024       4,863,178       4,844,190       4,863,178  

Rep Tec Intermediate Holdings, Inc.(2) (3)

  Software & Tech
Services
  Delayed Draw Term Loan   7.50% (L + 6.50%; 1.00% Floor)     06/19/2025       —         (23,772     —    

Rep Tec Intermediate Holdings, Inc.(2) (3)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     06/19/2025       —         (7,924     —    

Rep Tec Intermediate Holdings, Inc.(4)

  Software & Tech
Services
  Term Loan   7.50% (L + 6.50%; 1.00% Floor)     06/19/2025       4,164,398       4,089,771       4,164,398  

SecureLink, Inc(1)

  Software & Tech
Services
  Initial Term Loan   6.50% (L + 5.50%; 1.00% Floor)     10/01/2025       4,922,655       4,852,007       4,848,815  

SecureLink, Inc(2) (3)

  Software & Tech
Services
  Revolver   6.50% (L + 5.50%; 1.00% Floor)     10/01/2025       —         (6,262     (6,593

Sirsi Corporation(2) (3)

  Software & Tech
Services
  Revolver   5.75% (L + 4.75%; 1.00% Floor)     03/15/2024       —         (5,503     (6,921

Sirsi Corporation(1)

  Software & Tech
Services
  Term Loan   5.75% (L + 4.75%; 1.00% Floor)     03/15/2024       8,449,581       8,361,442       8,343,961  

Smartlinx Solutions, LLC(2) (3)

  Software & Tech
Services
  Revolver   7.00% (L + 6.00%; 1.00% Floor)     03/04/2026       —         (4,498     (9,974

Smartlinx Solutions, LLC(1) (4)

  Software & Tech
Services
  Term Loan   7.00% (L + 6.00%; 1.00% Floor)     03/04/2026       5,735,912       5,635,853       5,625,782  

Streamsets, Inc.(2) (3)

  Software & Tech
Services
  Revolver   6.75% (L + 5.00%; 0.75% PIK; 1.00% Floor)     11/25/2024       —         (9,115     (9,737

Streamsets, Inc.(4)

  Software & Tech
Services
  Term Loan   6.75% (L + 5.00%; 0.75% PIK; 1.00% Floor)     11/25/2024       2,103,146       2,048,309       2,044,721  

SugarCRM, Inc.(2) (3) (4)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     07/31/2024       —         (3,326     —    

SugarCRM, Inc.(1) (4)

  Software & Tech
Services
  Term Loan   7.50% (L + 6.50%; 1.00% Floor)     07/31/2024       4,268,824       4,215,403       4,268,824  

Swiftpage, Inc.(2) (3) (4)

  Software & Tech
Services
  Revolver   7.50% (L + 6.50%; 1.00% Floor)     06/13/2023       —         (2,232     (7,887

Swiftpage, Inc.(4)

  Software & Tech
Services
  Term Loan   7.50% (L + 6.50%; 1.00% Floor)     06/13/2023       2,471,441       2,445,531       2,384,940  

Swiftpage, Inc.(4)

  Software & Tech
Services
  Term Loan A   7.50% (L + 6.50%; 1.00% Floor)     06/13/2023       227,475       224,713       219,514  

Sysnet North America, Inc(2) (3)

  Software & Tech
Services
  Delayed Draw Term Loan
B1
  6.50% (L + 5.50%; 1.00% Floor)     12/01/2026       —         (28,973     (57,946

 

21


Table of Contents

Portfolio Company

  Industry   Facility Type  

Interest

  Maturity     Funded
Par Amount
    Cost     Fair Value  

Sysnet North America, Inc(1) (4)

  Software & Tech Services   Term Loan   6.50% (L + 5.50%; 1.00% Floor)     12/01/2026     $ 5,150,792     $ 5,073,530     $ 5,073,530  

Telesoft Holdings, LLC(2) (3)

  Software & Tech Services   Revolver   6.75% (L + 5.75%, 1.00% Floor)     12/16/2025       —         (11,150     (13,429

Telesoft Holdings, LLC(4)

  Software & Tech Services   Term Loan   6.75% (L + 5.75%, 1.00% Floor)     12/16/2025       5,923,900       5,811,092       5,790,612  

TRGRP, Inc.(2) (3)

  Software & Tech Services   Revolver   8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)     11/01/2023       —         (3,789     (6,666

TRGRP, Inc.(1)

  Software & Tech Services   Term Loan   8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)     11/01/2023       1,093,574       1,079,177       1,071,703  

TRGRP, Inc.(1) (4)

  Software & Tech Services   Term Loan   8.00% (L + 4.50%; 2.50% PIK; 1.00% Floor)     11/01/2023       4,894,320       4,836,011       4,796,433  

Velocity Purchaser Corporation(2) (3)

  Software & Tech Services   Revolver   7.00% (L + 6.00%; 1.00% Floor)     12/01/2022       —         (1,518     —    

Velocity Purchaser Corporation(1)

  Software & Tech Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/01/2022       660,247       653,553       660,247  

Velocity Purchaser Corporation(1)

  Software & Tech Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/01/2022       2,655,701       2,633,903       2,655,701  

Velocity Purchaser Corporation(1)

  Software & Tech Services   Third Amendment Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/01/2022       5,167,773       5,066,540       5,167,773  

Watermark Insights, LLC(1)

  Software & Tech Services   Delayed Draw Term Loan   5.00% (L + 4.00%; 1.00% Floor)     06/07/2024       324,557       323,118       317,255  

Watermark Insights, LLC(1)

  Software & Tech Services   Term Loan   5.00% (L + 4.00%; 1.00% Floor)     06/07/2024       2,586,180       2,570,238       2,527,991  

Dillon Logistics, Inc.(2)

  Transport & Logistics   Revolver   8.00% (L + 7.00%; 1.00% Floor)     12/11/2023       191,523       187,627       (28,059

Dillon Logistics, Inc.

  Transport & Logistics   Term Loan A   8.00% (L + 7.00%; 1.00% Floor)     12/11/2023       2,797,528       2,681,107       1,286,863  

Dillon Logistics, Inc.

  Transport & Logistics   Term Loan B   8.00% (L + 7.00%; 1.00% Floor)     12/11/2023       822,784       776,708       378,481  

OSG Bulk Ships,
Inc.(1)

  Transport & Logistics   Term Loan   5.16% (L + 5.00%)     12/21/2023       5,169,932       5,129,012       5,066,533  
           

 

 

   

 

 

 

Total U.S. 1st Lien/Senior Secured Debt

        506,794,869       499,889,111  

2nd Lien/Junior Secured Debt —5.13%

 

Brave Parent Holdings, Inc.(1)

  Energy   Term Loan   7.65% (L + 7.50%)     04/17/2026       1,230,107       1,208,583       1,202,429  

Foundation Risk Partners, Corp.(2) (3)

  Financials   2nd Lien Delayed Draw Term
Loan
  9.50% (L + 8.50%; 1.00% Floor)     11/10/2024       —         (15,711     (14,140

Foundation Risk Partners, Corp.(1)

  Financials   2nd Lien Term Loan   9.50% (L + 8.50%; 1.00% Floor)     11/10/2024       837,931       816,996       819,077  

Conterra Ultra Broadband Holdings, Inc.(1)

  Software & Tech Services   Term Loan   9.00% (L + 8.00%; 1.00% Floor)     04/30/2027       6,537,710       6,454,358       6,537,710  

Symplr Software,
Inc.(1)

  Software & Tech Services   2nd Lien Term Loan   8.625% (L + 7.875%; 0.75% Floor)     12/22/2028       2,909,482       2,851,443       2,851,293  
           

 

 

   

 

 

 

Total U.S. 2nd Lien/Junior Secured Debt

        11,315,669       11,396,369  
           

 

 

   

 

 

 

Total U.S. Corporate Debt

        518,110,538       511,285,480  

Canadian Corporate Debt —2.64%

 

1st Lien/Senior Secured Debt —2.64%

 

McNairn Holdings Ltd.(1) (4) (11) (12)

  Business Services   Term Loan   6.00% (L + 5.00%; 1.00% Floor)     11/25/2025       839,851       832,752       831,453  

Banneker V Acquisition,
Inc.(2) (3) (11)

  Software & Tech Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/04/2025       —         (20,464     (20,744

Banneker V Acquisition,
Inc.(2) (3) (11)

  Software & Tech Services   Revolver   7.00% (L + 6.00%; 1.00% Floor)     12/04/2025       —         (5,117     (5,186

Banneker V Acquisition, Inc.(4) (11)

  Software & Tech Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/04/2025       5,173,025       5,070,718       5,069,565  
           

 

 

   

 

 

 

Total Canadian 1st Lien/Senior Secured Debt

        5,877,889       5,875,088  
           

 

 

   

 

 

 

Total Canadian Corporate Debt

        5,877,889       5,875,088  

United Kingdom Corporate Debt —2.44%

 

1st Lien/Senior Secured Debt —2.44%

 

GlobalWebIndex
Inc.(2) (3)

  Software & Tech Services   Delayed Draw Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/30/2024       —         (36,837     (36,837

GlobalWebIndex
Inc.(4)

  Software & Tech Services   Term Loan   7.00% (L + 6.00%; 1.00% Floor)     12/30/2024       5,525,580       5,470,324       5,470,324  
           

 

 

   

 

 

 
             

Total United Kingdom 1st Lien/Senior Secured Debt

        5,433,487       5,433,487  
           

 

 

   

 

 

 

Total United Kingdom Corporate Debt

          5,433,487       5,433,487  

 

22


Table of Contents

Portfolio Company

   Industry                        Shares     Cost     Fair Value  

U.S. Preferred Stock —3.37%

 

Global Radar Holdings, LLC(13) (14)

   Business Services              125     $ 367,615     $ 367,618  

Concerto, LLC(13) (15)

   Healthcare & HCIT              65,614       349,977       349,977  

SBS Ultimate Holdings, LP(13)

   Healthcare & HCIT              217,710       861,879       620,472  

Datarobot, Inc.(13)

   Software & Tech Services              38,190       289,278       501,892  

Datarobot, Inc.(13)

   Software & Tech Services              6,715       88,248       88,248  

Degreed, Inc.(13)

   Software & Tech Services              43,819       278,541       438,190  

Heap(13)

   Software & Tech Services              189,617       696,351       696,351  

Netskope, Inc.(13)

   Software & Tech Services              36,144       302,536       302,536  

PerimeterX, Inc.(13)

   Software & Tech Services              282,034       838,601       838,601  

Phenom People, Inc.(13)

   Software & Tech Services              35,055       220,610       220,612  

Protoscale Rubrik(13)

   Software & Tech Services              25,397       598,212       598,201  

Punchh(13)

   Software & Tech Services              24,262       275,337       275,337  

Samsara Networks, Inc.(13)

   Software & Tech Services              33,451       369,998       369,998  

Streamsets, Inc.(13)

   Software & Tech Services              109,518       295,512       295,512  

Symplr Software Intermediate Holdings, Inc.(13)

   Software & Tech Services              1,196       1,160,532       1,532,404  
               

 

 

   

 

 

 

Total U.S. Preferred Stock

               6,993,227       7,495,949  

U.S. Common Stock - 1.20%

 

Neutral Connect, LLC(13) (16)

   Digital Infrastructure &
Services
             396,513       439,931       406,704  

Leeds FEG Investors, LLC(13)

   Education              320       321,309       341,595  

Nine Point Energy, LLC(13)

   Energy              3,567,059       —         —    

Health Platforms Group(13)

   Healthcare & HCIT              16,502       —         —    

Healthcare Services Acquisition(11) (13)

   Healthcare & HCIT              15,183       46       46  

Healthcare Services Acquisition(11) (13) (17)

   Healthcare & HCIT              28,158       281,580       287,775  

INH Group Holdings(13)

   Healthcare & HCIT              484,552       484,552       760,746  

Aggregator, LLC(13)

   Software & Tech Services              417,813       417,813       735,350  

American Safety Holdings Corp.(13) (18)

   Software & Tech Services              130,824       130,824       130,824  
               

 

 

   

 

 

 

Total U.S. Common Stock

               2,076,055       2,663,040  

U.S. Warrants —0.13%

 

Fuze, Inc., expire 09/20/2029(13)

   Digital Infrastructure &
Services
             196,328       615,168       11,505  

Healthcare Services Acquisition, expire
12/31/2027(11) (13)

   Healthcare & HCIT              14,079       —         —    

Healthcare Services Acquisition, expire
12/31/2027(11) (13)

   Healthcare & HCIT              23,721       23,721       23,721  

SBS Ultimate Holdings, LP, expire
09/18/2030(13)

   Healthcare & HCIT              17,419       —         —    

Alphasense, LLC, expire 05/29/2027(11) (13)

   Software & Tech Services              38,346       35,185       134,593  

Degreed, Inc., expire 05/31/2026(13)

   Software & Tech Services              26,294       46,823       95,800  

Streamsets, Inc., expire 11/25/2027(13)

   Software & Tech Services              23,382       16,367       16,367  
               

 

 

   

 

 

 

Total U.S. Warrants

               737,264       281,986  

 

23


Table of Contents

Portfolio Company

  

Industry

                      Shares     Cost     Fair
Value
 

United Kingdom Warrants —0.00%

 

GlobalWebIndex, Inc., expire 12/30/2027(13)

   Software & Tech Services             8,832     $ —       $ —    
              

 

 

   

 

 

 

Total United Kingdom Warrants

 

           —         —    

TOTAL INVESTMENTS—239.72%(19)

 

         $ 539,228,460     $ 533,035,030  
              

 

 

   

 

 

 

Cash Equivalents — 3.16%

 

U.S. Investment Companies —3.16%

 

Blackrock T Fund I(17) (20)

   Money Market Portfolio      0.01 %(21)           7,022,133     $ 7,022,133     $ 7,022,133  
              

 

 

   

 

 

 

Total U.S. Investment Companies

 

           7,022,133       7,022,133  
              

 

 

   

 

 

 

Total Cash Equivalents

 

           7,022,133       7,022,133  
              

 

 

   

 

 

 

LIABILITIES IN EXCESS OF OTHER ASSETS —(142.87%)

 

           $ (317,696,890
                

 

 

 

NET ASSETS—100.00%

 

           $ 222,360,273  
                

 

 

 

 

+ 

As of December 31, 2020, qualifying assets represented 96.99% of total assets. Under the 1940 Act we may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of our total assets.

* 

Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of Financial Accounting Standards Board’s Accounting Standards Codification 820 fair value hierarchy.

# 

Percentages are based on net assets.

^ 

Generally, the interest rate on floating interest rate investments is at benchmark rate plus spread. The borrower has an option to choose the benchmark rate, such as the London Interbank Offered Rate (“LIBOR”) or the U.S. Prime rate. The spread may change based on the type of rate used. The terms in the Consolidated Schedule of Investments disclose the actual interest rate in effect as of the reporting period. LIBOR loans are typically indexed to 30-day, 60-day, 90-day or 180-day LIBOR rates (1M L, 2M L, 3M L or 6M L, respectively) at the borrower’s option. LIBOR loans may be subject to interest floors. As of December 31, 2020, rates for weekly 1M L, 2M L, 3M L and 6M L are 0.15%, 0.19%, 0.23% and 0.26%, respectively. As of December 31, 2020, the U.S. Prime rate was 3.25%.

(1) 

Position, or a portion thereof, has been segregated to collateralize ABPCI Direct Lending Fund CLO VI Ltd.

(2) 

Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. See Note 6 “Commitments and Contingencies”.

(3) 

The negative cost is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value is the result of the capitalized discount on the loan.

(4) 

Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding II, LLC.

(5) 

Portion of security pledged as collateral for Secured Borrowings of the Fund.

(6) 

CutisPharma, Inc. has been renamed to Azurity Pharmaceuticals, Inc. in 2020.

(7) 

$304,934 of the funded par amount accrues interest at 10.50% (P + 2.00%; 5.25% PIK; 1.00% Floor).

(8) 

$128,492 of the funded par amount accrues interest at 9.25% (L + 3.00%; 5.25% PIK; 1.00% Floor).

(9) 

$233,055 of the funded par amount accrues interest at 7.50% (P + 4.25%; 1.00% Floor).

(10) 

Rhode Holdings, Inc. has been renamed to Kaseya Inc. in 2020.

(11) 

Positions considered non-qualified assets therefore excluded from the qualifying assets calculation as noted in footnote + above.

(12) 

JHMCRN Holdings, Inc. has been renamed to McNairn Holdings Ltd. in 2020.

(13) 

Non-income producing investment.

(14) 

Position or portion thereof is held by Global Radar Acquisition Holdings, LLC which is held by ABPCIC Global Radar LLC

(15) 

Concerto, LLC is held through ABPCIC Concerto Holdings LLC.

(16) 

Neutral Connect, LLC is held through ABPCIC NC Holdings LLC.

(17) 

Categorized as Level 1 assets under the definition of ASC 820 fair value hierarchy.

(18) 

Position or portion thereof is held by REP Coinvest II Tec, LP which is held by ABPCIC Equity Holdings, LLC.

(19) 

Aggregate gross unrealized appreciation for federal income tax purposes is $6,674,968; aggregate gross unrealized depreciation for federal income tax purposes is $13,046,945. Net unrealized depreciation is $6,371,977 based upon a tax cost basis of $539,407,008.

(20) 

Included within ‘Cash and cash equivalents’ on the Consolidated Statements of Assets and Liabilities.

(21) 

The rate shown is the annualized seven-day yield as of December 31, 2020.

 

L   -    LIBOR
P   -    Prime
PIK   -    Payment-In-Kind

 

24


Table of Contents

AB Private Credit Investors Corporation

Notes to Unaudited Consolidated Financial Statements

March 31, 2021

1. Organization

AB Private Credit Investors Corporation (the “Fund,” “we,” “our,” and “us”), an externally managed, non-diversified, closed-end, management investment company that elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), was incorporated under the laws of the state of Maryland on February 6, 2015. The Fund was formed to invest in primary-issue middle-market credit opportunities that are directly sourced and privately negotiated. AB Private Credit Investors LLC serves as the Fund’s external investment adviser (the “Adviser”).

Prior to 2017, there were no significant operations other than the sale and issuance of 100 shares of common stock of the Fund, par value $0.01 (“Shares”), on June 27, 2016, at an aggregate purchase price of $1,000 ($10.00 per Share) to the Adviser. The sale of Shares was approved by the unanimous consent of the Fund’s Board of Directors (the “Board”). In addition, prior to commencing operations in 2017, on May 26, 2017, the Fund issued and sold an additional 2,400 Shares at an aggregate purchase price of $24,000 ($10.00 per Share) to the Adviser. That sale was also approved by the unanimous consent of the Fund’s Board.

The Fund is conducting private offerings (each a “Private Offering”) of its common stock to investors in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). At the closing of any Private Offering, each investor will make a capital commitment (a “Capital Commitment”) to purchase Shares pursuant to a subscription agreement entered into with the Fund. Investors will be required to fund drawdowns to purchase Shares up to the amount of their respective Capital Commitment on an as-needed basis each time the Fund delivers a capital draw-down notice to its investors.

On September 29, 2017, the Fund completed the initial closing (“Initial Closing”) of its Private Offering after entering into subscription agreements (collectively, the “Subscription Agreements”) with several investors, providing for the private placement of Shares. At March 31, 2021, the Fund had total Capital Commitments of $456,870,158, of which 44% is unfunded. Capital Commitments may be drawn down by the Fund on a pro rata basis, as needed (including follow-on investments), for paying the Fund’s expenses, including fees under the Amended and Restated Advisory Agreement (as defined below), and/or maintaining a reserve account for the payment of future expenses or liabilities.

There were no operating activities from February 6, 2015 to November 15, 2017. As described above, the Fund completed its Initial Closing on September 29, 2017, and commenced operations on November 15, 2017 by issuing its first Capital Call (as defined below) on December 1, 2017. The Fund’s fiscal year ends on December 31.

On December 19, 2018, the Adviser established ABPCIC Funding I LLC (“ABPCIC Funding”), a Delaware limited liability company. ABPCIC Funding is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements commencing from the date of its formation.

On June 14, 2019, the Adviser established ABPCI Direct Lending Fund CLO VI Ltd (“CLO VI”), an exempted company incorporated with limited liability under the laws of the Cayman Islands. CLO VI is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements.

On August 9, 2019, ABPCIC Funding and CLO VI entered into a merger agreement, pursuant to which ABPCIC Funding has agreed to merge with and into CLO VI, with CLO VI as the surviving entity. CLO VI issued Class B, Class C and Subordinated Notes to the Fund through AB PCI Direct Lending Fund CLO VI Depositor LLC, a wholly-owned subsidiary of the Fund established on August 9, 2019.

On September 25, 2019, the Fund established ABPCIC NC Holdings LLC (“ABPCIC NC”), through which the Fund made an investment. ABPCIC NC is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements commencing from the date of its formation.

On December 17, 2019, the Fund established ABPCIC Concerto Holdings LLC (“ABPCIC Concerto”), through which the Fund made an investment. ABPCIC Concerto is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements commencing from the date of its formation.

On February 7, 2020, the Fund and an affiliate of Abbott Capital Management, LLC (“Abbott”) became members of, ABPCIC Equity Holdings, LLC (“ABPCICE”), a Delaware limited liability company and a special purpose vehicle designed to invest in private equity investments sourced by Abbott. The Fund is the managing member and owns 100% of the Class L Units and 93% of the Class A Units of ABPCICE. As a result, the Fund consolidates ABPCICE in its consolidated financial statements and records a non-controlling interest of the equity interests in ABPCICE not held by the Fund.

 

25


Table of Contents

On July 30, 2020, the Adviser established ABPCIC Funding II LLC (“ABPCIC Funding II”), a Delaware limited liability company. ABPCIC Funding II is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements commencing from the date of its formation.

On December 28, 2020, the Adviser established ABPCIC Global Radar, LLC (“ABPCIC Global Radar”), through which the Fund made an investment. ABPCIC Global Radar is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements commencing from the date of its formation.

On February 11, 2021, the Adviser established ABPCIC Funding III LLC (“ABPCIC Funding III”), a Delaware limited liability company. ABPCIC Funding III is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements commencing from the date of its formation.

2. Significant Accounting Policies

The Fund is an investment company under accounting principles generally accepted in the United States of America (“GAAP”) and follows the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 946, Financial Services – Investment Companies. The Fund has prepared the consolidated financial statements and related financial information pursuant to the requirements for reporting on Form 10-Q and Articles 6 and 10 of Regulation S-X. Accordingly, we have not included in this quarterly report all of the information and notes required by GAAP for annual financial statements. In the opinion of management, the unaudited financial information for the interim period presented in this report reflects all normal and recurring adjustments necessary for a fair statement of financial position and results from operations. Operating results for interim periods are not necessarily indicative of operating results for an entire year.

The functional currency of the Fund is U.S. dollars and these consolidated financial statements have been prepared in that currency.

Consolidation

The Fund will generally consolidate any wholly or substantially owned subsidiary when the design and purpose of the subsidiary is to act as an extension of the Fund’s investment operations and to facilitate the execution of the Fund’s investment strategy. Accordingly, the Fund consolidated the results of its subsidiaries (ABPCIC Funding, CLO VI, ABPCIC NC, ABPCIC Concerto, ABPCICE, ABPCIC Funding II, ABPCIC Funding III and ABPCIC Global Radar) in its consolidated financial statements. The portion of net assets that is attributable to non-controlling interest in ABPCICE is presented as “Non-Controlling Interest in ABPCIC Equity Holdings, LLC”, a component of total equity, on the Fund’s consolidated statements of assets and liabilities. All intercompany balances and transactions have been eliminated in consolidation.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current presentation, with no significant effect on our financial condition, results of operations or cash flows.

Cash and Cash Equivalents

Cash consists of demand deposits and money market accounts. Cash is carried at cost, which approximates fair value. The Fund maintains deposits of its cash with financial institutions, and, at times, cash held in bank accounts may exceed the Federal Deposit Insurance Corporation insured limit. The Fund considers all highly liquid investments, with original maturities of less than ninety days, as cash equivalents.

Revenue Recognition

Investment transactions are recorded on a trade-date basis. Interest income is recognized on an accrual basis. Interest income on debt instruments is accrued and recognized for those issuers who are currently paying in full or expected to pay in full. For those issuers who are in default or expected to default, interest is not accrued and is only recognized when received. Generally, when interest and/or principal payments on a loan become past due, or if the Fund otherwise does not expect the borrower to be able to service its debt and other obligations, the Fund will place the loan on non-accrual status and will cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to restructuring such that the interest income is deemed to be collectible. The Fund generally restores non-accrual loans to accrual status

 

26


Table of Contents

when past due principal and interest is paid and, in the management’s judgment, is likely to remain current. Interest income and expense include discounts accreted and premiums amortized on certain debt instruments as determined in good faith by the Adviser and calculated using the effective interest method. Loan origination fees, original issue discounts and market discounts or premiums are capitalized as part of the underlying cost of the investments and accreted or amortized over the life of the investment as interest income.

Realized gains and losses on investment transactions are determined on the specific identification method.

Certain investments in debt securities may contain a contractual payment-in-kind (“PIK”) interest provision. The PIK provisions generally feature the obligation, or the option, at each interest payment date of making interest payments in (i) cash, (ii) additional debt or (iii) a combination of cash and additional debt. PIK interest, computed at the contractual rate specified in the investment’s credit agreement, is accrued as interest income and recorded as interest receivable up to the interest payment date. On the interest payment date, the accrued interest receivable attributable to PIK is added to the principal balance of the investment. When additional debt is received on the interest payment date, it typically has the same terms, including maturity dates and interest rates, as the original loan. PIK interest generally becomes due on the investment’s maturity date or call date.

The Fund may earn various fees during the life of the loans. Such fees include, but are not limited to, syndication, commitment, administration, prepayment and amendment fees, some of which are paid to the Fund on an ongoing basis. These fees and any other income are recognized as earned.

Non-Accrual Investments

Investments are placed on non-accrual status when it is probable that principal, interest or dividends will not be collected according to the contractual terms. Accrued interest or dividends generally are reversed when an investment is placed on non-accrual status. Interest or dividend payments received on non-accrual investments may be recognized as income or applied to principal depending upon management’s judgment. Nonaccrual investments are restored to accrual status when past due principal and interest or dividends are paid and, in management’s judgment, principal and interest or dividend payments are likely to remain current. The Fund may make exceptions to this treatment if an investment has sufficient collateral value and is in the process of collection. As of March 31, 2021, the Fund had certain investments held in one portfolio company on non-accrual status, which represented 0.31% and 0.67% of the total investments (excluding investments in cash equivalents, if any) at amortized cost and at fair value. As of December 31, 2020, the Fund had no investments on non-accrual status.

Credit Facility Related Costs, Expenses and Deferred Financing Costs

The Revolving Credit Facilities (as defined in Note 4) are recorded at carrying value, which approximates fair value. Interest expense and unused commitment fees on the Revolving Credit Facilities are recorded on an accrual basis. Unused commitment fees are included in interest and borrowing expenses in the consolidated statements of operations. Deferred financing costs include capitalized expenses related to the closing of the Revolving Credit Facilities. Amortization of deferred financing costs is computed on the straight-line basis over the contractual term. The amortization of such costs is included in interest and borrowing expenses in the consolidated statements of operations, with any unamortized amounts included in deferred financing costs on the consolidated statements of assets and liabilities.

Notes Payable Related Costs, Expenses and Unamortized Debt Issuance Costs

The Notes (as defined in Note 4) are recorded at carrying value. Interest expense on notes payable is recorded on an accrual basis. Debt issuance costs relating to notes payable are amortized on a straight-line basis over the contractual term and included in interest and borrowing expenses in the consolidated statements of operations. The unamortized debt issuance costs are included as a direct reduction of the carrying value of the notes payable (i.e. a contra liability).

Upon early termination or partial principal pay down of the Notes, the unamortized costs related to the Notes are accelerated into interest and borrowing expenses on the Fund’s consolidated statements of operations.

Secured Borrowings

The Fund may finance the purchase of certain investments through sale/buy-back agreements. In a sale/buy-back agreement, the Fund enters into a trade to sell an investment and contemporaneously enters into a trade to buy the same investment back on a specified date in the future with the same counterparty. The Fund uses sale/buy-back agreements as a short-term financing alternative

 

27


Table of Contents

to its existing Revolving Credit Facilities. The Fund accounts for its sale/buy-back agreements (the “Secured Borrowings”) as secured borrowings and continues to present the investment as an asset and the obligation to return the cash received as a liability within secured borrowings on the consolidated statements of assets and liabilities. Interest income earned on investments pledged under sale/buy-back agreements and financing charges associated with the sale/buy-back agreements are included within interest income and interest and borrowing expenses, respectively, on the consolidated statements of operations. Accrued interest receivable on investments and accrued financing charges on the sale/buy-back agreements are included within interest receivable and interest and borrowing expenses payable, respectively, on the consolidated statements of assets and liabilities.

Income Taxes

ASC 740, “Accounting for Uncertainty in Income Taxes” (“ASC 740”) provides guidance on the accounting for and disclosure of uncertainty in tax positions. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Fund’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Based on its analysis of its tax position for all open tax years (the current and prior two years), the Fund has concluded that it does not have any uncertain tax positions that met the recognition or measurement criteria of ASC 740. Such open tax years remain subject to examination and adjustment by tax authorities.

The Fund has elected to be treated and intends to continue to be treated for federal income tax purposes as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). So long as the Fund is able to maintain its status as a RIC, it intends not to be subject to U.S. federal income tax on the portion of its taxable income and gains distributed to stockholders, if any. To qualify for RIC tax treatment, the Fund is required to distribute at least 90% of its investment company taxable income annually, meet diversification and income requirements quarterly, meet gross income requirements annually and file Form 1120-RIC, as provided by the Code. In order for the Fund not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Fund, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income. The Fund will accrue excise tax on estimated undistributed taxable income as required. For the three months ended March 31, 2021 and March 31, 2020, the Fund accrued excise taxes of $0 and $0, respectively. As of March 31, 2021, and December 31, 2020, $0 and $0, respectively, of accrued excise taxes remained payable.

The Fund may be subject to taxes imposed by countries in which the Fund invests. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued and applied to net investment income, net realized gains and net unrealized gain (loss) as such income and/or gains are earned.

The Fund remains subject to examination by U.S. federal and state jurisdictions, as well as international jurisdictions, and upon completion of these examinations (if undertaken by the taxing jurisdiction) tax adjustments may be necessary and retroactive to all open tax years.

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities, if any, at the date of the consolidated financial statements, and the reported amounts of revenues and expenses recorded during the reporting period. Actual results could differ from those estimates and such differences could be material.

Distributions

Distributions from net investment income and net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may differ from those amounts determined in accordance with GAAP. The Fund may pay distributions in excess of its taxable net investment income. This excess would be a tax-free return of capital in the period and reduce the stockholder’s tax basis in its Shares. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent they are charged or credited to paid-in capital in excess of par, accumulated undistributed net investment income or accumulated net realized gain (loss), as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and non-deductible expenses. These differences are generally determined in conjunction with the preparation of the Fund’s annual RIC tax

 

28


Table of Contents

return. Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by the Adviser. The Fund may pay distributions to its stockholders in a year in excess of its net ordinary income and capital gains for that year and, accordingly, a portion of such distributions may constitute a return of capital for U.S. federal income tax purposes. The Fund intends to timely distribute to its stockholders substantially all of its annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of the Fund’s taxable income earned in a year, the Fund may choose to carry forward taxable income for distribution in the following year and pay any applicable U.S. federal excise tax. The specific tax characteristics of the Fund’s distributions will be reported to stockholders after the end of the calendar year. All distributions will be subject to available funds, and no assurance can be given that the Fund will be able to declare such distributions in future periods.

The Fund has adopted a dividend reinvestment plan that provides for stockholders to receive dividends or other distributions declared by the Board in cash unless a stockholder elects to “opt in” to the dividend reinvestment plan. As a result, if the Board declares a cash distribution, then the stockholders who have “opted in” to the dividend reinvestment plan will have their cash distributions automatically reinvested in additional Shares, rather than receiving the cash distribution.

Recent Accounting Pronouncements

In March 2020, the FASB issued Accounting Standards Update 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). This update provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships, and other transactions affected by reference rate reform, if certain criteria are met. The amendments in this update are optional and effective from March 12, 2020 through December 31, 2022. Management is currently evaluating whether to employ the optional expedients or exceptions in ASU 2020-04, and have not used the expedients or exceptions for the three months ended March 31, 2021.

3. Related Party Transactions

Advisory Agreement

On November 13, 2019, the Fund entered into the Amended and Restated Advisory Agreement (the “Amended and Restated Advisory Agreement”), replacing the advisory agreement the Fund entered into with the Adviser on July 27, 2017 (the “Advisory Agreement”), pursuant to which the Fund will pay the Adviser, quarterly in arrears, a base management fee calculated at an annual rate of 1.50%. The base management fee is calculated based on a percentage of the average outstanding assets of the Fund (which equals the gross value of equity and debt instruments, including investments made utilizing leverage), excluding cash and cash equivalents, during such fiscal quarter. The average outstanding assets is calculated by taking the average of the amount of assets of the Fund at the beginning and end of each month that occurs during the calculation period. The base management fee is calculated and paid quarterly in arrears but will be accrued monthly by the Fund over the fiscal quarter for which such base management fee is paid. The base management fee for any partial month or quarter is appropriately prorated. For the three months ended March 31, 2021, the Fund incurred a management fee of $2,069,181, of which $183,001 was voluntarily waived by the Adviser. For the three months ended March 31, 2020, the Fund incurred a management fee of $1,352,351, of which $1,227,046 was voluntarily waived by the Adviser. As of March 31, 2021, and December 31, 2020, $3,419,518 and $1,533,338, respectively, of accrued management fee remained payable.

The Fund will also pay the Adviser an incentive fee that provides the Adviser with a share of the income that the Adviser generates for the Fund. The incentive fee will consist of an income-based incentive fee component and a capital-gains component, which are largely independent of each other, with the result that one component may be payable even if the other is not.

Income-Based Incentive Fee: The income-based incentive fee is calculated and payable quarterly in arrears based on the Fund’s net investment income prior to any deductions with respect to such income-based incentive fees and capital gains incentive fees (“Pre-incentive Fee Net Investment Income” or “PIFNII”) for the quarter, as further described below. PIFNII means interest income, dividend income and any other income (including any other fees, such as commitment, origination, structuring, diligence, managerial and consulting fees or other fees the Fund receives from portfolio companies) that the Fund accrues during the fiscal quarter, minus the Fund’s operating expenses for the quarter (including the base management fee, expenses payable under the administration agreement (the “Administration Agreement”) we have entered into with State Street Bank and Trust (the “Administrator”), and any interest expense and dividends paid on any issued and outstanding indebtedness or preferred stock, respectively, but excluding, for avoidance of doubt, the income-based incentive fee accrued under GAAP). PIFNII also includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with pay-in-kind interest and zero-coupon securities), accrued income that the Fund has not yet received in cash. The Adviser is not under any obligation to reimburse the Fund for any part of the income-based incentive fees it received that was based on accrued interest that the Fund never actually received.

 

29


Table of Contents

PIFNII does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Because of the structure of the income-based incentive fee, it is possible that the Fund may accrue such income-based incentive fee in a quarter where the Fund incurs a net loss. For example, if the Fund receives PIFNII in excess of a hurdle rate (as defined below) for a quarter, the Fund will accrue the applicable income-based incentive fee even if the Fund has incurred a realized and/or unrealized capital loss in that quarter. However, cash payment of the income-based incentive fee may be deferred in this situation, subject to the restrictions detailed at the end of this section.

PIFNII, expressed as a rate of return on the average value of the Fund’s net assets (defined as total assets, less indebtedness and before taking into account any incentive fees payable during the period) as of the first day of each month during the course of the immediately preceding calendar quarter, will be compared to various “hurdle rates,” with the income-based incentive fee rate of return increasing at each hurdle rate.

Description of Quarterly Incentive Fee Calculations

The Fund pays the Adviser an income-based incentive fee with respect to PIFNII in each calendar quarter as follows:

 

   

No income-based incentive fee in any calendar quarter in which PIFNII does not exceed 1.5% per quarter (6% per annum), the “6% Hurdle Rate”;

 

   

100% of PIFNII with respect to that portion of such PIFNII, if any, that exceeds the 6% Hurdle Rate but is less than 1.67% in any calendar quarter (the “6% Catch-up Cap”), approximately 6.67% per annum. This portion of PIFNII (which exceeds the 6% Hurdle Rate but is less than the 6% Catch-up Cap) is referred to as the “6% Catch-up.” The 6% Catch-up is meant to provide the Adviser with 10.0% of the PIFNII as if hurdle rate did not apply if this net investment income exceeded 1.67% but was less than 1.94% in any calendar quarter; and

 

   

10.0% of the amount of PIFNII, if any, that exceeds the 6% Catch-up Cap, but is less than 1.94% (the “7% Hurdle Rate”), approximately 7.78% per annum. The 7% Hurdle Rate is meant to limit the Adviser to 10% of the PIFNII until the amount of PIFNII exceeds 1.94%, approximately 7.78% per annum; and

 

   

100% of PIFNII with respect to that portion of such PIFNII, if any, that exceeds the 7% Hurdle Rate but is less than 2.06% in any calendar quarter (the “7% Catch-up Cap”), approximately 8.24% per annum. This portion of PIFNII (which exceeds the 7% Hurdle Rate but is less than the 7% Catch-up Cap) is referred to as the “7% Catch-up.” The 7% Catch-up is meant to provide the Adviser with 15.0% of the PIFNII as if a hurdle rate did not apply if this net investment income exceeded 2.06% but was less than 2.35% in any calendar quarter; and

 

   

15.0% of the amount of PIFNII, if any, that exceeds the 7% Catch-up Cap, but is less than 2.35% (the “8% Hurdle Rate”, approximately 9.41% per annum). The 8% Hurdle Rate is meant to limit the Adviser to 15% of the PIFNII until the amount of PIFNII exceeds 2.35%, approximately 9.41% per annum; and

 

   

100% of PIFNII with respect to that portion of such PIFNII, if any, that exceeds the 8% Hurdle Rate but is less than 2.50% in any calendar quarter (the “8% Catch-up Cap”), approximately 10% per annum. This portion of PIFNII (which exceeds the 8% Hurdle Rate but is less than the 8% Catch-up cap) is referred to as the “8% Catch-up”. The 8% Catch-up is meant to provide the Adviser with 20.0% of the PIFNII as if a hurdle rate did not apply if this net investment income exceeded 2.50% in any calendar quarter; and

 

   

20.0% of the amount of PIFNII, if any, that exceeds 2.50% in any calendar quarter.

For the three months ended March 31, 2021, the Fund incurred income-based incentive fees of $641,062. For the three months ended March 31, 2020, the Fund incurred income-based incentive fees of $769,023, of which $486,784 was voluntarily waived by the Adviser. As of March 31, 2021 and December 31, 2020, $2,994,136, and $2,353,074, respectively, of accrued income-based incentive fees remained payable.

Capital Gains Incentive Fee: The capital gains incentive fee is determined and payable at the end of each fiscal year as 20% of aggregate cumulative realized capital gains from the date of the Fund’s election to be regulated as a BDC through the end of that year, computed net of all aggregate cumulative realized capital losses and aggregate cumulative unrealized depreciation through the end of such year, less the aggregate amount of any previously paid capital gain incentive fees. For the foregoing purpose, “aggregate cumulative realized capital gains” will not include any unrealized appreciation. For accounting purposes only, we are required under GAAP to accrue a hypothetical capital gains incentive fee based upon net realized gains and unrealized depreciation for that calendar year (in accordance with the terms of the Amended and Restated Advisory Agreement), plus unrealized appreciation on investments held at the end of the period. The accrual of this hypothetical capital gains incentive fee assumes all unrealized capital gain and loss is realized in order to reflect a hypothetical capital gains incentive fee that would be payable to the Adviser at each measurement date.

 

30


Table of Contents

The capital gains incentive fee is not subject to any minimum return to stockholders. If such amount is negative, then no capital gains incentive fee will be payable for such year. Additionally, if the Amended and Restated Advisory Agreement is terminated as of a date that is not a calendar year end, the termination date will be treated as though it were a calendar year end for purposes of calculating and paying the capital gains incentive fee.

Since inception, no capital gains incentive fees have been incurred or are payable as of March 31, 2021 and December 31, 2020.

The amount of capital gains incentive fee expense related to a hypothetical liquidation of the portfolio (and assuming no other changes in realized or unrealized gains and losses) would only become payable to the Adviser in the event of a complete liquidation of the Fund’s portfolio as of period end and the termination of the Amended and Restated Advisory Agreement on such date. Also, it should be noted that the capital gains incentive fee expense fluctuates with the Fund’s overall investment results.

The Fund will defer cash payment of any income-based incentive fee and/or any capital gains incentive fee otherwise earned by the Adviser if during the most recent four full fiscal quarter periods ending on or prior to the date such payment is to be made, the sum of (a) the PIFNII, and (b) the realized capital gain / loss and (c) unrealized capital appreciation/ depreciation expressed as a rate of return on the value of our net assets, is less than 6.0%. Any such deferred fees are carried over for payment in subsequent calculation periods to the extent such payment is payable under the Amended and Restated Advisory Agreement.

Administration Agreement and Expense Reimbursement Agreement

We have entered into the Administration Agreement with the Administrator and a separate expense reimbursement agreement with the Adviser (the “Expense Reimbursement Agreement”) under which any allocable portion of the cost of our Chief Compliance Officer and Chief Financial Officer and their respective staffs will be reimbursed by the Fund. Under the Administration Agreement, the Administrator will be responsible for providing us with clerical, bookkeeping, recordkeeping and other administrative services. We will reimburse the Adviser an amount equal to our allocable portion (subject to the review of our Board) of its overhead resulting from its obligations under the Expense Reimbursement Agreement, including the allocable portion of the cost of our Chief Compliance Officer and Chief Financial Officer and their respective staffs.

Expense Support and Conditional Reimbursement Agreement

On September 29, 2017, the Fund and the Adviser entered into an agreement (the “Expense Support and Conditional Reimbursement Agreement”) to limit certain of the Fund’s Operating Expenses, as defined below, to no more than 1.5% of the Fund’s average quarterly gross assets. To achieve this percentage limitation, the Adviser has agreed to reimburse the Fund for certain Operating Expenses on a quarterly basis (any such payment by the Adviser, an “Expense Payment”) and the Fund has agreed to later repay such amounts (any such payment by the Fund, a “Reimbursement Payment”), pursuant to the terms of the Expense Support and Conditional Reimbursement Agreement. The actual percentage of Operating Expenses paid by the Fund in any quarter after deducting any Expense Payment, as a percentage of the Fund’s average quarterly gross assets, is referred to as the “Percentage Limit.”

Any Expense Payment by the Adviser pursuant to the Expense Support and Conditional Reimbursement Agreement will be subject to repayment by the Fund on a quarterly basis within the three years following the fiscal quarter of the Fund in which the Operating Expenses were paid or absorbed, if the total Operating Expenses for the current quarter, including Reimbursement Payments, expressed as a percentage of the Fund’s average gross assets during such quarter is less than the then-current Percentage Limit, if any, and the Percentage Limit that was in effect at the time when the Adviser reimbursed the Operating Expenses that are the subject of the repayment, subject to certain provisions of the Expense Support and Conditional Reimbursement Agreement, as described below. For purposes of the Expense Support and Conditional Reimbursement Agreement, “Operating Expenses” means the Fund’s Total Operating Expenses (as defined below), excluding base management fees, incentive fees, distribution and stockholder servicing fees, financing fees and costs, interest expense, brokerage commissions and extraordinary expenses and “Total Operating Expenses” means all of the Fund’s operating costs and expenses incurred, as determined in accordance with generally accepted accounting principles for investment companies.

However, no Reimbursement Payment for any quarter will be made if: (1) the Effective Rate of Distributions Per Share (as defined below) declared by the Fund at the time of such Reimbursement Payment is less than or equal to the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Fund’s Operating Expense Ratio at the time of such Reimbursement Payment is greater than or equal to the Operating Expense Ratio (as defined below) at the time the Expense Payment was made to which such Reimbursement Payment relates. For purposes of the Expense Support and Conditional Reimbursement Agreement, “Effective Rate of Distributions Per Share” means the annualized rate (based on a 365- day year) of regular cash distributions per Share exclusive of returns of capital, distribution rate reductions due to distribution and stockholder fees, and declared special dividends or special distributions, if any. The “Operating Expense Ratio” is calculated by dividing Operating Expenses in any quarter by the Fund’s average net assets in such quarter.

 

31


Table of Contents

The specific amount of expenses paid by the Adviser, if any, will be determined at the end of each quarter. The Fund or the Adviser may terminate the Expense Support and Conditional Reimbursement Agreement at any time, with or without notice. The Expense Support and Conditional Reimbursement Agreement will automatically terminate in the event of (a) the termination of the Amended and Restated Advisory Agreement, or (b) the Board of the Fund making a determination to dissolve or liquidate the Fund. Upon termination of the Expense Support and Conditional Reimbursement Agreement, the Fund will be required to fund any Expense Payments, subject to the aforementioned requirements per the Expense Support and Conditional Reimbursement Agreement, that have not been reimbursed by the Fund to the Adviser.

As of March 31, 2021, the amount of Expense Payments provided by the Adviser since inception is $4,874,139. The following table reflects the Expense Payments that may be subject to reimbursement pursuant to the Expense Agreement:

 

For the Quarters Ended

   Amount of
Expense Support
     Amount of
Reimbursement
Payment
     Amount of
Unreimbursed
Expense
Support
     Effective Rate of
Distribution
per Share (1)
    Reimbursement Eligibility
Expiration
     Percentage
Limit (2)
 

September 30, 2017

   $ 1,002,147      $ 1,002,147      $ —          n/a       September 30, 2020        1.5

December 31, 2017

     1,027,398        1,027,398        —          n/a       December 31, 2020        1.5

March 31, 2018

     503,592        503,592        —          n/a       March 31, 2021        1.5

June 30, 2018

     1,086,482        294,658        791,824        4.787     June 30, 2021        1.0

September 30, 2018

     462,465        —          462,465        4.715     September 30, 2021        1.0

December 31, 2018

     254,742        —          254,742        6.762     December 31, 2021        1.0

March 31, 2019

     156,418        —          156,418        5.599     March 31, 2022        1.0

June 30, 2019

     259,263        —          259,263        6.057     June 30, 2022        1.0

September 30, 2019

     31,875        —          31,875        5.154     September 30, 2022        1.0

December 31, 2019

     —          —          —          6.423     December 31, 2022        1.0

March 31, 2020

     89,757        —          89,757        10.17     March 31, 2023        1.0

June 30, 2020

     —          —          —          5.662     June 30, 2023        1.5

September 30, 2020

     —          —          —          6.063     September 30, 2023        1.5

December 31, 2020

     —          —          —          6.266     December 31, 2023        1.5

March 31, 2021

     —          —          —          6.241     March 31, 2024        1.0
  

 

 

    

 

 

    

 

 

         

Total

   $ 4,874,139      $ 2,827,795      $ 2,046,344          
  

 

 

    

 

 

    

 

 

         

 

(1)

The effective rate of distribution per Share is expressed as a percentage equal to the projected annualized distribution amount as of the end of the applicable period (which is calculated by annualizing the regular quarterly cash distributions per Share as of such date without compounding), divided by the Fund’s gross offering price per Share as of such date.

(2)

Represents the actual percentage of Operating Expenses paid by the Fund in any quarter after deducting any Expense Payment, as a percentage of the Fund’s average quarterly gross assets.

Transfer Agency Agreement

On September 26, 2017, the Fund and AllianceBernstein Investor Services, Inc. (“ABIS”), an affiliate of the Fund, entered into an agreement pursuant to which ABIS will provide transfer agent services to the Fund. The Fund bears the expenses related to the agreement with ABIS.

For the three months ended March 31, 2021 and March 31, 2020, the Fund accrued $16,386 and $10,758 in transfer agent fees, respectively. As of March 31, 2021 and December 31, 2020, $30,195 and $13,809, respectively, of accrued transfer agent fees remained payable.

4. Borrowings

Credit Facilities

On November 15, 2017, the Fund entered into a credit agreement (the “HSBC Credit Agreement”) to establish a revolving credit facility (the “HSBC Credit Facility”) with HSBC Bank USA, National Association (“HSBC”) as administrative agent (the “HSBC Administrative Agent”). The maximum commitment amount (the “HSBC Maximum Commitment”) under the HSBC Credit Facility was initially $30 million and may be increased in a minimum amount of $10 million and in $5 million increments thereof with the consent of HSBC or reduced upon request of the Fund. As of January 31, 2019, the Fund has increased the HSBC Maximum

 

32


Table of Contents

Commitment to $50 million. So long as no request for borrowing is outstanding, the Fund may terminate the lenders’ commitments (the “Commitments”) or reduce the HSBC Maximum Commitment by giving prior irrevocable written notice to the HSBC Administrative Agent. Any reduction of the HSBC Maximum Commitment shall be in an amount equal to $10 million or multiples thereof; and in no event shall a reduction by the Fund reduce the Commitments to $35 million or less (in each case, except for a termination of all the Commitments). Proceeds under the HSBC Credit Agreement may be used for any purpose permitted under the Fund’s organizational documents, including general corporate purposes such as the making of investments. The HSBC Credit Agreement contains certain customary covenants and events of default, with customary cure and notice provisions. As of March 31, 2021, the Fund is in compliance with these covenants. The Fund’s obligations under the HSBC Credit Agreement are secured by the Capital Commitments and Capital Contributions (as defined below).

Borrowings under the HSBC Credit Agreement bear interest, at the Fund’s election at the time of drawdown, at a rate per annum equal to (i) with respect to LIBOR Rate Loans (as defined in the HSBC Credit Agreement), Adjusted LIBOR (as defined in the HSBC Credit Agreement) for the applicable Interest Period (as defined in the HSBC Credit Agreement); and (ii) with respect to Reference Rate Loans (as defined in the HSBC Credit Agreement), the greatest of: (x) the rate of interest per annum publicly announced from time to time by HSBC as its prime rate, (y) the rate per annum equal to the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers on such day, plus two hundred basis points (2.00%), provided that if such rate is not so published for any day that is a Business Day (as defined in the HSBC Credit Agreement), the average of the quotation for such day on such transactions received by the HSBC Administrative Agent, from three (3) Federal funds brokers of recognized standing selected by the HSBC Administrative Agent and, upon request of Borrowers (as defined in the HSBC Credit Agreement), with notice of such quotations to the Borrowers and (z) except during any period of time during which LIBOR is unavailable, one-month Adjusted LIBOR plus one hundred ninety basis points (1.90%). The Fund will also pay an unused commitment fee of 35 basis points (0.35%) on any unused commitments.

On November 10, 2020, the Fund entered into an amendment to the HSBC Credit Agreement (the “HSBC Credit Agreement Amendment”) concerning the HSBC Credit Facility. The HSBC Credit Agreement Amendment (i) extended the maturity date of the HSBC Credit Facility from November 11, 2020 to November 9, 2021, and (ii) inserted a provision permitting the Fund and the HSBC Administrative Agent to, upon the occurrence of certain conditions, amend the HSBC Credit Agreement to replace references to LIBOR with references to an alternate benchmark rate that may include a forward-looking rate based on the Secured Overnight Financing Rate or another alternate benchmark rate subject to certain conditions. The Fund has an option to extend the maturity date for up to one additional term not longer than 364 days, subject to the following conditions: (i) each of the Lenders (as defined in the HSBC Credit Agreement) and the HSBC Administrative Agent consents to the extension in their sole discretion; (ii) the Fund has paid an extension fee to the HSBC Administrative Agent for the benefit of the extending Lenders consenting to such extension in an amount agreed to by the HSBC Administrative Agent and the Borrowers at the time of the extension and as set forth in the applicable extension request; (iii) no potential default or event of default has occurred and is continuing on the date on which notice is given in accordance with the following clause (iv) or on November 9, 2021; and (iv) the Fund has delivered an extension request to the HSBC Administrative Agent not more than one hundred twenty (120) days or less than forty-five (45) days prior to November 9, 2021.

On October 15, 2020, ABPCIC Funding II entered into a revolving credit facility (the “Synovus Credit Facility”) with Synovus Bank, Specialty Finance Division (“Synovus”), as facility agent, and U.S. Bank, as collateral agent (in such capacity, the “Synovus Collateral Agent”), collateral custodian (in such capacity, the “Synovus Collateral Custodian”) and securities intermediary (in such capacity, the “Synovus Securities Intermediary”).

The Synovus Credit Facility provides for borrowings in an aggregate amount up to $100,000,000. Borrowings under the Synovus Credit Facility bear interest based on an annual adjusted LIBOR for the relevant interest period or the applicable replacement thereto provided, plus an applicable spread. Interest is payable quarterly in arrears. Any amounts borrowed under the Synovus Credit Facility will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) October 15, 2025 (or such later date mutually agreed to by ABPCIC Funding II and Synovus) or (ii) upon certain events which result in accelerated maturity under the agreements establishing the Synovus Credit Facility. Borrowing under the Synovus Credit Facility is subject to certain restrictions contained in the 1940 Act.

Borrowings under the Synovus Credit Facility are secured by all of the assets held by ABPCIC Funding II. Pursuant to the agreements establishing the Synovus Credit Facility, the Adviser will perform certain duties with respect to the purchase and management of the assets securing the Synovus Credit Facility. The Adviser will not receive a fee for these services so long as the Adviser or an affiliate thereof continues providing such services. ABPCIC Funding II will reimburse all reasonable expenses, disbursements and advances incurred or made by the Adviser in the performance of its obligations relating to the Synovus Credit Facility.

 

33


Table of Contents

All of the collateral pledged to the lenders by ABPCIC Funding II under the Synovus Credit Facility is held in the custody of the Synovus Collateral Custodian or the Synovus Securities Intermediary. The Synovus Collateral Custodian will maintain and perform certain custodial services with respect to the collateral pledged to support the Synovus Credit Facility. As compensation for the services rendered by U.S. Bank in its capacities as Synovus Collateral Custodian and Synovus Collateral Agent, ABPCIC Funding II will pay U.S. Bank, on a quarterly basis, customary fee amounts and reimburse U.S. Bank for its reasonable out-of-pocket expenses. The Synovus Credit Facility contains certain customary covenants and events of default, with customary cure and notice provisions. As of March 31, 2021, the Fund is in compliance with these covenants.

On March 24, 2021, ABPCIC Funding III entered into a warehouse financing transaction (the “Natixis Credit Facility,” and together with the HSBC Credit Facility and the Synovus Credit Facility, the “Revolving Credit Facilities”) with Natixis, New York Branch, as administrative agent (in such capacity, the “Natixis Administrative Agent”) and U.S. Bank, as collateral agent (in such capacity, the “Natixis Collateral Agent”), collateral administrator (in such capacity, the “Natixis Collateral Administrator”) and custodian (in such capacity, the “Natixis Custodian”). In connection with the Natixis Credit Facility, ABPCIC Funding III entered into, among other agreements, (i) the credit agreement (the “Natixis Credit Agreement”) among ABPCIC Funding III, the lenders referred to therein, the Natixis Administrative Agent, the Natixis Collateral Agent, the Natixis Collateral Administrator and the Natixis Custodian, (ii) the account control agreement (the “Natixis Account Control Agreement”) among ABPCIC Funding III, as debtor, the Natixis Collateral Agent, as secured party, and U.S. Bank National Association, as securities intermediary (in such capacity, the “Natixis Securities Intermediary”), (iii) the collateral management agreement (the “Natixis Collateral Management Agreement”), between ABPCIC Funding III and the Adviser, as collateral manager (in such capacity, the “Natixis Collateral Manager”), (iv) the collateral administration agreement (the “Natixis Collateral Administration Agreement”), among ABPCIC Funding III, the Natixis Collateral Manager and the Natixis Collateral Administrator and (v) the master loan sale and contribution agreement (the “Natixis Transfer Agreement”) between ABPCIC Funding III and the Fund.

The Natixis Credit Facility provides for borrowings in an aggregate amount up to $100,000,000. Borrowings under the Natixis Credit Agreement will bear interest based on an annual adjusted LIBOR for the relevant interest period or the applicable replacement thereto provided for in the Natixis Credit Agreement, in each case, plus an applicable spread. Interest is payable quarterly in arrears. Any amounts borrowed under the Natixis Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) March 24, 2031 (or such later date mutually agreed to by ABPCIC Funding III and the Natixis Administrative Agent) or (ii) upon certain other events which result in accelerated maturity under the Natixis Credit Facility. Borrowing under the Natixis Credit Facility is subject to certain restrictions contained in the 1940 Act.

Borrowings under the Natixis Credit Agreement are secured by all of the assets held by ABPCIC Funding III. Pursuant to the Natixis Collateral Management Agreement, the Natixis Collateral Manager will perform certain duties with respect to the purchase and management of the assets securing the Natixis Credit Facility. The Natixis Collateral Manager will not receive a fee for these services so long as the Adviser or an affiliate thereof continues providing such services. ABPCIC Funding III will reimburse the expenses incurred by the Natixis Collateral Manager in the performance of its obligations under the Natixis Collateral Management Agreement other than any ordinary overhead expenses, which shall not be reimbursed. ABPCIC Funding III has made customary representations and warranties under the Natixis Collateral Management Agreement and is required to comply with various covenants, reporting requirements and other customary requirements for similar credit facilities.

All of the collateral pledged to the lenders by ABPCIC Funding III under the Natixis Credit Agreement is held in the custody of the Natixis Custodian under the Natixis Account Control Agreement. The Natixis Collateral Administrator will maintain and perform certain collateral administration services with respect to the collateral pursuant to the Natixis Collateral Administration Agreement. As compensation for the services rendered by the Natixis Collateral Administrator, ABPCIC Funding III will pay the Natixis Collateral Administrator, on a quarterly basis, customary fee amounts and reimburse the Natixis Collateral Administrator for its reasonable out-of-pocket expenses. The Natixis Collateral Administration Agreement and the obligations of the Natixis Collateral Administrator will continue until the earlier of (i) the liquidation of the collateral and the final distribution of the proceeds of such liquidation, (ii) the date on which all obligations have been paid in full or (iii) the termination of the Natixis Collateral Management Agreement.

The Fund’s outstanding borrowings through the Revolving Credit Facilities as of March 31, 2021 were as follows:

 

     Aggregate Borrowing
Amount Committed
     Outstanding
Borrowing
     Amount
Available
     Carrying
Value
 

HSBC

   $ 50,000,000      $ —        $ 50,000,000      $ —    

Synovus

     100,000,000        89,700,000        10,300,000        89,700,000  

Natixis

     100,000,000        59,800,000        40,200,000        59,800,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 250,000,000      $ 149,500,000      $ 100,500,000      $ 149,500,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

34


Table of Contents

The Fund’s outstanding borrowings through the Revolving Credit Facilities as of December 31, 2020 were as follows:

 

     Aggregate Borrowing
Amount Committed
     Outstanding
Borrowing
     Amount
Available
     Carrying
Value
 

HSBC

   $ 50,000,000      $ 46,000,000      $ 4,000,000      $ 46,000,000  

Synovus

     100,000,000        84,700,000        15,300,000        84,700,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 150,000,000      $ 130,700,000      $ 19,300,000      $ 130,700,000  
  

 

 

    

 

 

    

 

 

    

 

 

 

As of March 31, 2021 and December 31, 2020, deferred financing costs were $2,306,376 and $1,648,701, respectively, which remain to be amortized, and are reflected on the consolidated statements of assets and liabilities.

Collateralized Loan Obligations

On August 9, 2019, CLO VI (the “Issuer”) and ABPCI Direct Lending Fund CLO VI LLC, a limited liability company organized under the laws of the State of Delaware (the “Co-Issuer,” and together with the Issuer, the “Co-Issuers”), each a newly formed special purpose vehicle, completed a $300,500,000 term debt securitization (the “CLO Transaction”). The stated reinvestment date is August 9, 2022.

The CLO Transaction was executed through a private placement and the notes offered (the “Notes”) that remain outstanding as of March 31, 2021 and December 31, 2020 were as follows:

 

March 31, 2021  
     Principal
Amount
     Interest
Rate
    Carrying
Value(1)
 

Class A-1 Senior Secured Floating Rate Note (“Class A-1”)

   $ 178,200,000        L + 1.73   $ 176,935,979  

Class A-2A Senior Secured Floating Rate Note (“Class A-2A”)

   $ 25,000,000        L + 2.45   $ 24,822,668  

Class A-2B Senior Secured Fixed Rate Note (“Class A-2B”)

   $ 9,950,000        4.23   $ 9,854,301  

Class B Secured Deferrable Floating Rate Note (“Class B”)

   $ 16,400,000        L + 3.40   $ —  

Class C Secured Deferrable Floating Rate Note (“Class C”)

   $ 17,350,000        L + 4.40   $ —  

Subordinated Notes

   $ 53,600,000        N/A     $ —  

 

*

Class B, Class C and Subordinated Notes have been eliminated in consolidation.

(1)

Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $25,300 and $1,511,752, respectively, as of March 31, 2021 and are reflected on the consolidated statements of assets and liabilities.

 

December 31, 2020  
     Principal
Amount
     Interest
Rate
    Carrying
Value(1)
 

Class A-1 Senior Secured Floating Rate Note (“Class A-1”)

   $ 178,200,000        L + 1.73   $ 176,706,612  

Class A-2A Senior Secured Floating Rate Note (“Class A-2A”)

   $ 25,000,000        L + 2.45   $ 24,790,490  

Class A-2B Senior Secured Fixed Rate Note (“Class A-2B”)

   $ 9,950,000        4.23   $ 9,840,396  

Class B Secured Deferrable Floating Rate Note (“Class B”)

   $ 16,400,000        L + 3.40   $ —  

Class C Secured Deferrable Floating Rate Note (“Class C”)

   $ 17,350,000        L + 4.40   $ —  

Subordinated Notes

   $ 53,600,000        N/A     $ —  

 

*

Class B, Class C and Subordinated Notes have been eliminated in consolidation.

(1)

Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $26,440 and $1,786,062, respectively, as of December 31, 2020 and are reflected on the consolidated statements of assets and liabilities.

 

35


Table of Contents

The Notes are scheduled to mature on August 9, 2030.

The CLO VI indenture provides that the holders of the CLO VI Class A-1, Class A-2A, Class A-2B, Class B and Class C Notes are to receive quarterly interest payments, in arrears, on the 20th day in January, April, July and October of each year, commencing in August 2019.

The Notes are the secured obligations of the Co-Issuers, and the indenture governing the Notes includes customary covenants and events of default. The Notes have not been, and will not be, registered under the Securities Act or any state securities or “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from registration.

The Adviser serves as collateral manager to the Issuer pursuant to a collateral management agreement between the Adviser and the Issuer (the “CLO Collateral Management Agreement”). For so long as the Adviser serves as collateral manager to the Issuer, the Adviser will elect to irrevocably waive any base management fee or subordinated interest to which it may be entitled under the CLO Collateral Management Agreement. For the three months ended March 31, 2021, the Fund incurred a collateral management fee of $454,343, which was voluntarily waived by the Adviser. For the three months ended March 31, 2020, the Fund incurred a collateral management fee of $459,059, which was voluntarily waived by the Adviser.

Secured Borrowings

From time to time, the Fund may engage in sale/buy-back agreements, which are a type of secured borrowing. The amount, interest rate and terms of these agreements will be individually negotiated on a transaction-by-transaction basis. Each borrowing is secured by an interest in an underlying asset which is participated or assigned to the sale/buy-back counterparty for the duration of the agreement.

On September 29, 2020, the Fund entered into a sale/buy-back agreement with Macquarie US Trading LLC (“Macquarie”), and pursuant to the agreement, the Fund assigned certain assets to Macquarie, with a corresponding repurchase obligation at an agreed-upon price within 30 days after the sale date (the “Macquarie Sale/Buy-Back”). The Macquarie Sale/Buy-Back had a funding cost of 1.25 bps per day and was not subject to any additional fees. On January 14, 2021, the Fund repurchased the assets it assigned to Macquarie pursuant to the Macquarie Sale/Buy-Back. As of March 31, 2021, Secured Borrowings pursuant to the Macquarie Sale/Buy-Back were $0. As of December 31, 2020, Secured Borrowings pursuant to the Macquarie Sale/Buy-Back were $18,870,856, with a maturity of less than thirty days. Interest expense and amortization of deferred financing costs on Secured Borrowings for the three months ended March 31, 2021 were $30,665 and $15,421, respectively.

There were no Secured Borrowings outstanding as of March 31, 2021.

Secured Borrowings outstanding as of December 31, 2020 were as follows:

 

Loan Name

   Trade Date     

Maturity Date

   bps Daily Rate      Amount  

Businessolver.com, Inc.

     12/23/2020      60 days or less from trade date      1.25      $ 5,312,058  

Medbridge Holdings, LLC

     12/23/2020      60 days or less from trade date      1.25        7,710,514  

Higginbotham Insurance Agency, Inc.

     12/23/2020      60 days or less from trade date      1.25        5,848,284  
           

 

 

 
            $ 18,870,856  

As of March 31, 2021 and December 31, 2020, outstanding borrowings under the Revolving Credit Facilities, Notes and Secured Borrowings were $361,112,948 and $360,908,354, respectively.

For the three months ended March 31, 2021 and March 31, 2020, the components of interest and other debt expenses related to the borrowings were as follows:

 

    

For the three months ended

March 31,

 
     2021     2020  

Interest and borrowing expenses

   $ 2,069,551     $ 2,144,095  

Commitment fees

     42,717       28,258  

Amortization of debt issuance and deferred financing costs

     492,785       396,314  
  

 

 

   

 

 

 

Total

   $ 2,605,053     $ 2,568,667  
  

 

 

   

 

 

 

Weighted average interest rate (1)

     2.52     3.73

Average outstanding balance

   $ 333,224,679     $ 231,210,440  

 

(1)

Calculated as the amount of the stated interest and borrowing expenses divided by average borrowings during the period.

 

36


Table of Contents

5. Fair Value Measurement

In accordance with ASC 820, fair value is defined as the price that the Fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a framework for measuring fair value and a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability as of the reporting date.

Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Fund. Unobservable inputs reflect the Fund’s own assumptions about the assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. Each investment is assigned a level based upon the observability of the inputs which are significant to the overall valuation.

The three-tier hierarchy of inputs is summarized below:

 

   

Level 1 – Quoted prices in active markets for identical investments.

 

   

Level 2 – Other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

 

   

Level 3 – Significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments at the reporting date).

The level in the fair value hierarchy within which the fair value measurement is categorized in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. If a fair value measurement uses price data vendors or observable market price quotations, that measurement is a Level 2 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgment, considering factors specific to the asset or liability.

The determination of what constitutes “observable” requires significant judgment by the Fund. The Fund considers observable data to be that market data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market.

Valuation of Investments

Investments are valued at fair value as determined in good faith by our Board, based on input of management, the audit committee and independent valuation firms that have been engaged to assist in the valuation of each portfolio investment without a readily available market quotation at least once during a trailing twelve-month period under a valuation policy and a consistently applied valuation process. This valuation process is conducted at the end of each fiscal quarter.

The fair values of loan investments based upon pricing data vendors or observable market price quotations are generally categorized as Level 2; however, those priced using models with significant unobservable inputs are categorized as Level 3.

In determining the fair value of the Fund’s Level 3 debt and equity positions, the Adviser uses the following factors where relevant: loan to value (“LTV”) based on an enterprise value determined using the original purchase price, public equity comparable, recent M&A transaction, and a discounted cash flow (“DCF”) analysis, and yields from comparable loans, comparable high yield bonds, high yield indexes and loan indexes (“comparable yields”).

 

37


Table of Contents

Due to the inherent uncertainty of valuations, however, estimated fair values may differ from the values that would have been used had a readily available market for the securities existed and the differences could be material.

The following tables summarize the valuation of the Fund’s investments as of March 31, 2021:

 

Assets*

   Level 1      Level 2      Level 3      Total  

Cash Equivalents

           

Investment Companies

   $ 4,854,867      $ —        $ —        $ 4,854,867  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 4,854,867      $ —        $ —        $ 4,854,867  
  

 

 

    

 

 

    

 

 

    

 

 

 

Assets*

   Level 1      Level 2      Level 3      Total  

1st Lien/Senior Secured Debt

   $ —        $ —        $ 558,929,700      $ 558,929,700  

2nd Lien/Junior Secured Debt

     —          —          11,396,370        11,396,370  

U.S. Preferred Stock

     —          —          8,174,321        8,174,321  

U.S. Common Stock

     282,143        —          3,359,418        3,641,561  

Warrants

     —          —          548,104        548,104  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 282,143      $ —        $ 582,407,913      $ 582,690,056  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

*

See consolidated schedule of investments for industry classifications.

The following table summarizes the valuation of the Fund’s investments as of December 31, 2020:

 

Assets*

   Level 1      Level 2      Level 3      Total  

Cash Equivalents

           

Investment Companies

   $ 7,022,133      $ —        $ —        $ 7,022,133  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 7,022,133      $ —        $ —        $ 7,022,133  
  

 

 

    

 

 

    

 

 

    

 

 

 

Assets*

   Level 1      Level 2      Level 3      Total  

1st Lien/Senior Secured Debt

   $ —        $ —        $ 511,197,686      $ 511,197,686  

2nd Lien/Junior Secured Debt

     —          —          11,396,369        11,396,369  

U.S. Preferred Stock

     —          —          7,495,949        7,495,949  

U.S. Common Stock

     287,775        —          2,375,265        2,663,040  

Warrants

     —          —          281,986        281,986  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

   $ 287,775      $ —        $ 532,747,255      $ 533,035,030  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

*

See consolidated schedule of investments for industry classifications.

The following is a reconciliation of Level 3 assets for the three months ended March 31, 2021:

 

     1st Lien/Senior
Secured Debt
    2nd Lien/
Junior
Secured
Debt
    U.S. Common
Stock
     U.S. Preferred
Stock
     Warrants      Total  

Balance as of January 1, 2021

   $ 511,197,686     $ 11,396,369     $ 2,375,265      $ 7,495,949      $ 281,986      $ 532,747,255  

Purchases (including PIK)

     69,564,607       —         830,295           218,049        70,612,951  

Sales and principal payments

     (23,559,275     —         —          —          —          (23,559,275

Realized Gain (Loss)

     59,470       —         —          —          —          59,470  

Net Amortization of Premium/Discount

     781,908       6,363         —          —          —          788,271  

Transfers In

     —               —          —          —          —    

Transfers Out

     —         —         —          —          —          —    

Net Change in Unrealized Appreciation (Depreciation)

     885,304       (6,362     153,858        678,372        48,069        1,759,241  
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Balance as of March 31, 2021

   $ 558,929,700     $ 11,396,370     $ 3,359,418      $ 8,174,321      $ 548,104      $ 582,407,913  
  

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Change in Unrealized Appreciation (Depreciation) for Investments Still Held

   $ 1,092,986     $ (6,362   $ 153,858      $ 678,372      $ 48,069      $ 1,966,923  

 

 

38


Table of Contents

For the three months ended March 31, 2021, there were no transfers to or from Level 3.

The following is a reconciliation of Level 3 assets for the year ended December 31, 2020:

 

     1st Lien/Senior
Secured Debt
    2nd Lien/
Junior
Secured
Debt
     U.S. Common
Stock
     U.S. Preferred
Stock
    U.S.
Warrants
    Total  

Balance as of January 1, 2020

   $ 318,300,993     $ 7,620,547      $ 1,518,353      $ 4,861,847     $ 631,366     $ 332,933,106  

Purchases (including PIK)

     279,269,615       3,652,564        170,276        2,573,882       105,898       285,772,235  

Sales and principal payments

     (95,946,474     —          —          (777,440     —         (96,723,914

Realized Gain (Loss)

     20,809       —          —          548,560       —         569,369  

Net Amortization of Premium/Discount

     2,441,903       13,547        —          —         —         2,455,450  

Transfers In

     12,092,212       —          —          —         —         12,092,212  

Transfers Out

     —         —          —          —         —         —    

Net Change in Unrealized Appreciation (Depreciation)

     (4,981,372     109,711        686,636        289,100       (455,278     (4,351,203
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Balance as of December 31, 2020

   $ 511,197,686     $ 11,396,369      $ 2,375,265      $ 7,495,949     $ 281,986     $ 532,747,255  
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Change in Unrealized Appreciation (Depreciation) for Investments Still Held

   $ (5,261,160   $ 109,711      $ 686,636      $ 289,100     $ (455,278   $ (4,630,991

For the year ended December 31, 2020, there were transfers of $12,092,212 from Level 2 to Level 3 fair value measurements for the Fund due to lack of observability and liquidity. There were no transfers from Level 3.

The following tables present the ranges of significant unobservable inputs used to value the Fund’s Level 3 investments as of March 31, 2021 and December 31, 2020, respectively. These ranges represent the significant unobservable inputs that were used in the valuation of each type of investment. These inputs are not representative of the inputs that could have been used in the valuation of any one investment. Accordingly, the ranges of inputs presented below do not represent uncertainty in, or possible ranges of, fair value measurements of the Fund’s Level 3 investments.

 

39


Table of Contents
     Fair Value
as of
March 31, 2021
    

Valuation

Techniques

  

Unobservable

Input

  

Range

(Weighted

Average) (1)

  

Impact to

Valuation from

an Increase in

Input

Assets:

              

1st Lien/Senior Secured Debt

   $ 431,702,229      Market Yield Analysis    Market Yield   

5.0%-19.9%

(8.0%)

   Decrease
     1,795,060      Asset Value    Asset Value    N/A    Increase
     12,739,625      Expected Repayment    Redemption Price    N/A    Increase
     8,997,851      Recent Transaction    Transaction Price    N/A    N/A
     103,694,935      Recent Purchase    Purchase Price    N/A    N/A

2nd Lien/Junior Secured Debt

     8,545,077      Market Yield Analysis    Market Yield   

8.5%-10.2%

(9.0%)

   Decrease
     2,851,293      Recent Purchase    Purchase Price    N/A    N/A

U.S. Common Stock

     1,270,036      Market Approach    EBITDA Multiple   

10.0x-16.0x

(14.1x)

   Increase
     852,338      Market Approach    Recurring Revenue Multiple    5.0x    Increase
     406,750      Recent Transaction    Transaction Price    N/A    N/A
     830,294      Recent Purchase    Purchase Price    N/A    N/A

U.S. Preferred Stock

     2,194,320      Market Approach    EBITDA Multiple   

8.0x-19.9x

(16.5x)

   Increase
     1,939,988      Market Approach    Revenue Multiple   

8.3x-21.0x

(12.0x)

   Increase
     704,606      Recent Transaction    Transaction Price    N/A    N/A
     3,335,407      Recent Purchase    Purchase Price    N/A    N/A

Warrants

     298,744      Market Approach    Revenue Multiple    10.7x-13.2x (11.9x)    Increase
     249,360      Recent Purchase    Purchase Price    N/A    N/A
  

 

 

             

Total Assets

   $ 582,407,913              

 

(1)

Weighted averages are calculated based on fair value of investments.

 

40


Table of Contents
     Fair Value
as of
December 31, 2020
    

Valuation

Techniques

  

Unobservable

Input

  

Range

(Weighted

Average) (1)

  

Impact to

Valuation from

an Increase in

Input

Assets:

              
1st Lien/Senior Secured Debt    $ 329,808,025      Market Yield Analysis    Market Yield    5.0%-18.5%(7.8%)    Decrease
     6,586,623      Market Approach    EBITDA Multiple    1.9x-10.2x(4.0x)    Increase
     10,538,095      Expected Repayment    Redemption Price    N/A    Increase
     13,914,273      Recent Transaction    Transaction Price    N/A    N/A
     150,350,670      Recent Purchase    Purchase Price    N/A    N/A

2nd Lien/Junior Secured Debt

     7,740,139      Market Yield Analysis    Market Yield    8.6%-9.0%(8.9%)    Decrease
     3,656,230      Recent Purchase    Purchase Price    N/A    N/A

U.S. Common Stock

     1,233,165      Market Approach    EBITDA Multiple    10.0x-16.0x(14.1x)    Increase
     735,350      Market Approach    Recurring Revenue Multiple    5.0x    Increase
     406,750      Recent Transaction    Transaction Price    N/A    N/A

U.S. Preferred Stock

     2,751,077      Market Approach    EBITDA Multiple    8.3x-13.6x(11.8x)    Increase
     2,214,811      Market Approach    Revenue Multiple    8.9x-23.1x(13.5x)    Increase
     438,190      Recent Transaction    Transaction Price    N/A    N/A
     2,091,871      Recent Purchase    Purchase Price    N/A    N/A

Warrants

     146,098      Market Approach    Revenue Multiple    4.5x-10.7x(10.2x)    Increase
     95,800      Recent Transaction    Transaction Price    N/A    N/A
     40,088      Recent Purchase    Purchase Price    N/A    N/A
  

 

 

             

Total Assets

   $ 532,747,255              

 

(1)

Weighted averages are calculated based on fair value of investments.

Financial Instruments Disclosed, But Not Carried, At Fair Value

The following table presents the carrying value and fair value of the Fund’s financial liabilities disclosed, but not carried, at fair value as of March 31, 2021 and the level of each financial liability within the fair value hierarchy.

 

     Carrying      Fair                       
     Value (1)      Value      Level 1      Level 2      Level 3  

Class A-1 Senior Secured Notes

   $ 176,935,979      $ 179,488,921      $ —        $ —        $ 179,488,921  

Class A-2A Senior Secured Notes

     24,822,668        25,586,325        —          —          25,586,325  

Class A-2B Senior Secured Notes

     9,854,301        10,469,639        —          —          10,469,639  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 211,612,948      $ 215,544,885      $ —        $ —        $ 215,544,885  

 

(1)

Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $25,300 and $1,511,752 as of March 31, 2021 and are reflected on the consolidated statements of assets and liabilities.

The following table presents the carrying value and fair value of the Fund’s financial liabilities disclosed, but not carried, at fair value as of December 31, 2020 and the level of each financial liability within the fair value hierarchy.

 

41


Table of Contents
     Carrying
Value (1)
     Fair
Value
     Level 1      Level 2      Level 3  

Class A-1 Senior Secured Notes

   $ 176,706,612      $ 178,352,361      $ —        $ —        $ 178,352,361  

Class A-2A Senior Secured Notes

     24,790,490        25,361,000        —          —          25,361,000  

Class A-2B Senior Secured Notes

     9,840,396        10,639,316        —          —          10,639,316  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 211,337,498      $ 214,352,677      $ —        $ —        $ 214,352,677  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(1)

Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $26,440 and $1,786,062 as of December 31, 2020 and are reflected on the consolidated statements of assets and liabilities.

6. Commitments & Contingencies

Commitments

The Fund may enter into commitments to fund investments. As of March 31, 2021, the Adviser believed that the Fund had adequate financial resources to satisfy its unfunded commitments. The amounts associated with unfunded commitments to provide funds to portfolio companies are not recorded in the Fund’s consolidated statements of assets and liabilities. Since these commitments and the associated amounts may expire without being drawn upon, the total commitment amount does not necessarily represent a future cash requirement. The Fund had the following unfunded commitments by investment types as of March 31, 2021:

 

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

1st Lien/Senior Secured Debt

           

5 Bars, LLC

   Delayed Draw Term Loan      09/27/2022      $ 3,448,816      $ —    

5 Bars, LLC

   Revolver      09/27/2024        646,653        —    

Accelerate Resources Operating, LLC

   Delayed Draw Term Loan      08/24/2021        1,659,057        (49,772

Accelerate Resources Operating, LLC

   Revolver      02/24/2026        414,764        (12,443

AEG Holding Company, Inc.

   Revolver      11/20/2023        1,116,864        (22,337

Alphasense, Inc.

   Delayed Draw Term Loan      12/22/2021        1,937,915        —    

Alphasense, Inc.

   Revolver      05/29/2024        872,355        —    

AmerCareRoyal, LLC

   Delayed Draw Term Loan      10/26/2021        614,480        —    

American Physician Partners, LLC

   Revolver      12/21/2021        97,681        (3,907

AMI US Holdings, Inc.

   Revolver      04/01/2024        306,489        (4,598

Analogic Corporation

   Revolver      06/22/2023        213,889        (7,486

Arrowstream Acquisition Co., Inc.

   Revolver      12/15/2025        386,309        (7,726

Avetta, LLC

   Revolver      04/10/2024        494,396        (9,888

Azurity Pharmaceuticals, Inc.

   Delayed Draw Term Loan      05/17/2021        482,932        —    

Azurity Pharmaceuticals, Inc.

   Revolver      03/21/2023        482,932        —    

Banneker V Acquisition, Inc.

   Delayed Draw Term Loan      12/04/2021        1,037,198        (20,744

Banneker V Acquisition, Inc.

   Revolver      12/04/2025        259,300        (5,186

BEP Borrower Holdco, LLC

   Delayed Draw Term Loan A      06/12/2021        1,288,304        (12,883

BEP Borrower Holdco, LLC

   Revolver      06/12/2024        429,435        (6,442

BK Medical Holding Company, Inc.

   Revolver      06/22/2023        321,733        (8,848

Businesssolver.com, Inc.

   Revolver      05/15/2023        323,529        —    

Captain D’s, Inc.

   Revolver      12/15/2023        195,053        (1,950

Coding Solutions Acquisition, Inc

   Delayed Draw Term Loan      12/31/2022        2,443,965        (24,440

Coding Solutions Acquisition, Inc

   Revolver      12/31/2025        96,983        (1,940

 

42


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

Datacor Holdings, Inc.

   First Lien Delayed Draw Term Loan      12/28/2022        2,575,396        (25,754

Datacor Holdings, Inc.

   Revolver      12/26/2025        643,849        (12,877

Degreed, Inc.

   Delayed Draw Term Loan      03/24/2023        1,391,394        (6,957

Delaware Valley Management Holdings, Inc.

   Delayed Draw Term Loan      09/18/2022        1,053,759        (150,161

Dillon Logistics, Inc.

   Revolver      12/11/2023        56,484        (30,953

Dispatch Track, LLC

   Revolver      12/17/2024        301,930        (3,019

EnterpriseDB Corporation

   Revolver      06/21/2024        696,355        (3,482

Ethos Veterinary Health LLC

   Delayed Draw Term Loan      05/17/2021        839,091        —    

EvolveIP, LLC

   Delayed Draw Term Loan      11/26/2021        642,451        (1,606

EvolveIP, LLC

   Revolver      06/07/2023        566,868        (1,417

Exterro, Inc.

   Revolver      05/31/2024        247,500        (1,237

Faithlife, LLC

   Delayed Draw Term Loan      09/19/2022        1,328,991        —    

Faithlife, LLC

   Revolver      09/18/2025        279,053        —    

Fatbeam, LLC

   Delayed Draw Term Loan 1      02/22/2022        1,609,623        (36,216

Fatbeam, LLC

   Delayed Draw Term Loan 2      02/22/2023        1,609,623        (36,216

Fatbeam, LLC

   Revolver      02/22/2026        643,849        (14,487

Finalsite Holdings, Inc.

   Revolver      09/25/2024        253,142        (4,430

Foundation Risk Partners, Corp.

   First Lien Delayed Draw Term Loan      12/30/2022        2,932,758        (29,328

Freddy’s Frozen Custard, L.L.C

   Revolver      03/03/2027        329,816        (4,122

Fuze, Inc.

   Delayed Draw Term Loan      09/20/2021        1,814,240        (7,438

Fuze, Inc.

   Revolver      09/20/2024        1,295,886        (18,531

GHA Buyer, Inc.

   Fifth Amendment Delayed Draw Term loan      12/14/2021        58,528        —    

GHA Buyer, Inc.

   Revolver      06/24/2025        951,077        —    

Global Radar Holdings, LLC

   Revolver      12/31/2025        581,896        (11,638

GlobalWebIndex Inc.

   Delayed Draw Term Loan      12/30/2021        3,683,720        (36,837

Greenhouse Software, Inc.

   Revolver      03/01/2027        1,232,251        (27,726

GS AcquisitionCo, Inc.

   Fourth Supplemental Delayed Draw Term Loan      12/02/2021        498,802        (3,741

GS AcquisitionCo, Inc.

   Revolver      05/24/2024        212,731        (3,191

Higginbotham Insurance Agency, Inc.

   Delayed Draw Term Loan      11/25/2022        1,671,253        (12,534

INH Buyer, Inc.

   Revolver      01/31/2024        205,858        (3,088

Kaseya Inc.

   Delayed Draw Term Loan      03/04/2022        288,720        (3,320

Kaseya Inc.

   Revolver      05/02/2025        191,755        (1,918

Kindeva Drug Delivery L.P.

   Revolver      05/01/2025        1,011,725        (25,293

Lexipol, LLC

   Delayed Draw Term Loan      07/08/2021        72,969        (1,277

Medbridge Holdings, LLC

   Revolver      12/23/2026        1,376,227        (27,525

Metametrics, Inc.

   Revolver      09/10/2025        651,183        (6,512

MSM Acquisitions, Inc.

   Delayed Draw Term Loan      06/09/2022        1,512,931        (19,048

MSM Acquisitions, Inc.

   Revolver      12/09/2026        1,225,045        (24,501

Netwrix Corporation And Concept Searching Inc.

   Revolver      09/30/2026        166,551        (5,413

Netwrix Corporation And Concept Searching Inc.

   Tranche 2 Delayed Draw Term Loan      03/23/2022        2,486,046        (49,721

 

43


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair Value (3)  

Nine Point Energy, LLC

  

DIP Delayed Draw Term Loan

     07/08/2021        109,375        —    

OMH-HealthEdge Holdings, LLC

  

Revolver

     10/24/2024        458,721        (4,587

Pace Health Companies, LLC

  

Revolver

     08/02/2024        616,682        (6,167

PerimeterX, Inc.

  

Delayed Draw Term Loan

     05/23/2022        698,833        (6,988

PerimeterX, Inc.

  

Revolver

     11/22/2024        279,533        (2,795

PF Growth Partners, LLC

  

Delayed Draw Term Loan

     07/11/2021        240,285        (4,805

Pinnacle Dermatology Management, LLC

  

Delayed Draw Term Loan

     10/31/2021        1,767,548        (35,351

Pinnacle Dermatology Management, LLC

  

Revolver

     05/18/2023        322,749        (6,455

Pinnacle Treatment Centers, Inc.

   Seventh Amendment Delayed Draw Term Loan      01/17/2022        234,363        —    

Pinnacle Treatment Centers, Inc.

  

Seventh Amendment Revolver

     12/31/2022        292,954        —    

Real Capital Analytics, Inc.

  

Revolver

     10/02/2024        694,740        —    

Rep Tec Intermediate Holdings, Inc.

  

Revolver

     06/19/2025        442,112        —    

Salisbury House, LLC

  

Revolver

     08/30/2025        448,343        (11,209

SCA Buyer, LLC

  

Revolver

     01/20/2026        515,079        (7,726

SecureLink, Inc

  

Revolver

     10/01/2025        439,523        (6,593

Single Digits, Inc.

  

Revolver

     12/21/2023        416,148        (33,292

Sirsi Corporation

  

Revolver

     03/15/2024        553,741        (6,922

SIS Purchaser, Inc.

  

Revolver

     10/15/2026        1,165,951        (20,404

Smartlinx Solutions, LLC

  

Revolver

     03/04/2026        519,484        (9,974

Smile Brands, Inc.

  

Revolver

     09/30/2024        254,808        (4,459

Streamsets, Inc.

  

Revolver

     11/25/2024        350,524        (9,349

SugarCRM, Inc.

  

Revolver

     07/31/2024        310,244        —    

Swiftpage, Inc.

  

Revolver

     06/13/2023        225,317        (7,886

Sysnet North America, Inc

  

Delayed Draw Term Loan B1

     12/30/2021        3,863,094        (57,946

Telesoft Holdings, LLC

  

Revolver

     12/16/2025        596,866        (8,953

The Center for Orthopedic and Research Excellence, Inc.

  

Delayed Draw Term Loan

     08/15/2021        1,148,009        (13,432

The Center for Orthopedic and Research Excellence, Inc.

  

Revolver

     08/15/2025        690,532        (12,084

Theranest, LLC

  

Revolver

     07/24/2023        428,571        —    

Thrive Buyer, Inc

  

Delayed Draw Term Loan

     01/22/2023        1,877,085        (37,542

Thrive Buyer, Inc

  

Revolver

     01/22/2027        750,834        (15,017

TRGRP, Inc.

  

Revolver

     11/01/2023        333,333        (6,667

Valcourt Holdings II, LLC

  

Delayed Draw Term Loan

     01/07/2023        1,725,026        (34,501

Vectra AI, Inc

  

Delayed Draw Term Loan

     03/18/2023        2,327,586        (58,190

Vectra AI, Inc

  

Revolver

     03/18/2026        232,759        (5,819

Velocity Purchaser Corporation

  

Revolver

     12/01/2022        193,237        —    

Women’s Health USA, Inc.

  

Revolver

     10/09/2023        52,675        (659

ZBS Alliance Animal Health, LLC

   First Amendment Delayed Draw Term Loan      10/19/2022        1,393,289        (27,866

ZBS Alliance Animal Health, LLC

  

Revolver

     11/08/2025        680,340        (13,607
        

 

 

    

 

 

 

Total 1st Lien/Senior Secured Debt

           86,412,651        (1,329,349
        

 

 

    

 

 

 

Foundation Risk Partners, Corp.

  

2nd Lien Delayed Draw Term Loan

     12/30/2022        1,256,896        (14,140
        

 

 

    

 

 

 

Total 2nd Lien/Senior Secured Debt

           1,256,896        (14,140
        

 

 

    

 

 

 

Total

         $ 87,669,547      $ (1,343,489
        

 

 

    

 

 

 

 

44


Table of Contents

The Fund had the following unfunded commitments by investment types as of December 31, 2020:

 

Investment

Type    

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

1st Lien/Senior Secured Debt

           

5 Bars, LLC

   Delayed Draw Term Loan      09/27/2022      $ 3,448,816      $ —    

5 Bars, LLC

   Revolver      09/27/2024        646,653        —    

Accelerate Resources Operating, LLC

   Delayed Draw Term Loan      08/24/2021        1,659,057        (49,772

Accelerate Resources Operating, LLC

   Revolver      02/24/2026        414,764        (12,443

AEG Holding Company, Inc.

   Revolver      11/20/2023        1,116,864        (22,337

Alphasense, Inc.

   Delayed Draw Term Loan      12/22/2021        1,937,915        —    

Alphasense, Inc.

   Revolver      05/29/2024        872,355        —    

American Physician Partners, LLC

   Revolver      12/21/2021        97,681        (3,907

AMI US Holdings, Inc.

   Revolver      04/01/2024        306,489        (4,597

Analogic Corporation

   Revolver      06/22/2023        213,889        (7,486

Arrowstream Acquisition Co., Inc.

   Revolver      12/15/2025        386,309        (7,726

Avetta, LLC

   Revolver      04/10/2024        494,396        (9,888

Azurity Pharmaceuticals, Inc.

   Delayed Draw Term Loan      05/17/2021        482,932        (9,659

Azurity Pharmaceuticals, Inc.

   Revolver      03/21/2023        482,932        (9,659

Banneker V Acquisition, Inc.

   Delayed Draw Term Loan      12/04/2021        1,037,198        (20,744

Banneker V Acquisition, Inc.

   Revolver      12/04/2025        259,300        (5,186

BEP Borrower Holdco, LLC

   Delayed Draw Term Loan A      06/12/2021        1,288,304        (19,325

BEP Borrower Holdco, LLC

   Revolver      06/12/2024        429,435        (4,295

BK Medical Holding Company, Inc.

   Revolver      06/22/2023        321,733        (12,870

Businesssolver.com, Inc.

   Revolver      05/15/2023        323,529        —    

Captain D’s, Inc.

   Revolver      12/15/2023        51,331        (513

Coding Solutions Acquisition, Inc

   Delayed Draw Term Loan      12/31/2022        2,443,965        (24,440

Coding Solutions Acquisition, Inc

   Revolver      12/31/2025        96,983        (1,939

Datacor Holdings, Inc.

   Revolver      12/26/2025        643,849        (12,877

Datacor Holdings, Inc.

   First Lien Delayed Draw Term Loan      12/28/2022        2,575,396        (25,754

Delaware Valley Management Holdings, Inc.

   Delayed Draw Term Loan      03/21/2021        1,053,759        (160,698

Dillon Logistics, Inc.

   Revolver      12/11/2023        215,110        (116,160

Dispatch Track, LLC

   Revolver      12/17/2024        301,930        (3,020

E2open LLC

   Revolver      11/26/2024        72,652        —    

Engage2Excel, Inc.

   Revolver      03/07/2023        119,353        (4,774

EnterpriseDB Corporation

   Revolver      06/21/2024        696,355        (6,964

Ethos Veterinary Health LLC

   Delayed Draw Term Loan      05/17/2021        839,091        (4,195

EvolveIP, LLC

   Delayed Draw Term Loan      11/26/2021        642,451        (9,636

EvolveIP, LLC

   Revolver      06/07/2023        566,868        (8,503

Exterro, Inc.

   Revolver      05/31/2024        247,500        (1,238

Faithlife, LLC

   Delayed Draw Term Loan      09/19/2022        1,328,991        (26,580

Faithlife, LLC

   Revolver      09/18/2025        279,053        (5,581

Finalsite Holdings, Inc.

   Revolver      09/25/2024        253,142        (4,430

 

45


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

Foundation Risk Partners, Corp.

   First Lien Delayed Draw Term Loan      12/30/2022        2,932,758        (29,327

Fuze, Inc.

   Delayed Draw Term Loan      09/20/2021        1,814,240        (7,439

Fuze, Inc.

   Revolver      09/20/2024        1,295,886        (18,531

GHA Buyer, Inc.

   Fifth Amendment Delayed Draw Term loan      12/14/2021        58,528        —    

GHA Buyer, Inc.

   Revolver      06/24/2025        951,077        —    

Global Radar Holdings, LLC

   Revolver      12/31/2025        581,896        (11,637

GlobalWebIndex Inc.

   Delayed Draw Term Loan      12/30/2021        3,683,720        (36,837

GS AcquisitionCo, Inc.

   Fourth Delayed Draw Term Loan      12/02/2021        498,802        (3,741

GS AcquisitionCo, Inc.

   Revolver      05/24/2024        382,916        (5,743

Higginbotham Insurance Agency, Inc.

   Delayed Draw Term Loan      11/25/2022        1,671,253        (12,535

INH Buyer, Inc.

   Revolver      01/31/2024        205,858        (3,088

Kaseya Inc.

   Delayed Draw Term Loan      03/04/2022        481,201        (6,015

Kaseya Inc.

   Revolver      05/02/2025        191,755        (3,835

Kindeva Drug Delivery L.P.

   Revolver      05/01/2025        1,445,322        (36,133

Medbridge Holdings, LLC

   Revolver      12/23/2026        1,376,227        (27,524

Metametrics, Inc.

   Revolver      09/10/2025        651,183        (13,024

MSM Acquisitions, Inc.

   Delayed Draw Term Loan      06/09/2022        3,062,613        (15,313

MSM Acquisitions, Inc.

   Revolver      12/09/2026        1,225,045        (24,501

Netwrix Corporation And Concept Searching Inc.

   Revolver      09/30/2026        166,551        (3,956

Netwrix Corporation And Concept Searching Inc.

   Delayed Draw Term Loan      09/30/2021        1,001,811        (23,794

Nine Point Energy, LLC

   Delayed Draw Term Loan      06/07/2021        328,125        (42,656

OMH-HealthEdge Holdings, LLC

   Revolver      10/24/2024        458,721        (10,322

Pace Health Companies, LLC

   Revolver      08/02/2024        616,682        (6,167

PerimeterX, Inc.

   Delayed Draw Term Loan      05/23/2022        698,833        (6,989

PerimeterX, Inc.

   Revolver      11/22/2024        279,533        (2,795

PF Growth Partners, LLC

   Delayed Draw Term Loan      07/11/2021        240,285        (4,806

Pinnacle Dermatology Management, LLC

   Delayed Draw Term Loan      10/31/2021        1,767,548        (35,351

Pinnacle Dermatology Management, LLC

   Revolver      05/18/2023        322,749        (6,455

Pinnacle Treatment Centers, Inc.

   Delayed Draw Term Loan      01/17/2022        234,363        (2,343

Pinnacle Treatment Centers, Inc.

   Revolver      12/31/2022        292,954        (2,929

Real Capital Analytics, Inc.

   Revolver      10/02/2024        694,740        —    

Rep Tec Intermediate Holdings, Inc.

   Delayed Draw Term Loan      03/19/2021        1,326,335        —    

Rep Tec Intermediate Holdings, Inc.

   Revolver      06/19/2025        442,112        —    

Salisbury House, LLC

   Revolver      08/30/2025        448,343        (11,209

SecureLink, Inc

   Revolver      10/01/2025        439,523        (6,593

Single Digits, Inc.

   Revolver      12/21/2023        416,148        (33,292

Sirsi Corporation

   Revolver      03/15/2024        553,741        (6,921

SIS Purchaser, Inc.

   Revolver      10/15/2026        1,165,951        (20,405

Smartlinx Solutions, LLC

   Revolver      03/04/2026        519,484        (9,974

Smile Brands, Inc.

   Revolver      10/12/2023        254,808        (4,459

Star2star Communications, LLC

   Delayed Draw Term Loan      03/11/2022        640,576        —    

Star2star Communications, LLC

   Revolver      03/13/2025        960,864        —    

Streamsets, Inc.

   Revolver      11/25/2024        350,524        (9,737

SugarCRM, Inc.

   Revolver      07/31/2024        310,244        —    

Swiftpage, Inc.

   Revolver      06/13/2023        225,317        (7,887

Sysnet North America, Inc

   Delayed Draw Term Loan B1      12/30/2021        3,863,094        (57,946

 

46


Table of Contents

Investment

Type

  

Facility

Type

   Commitment
Expiration Date (1)
     Unfunded
Commitment (2)
     Fair
Value (3)
 

Telesoft Holdings, LLC

   Revolver      12/16/2025        596,866        (13,429

The Center for Orthopedic and Research Excellence, Inc.

   Delayed Draw Term Loan      08/15/2021        1,148,009        (13,432

The Center for Orthopedic and Research Excellence, Inc.

   Revolver      08/15/2025        690,532        (12,084

Theranest, LLC

   Revolver      07/24/2023        428,571        (10,714

TRGRP, Inc.

   Revolver      11/01/2023        333,333        (6,666

Velocity Purchaser Corporation

   Revolver      12/01/2022        193,237        —    

Women’s Health USA, Inc.

   Revolver      10/09/2023        175,583        (2,195

ZBS Alliance Animal Health, LLC

   First Amendment Delayed Draw Term Loan      10/19/2022        2,253,772        (45,076

ZBS Alliance Animal Health, LLC

   Revolver      11/08/2025        226,780        (4,536
        

 

 

    

 

 

 

Total 1st Lien/Senior Secured Debt

           76,225,252        (1,297,537
        

 

 

    

 

 

 

Foundation Risk Partners, Corp.

   2nd Lien Delayed Draw Term Loan      12/30/2022        1,256,896        (14,140
        

 

 

    

 

 

 

Total 2nd Lien/Senior Secured Debt

           1,256,896        (14,140
        

 

 

    

 

 

 

Total

         $ 77,482,148      $ (1,311,677

 

(1)

Commitments are generally subject to borrowers meeting certain criteria such as compliance with covenants and certain operational metrics. These amounts may remain outstanding until the commitment period of an applicable loan expires, which may be shorter than its maturity.

(2)

Net of capitalized fees, expenses and original issue discount (“OID”).

(3)

A negative fair value was reflected as investments, at fair value in the consolidated statements of assets and liabilities. The negative fair value is the result of the capitalized discount on the loan.

 

47


Table of Contents

Contingencies

In the normal course of business, the Fund enters into contracts that provide a variety of general indemnifications. Any exposure to the Fund under these arrangements could involve future claims that may be made against the Fund. Currently, no such claims exist or are expected to arise and, accordingly, the Fund has not accrued any liability in connection with such indemnifications.

7. Net Assets

Equity Issuance

In connection with its formation, the Fund has the authority to issue 200,000,000 Shares.

On September 29, 2017, the Fund completed its Initial Closing after entering into Subscription Agreements with several investors, including the Adviser, providing for the private placement of Shares. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase Shares up to the amount of their respective Capital Commitments on an as-needed basis upon the issuance of a capital draw-down notice. At March 31, 2021 the Fund had total Capital Commitments of $456,870,158, of which 44% is unfunded. At December 31, 2020 the Fund had total Capital Commitments of $447,843,050, of which 52% was unfunded. The minimum Capital Commitment of an investor is $50,000. The Adviser, however, may waive the minimum Capital Commitment at its discretion.

Capital Commitments may be drawn down by the Fund on a pro rata basis, as needed (including for follow-on investments), for paying the Fund’s expenses, including fees under the Amended and Restated Advisory Agreement, and/or maintaining a reserve account for the payment of future expenses or liabilities.

The following table summarizes the total Shares issued and amount received related to capital drawdowns delivered pursuant to the Subscription Agreements during the three months ended March 31, 2021 and March 31, 2020:

 

     For the three months ended
March 31, 2021
     For the three months ended
March 31, 2020
 

Quarter Ended

   Shares      Amount      Shares      Amount  

March 31

     4,001,981      $ 37,708,999        4,876,625      $ 41,844,852  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total capital drawdowns

     4,001,981      $ 37,708,999        4,876,625      $ 41,844,852  
  

 

 

    

 

 

    

 

 

    

 

 

 

Distributions

The following tables reflect the distributions declared on Shares during the three months ended March 31, 2021 and March 31, 2020:

 

Date Declared

 

Record Date

 

Payment Date

 

Amount Per Share

 

Dollar Amount

3/29/2021

  3/29/2021   4/28/2021   $0.16   $4,358,022
       

 

        $4,358,022
       

 

 

Date Declared

 

Record Date

 

Payment Date

 

Amount Per Share

 

Dollar Amount

3/27/2020

  3/27/2020   4/29/2020   $0.24   $3,551,533
       

 

        $3,551,533
       

 

Distribution Reinvestment Plan

On September 26, 2017, the Fund adopted a dividend reinvestment plan, which was amended and restated on August 6, 2018 (the “DRIP”). Pursuant to the DRIP (both before and after it was amended), stockholders receive dividends or other distributions in cash unless a stockholder elects to reinvest his or her dividends and other distributions. As a result of adopting the DRIP, if the Board authorizes, and the Fund declares, a cash dividend or distribution, stockholders who have opted into the DRIP will have their cash dividends or distributions automatically reinvested in additional Shares, rather than receiving cash.

 

48


Table of Contents

The following tables summarize Shares distributed pursuant to the DRIP during the three months ended March 31, 2021 and March 31, 2020 to stockholders who opted into the DRIP:

 

Date Declared

 

Record Date

 

Reinvestment Date

 

Shares

 

Dollar Amount

3/29/2021

  3/29/2021   3/31/2021   229,904   $2,167,568
       

 

        $2,167,568
       

 

 

Date Declared

 

Record Date

 

Reinvestment Date

 

Shares

 

Dollar Amount

3/27/2020

  3/27/2020   3/31/2020   225,117   $1,931,666
       

 

        $1,931,666
       

 

General Tender Program

Beginning with the quarter ended March 31, 2021, the Fund began to conduct quarterly general tender offers (each, a “General Tender,” and collectively, the “General Tender Program”), at the Board’s discretion, in accordance with the requirements of Rule 13e-4 under the Exchange Act and the 1940 Act, to allow each of its stockholders to tender Shares at a specific per Share price (the “Purchase Price”) based on the Fund’s net asset value as of the last date of the quarter in which the General Tender is conducted. The Fund intends to conduct each General Tender on approximately 2.5% of the weighted average of the number of Shares outstanding during the three-month period prior to the quarter in which the General Tender is conducted. The General Tender Program includes numerous restrictions that limit stockholders’ ability to sell their Shares.

On February 26, 2021, the Fund commenced a General Tender (the “Q1 2021 Tender Offer”) for up to 502,190.45 Shares (the “Q1 2021 Tender Offer Cap”) tendered prior to March 31, 2021 (the “Initial Expiration Date”). As a result of the number of Shares tendered to the Fund prior to the Initial Expiration Date, the Fund extended the Q1 2021 Tender Offer and increased the Q1 2021 Tender Offer Cap to 2,083,220 Shares. Stockholders who tendered Shares in the Q1 2021 Tender Offer received, at the expiration of the Q1 2021 Tender Offer, a non-interest bearing, non-transferable promissory note entitling such stockholders to an amount in cash equal to the number of Shares accepted for purchase multiplied by the Purchase Price. The Purchase Price for the Q1 2021 Tender Offer was $9.43 per Share and the Q1 2021 Tender Offer expired on April 16, 2021. The following table summarizes Shares purchased during the Q1 2021 Tender Offer:

 

Payment Date

 

Shares

 

Dollar Amount

May 6, 2021

  1,173,288   $11,061,881

8. Earnings Per Share

The following information sets forth the computation of basic and diluted earnings per Share for the three months ended March 31, 2021 and March 31, 2020:

 

     For the three months ended
March 31,
 
     2021      2020  

Net increase (decrease) in net assets from operations

   $ 6,171,513      $ (15,497,328

Weighted average common shares outstanding

     26,432,156        14,683,464  

Earnings per common share-basic and diluted

   $ 0.23      $ (1.06

 

49


Table of Contents

9. Financial Highlights

Below is the schedule of financial highlights of the Fund for the three months ended March 31, 2021 and March 31, 2020:

 

     For the three months
ended

March 31, 2021
    For the three months
ended

March 31, 2020
 

Per Share Data:(1)(2)

 

Net asset value, beginning of period

   $ 9.35     $ 9.88  

Net investment income (loss)

     0.16       0.24  

Net realized and unrealized gains (losses) on investments

     0.08       (1.30
  

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

     0.24       (1.06
  

 

 

   

 

 

 

Distributions to stockholders(3)

     (0.16     (0.24
  

 

 

   

 

 

 

Net asset value, end of period

   $ 9.43     $ 8.58  

Shares outstanding, end of period

     26,833,819       19,729,143  

Total return at net asset value before incentive fees(4)(5)

     2.73     (10.53 )% 

Total return at net asset value after incentive fees(4)(5)

     2.49     (10.72 )% 

Ratio/Supplemental Data:(2)

 

Net assets, end of period

   $ 252,987,809     $ 169,290,052  

Ratio of total expenses to weighted average net assets(6)

     10.11     13.08

Ratio of net expenses to weighted average net assets(6)(7)

     9.30     8.32

Ratio of net investment income (loss) before waivers to weighted average net assets(6)

     8.42     5.99

Ratio of net investment income (loss) after waivers to weighted average net assets(6)(7)

     9.23     10.75

Ratio of interest and credit facility expenses to weighted average net assets(6)

     4.45     6.58

Ratio of incentive fees to weighted average net assets(5)(8)

     0.27     0.49

Portfolio turnover rate(5)

     4.23     3.75

Asset coverage ratio(9)

     170     167

 

(1)

The per share data was derived by using the weighted average shares outstanding during the applicable period.

(2)

Ratios calculated with Net Assets excluding the Non-Controlling Interest in ABPCICE.

(3)

The per share data for distributions is the actual amount of distributions paid or payable per share of common stock outstanding during the entire period.

(4)

Total return based on NAV is calculated as the change in NAV per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Fund’s dividend reinvestment plan.

(5)

Not annualized.

(6)

Annualized, except for professional fees, directors’ fees and incentive fees.

(7)

For the three months ended March 31, 2021 and March 31, 2020, the Adviser voluntarily waived a portion of their management fees, incentive fees, and collateral management fees. Additionally, the Adviser also reimbursed the Fund for operating expenses exceeding the percentage limit as per the Expense Support and Conditional Reimbursement Agreement. The ratios include the effects of the waived expenses of 1.09% and 4.63% for the three months ended March 31, 2021 and March 31, 2020, respectively.

(8)

Ratio of incentive fees to weighted average net assets calculated before the voluntary waiver of incentive fees by the Adviser.

(9)

Asset coverage ratio is equal to (i) the sum of (A) net assets at end of period and (B) debt outstanding at end of period, divided by (ii) total debt outstanding at the end of the period.

10. Subsequent Events

Subsequent events after the consolidated statements of assets and liabilities date have been evaluated through the date the financial statements were issued. The Fund has concluded that there are no events requiring adjustment or disclosure in the financial statements, other than as described below.

As described in Note 7, the Fund conducted the Q1 2021 Tender Offer, which expired on April 16, 2021. On April 20, 2021, the fund issued a promissory note in the amount of $11,061,881 to the stockholders who tendered Shares in the Q1 2021 Tender Offer. This promissory note was paid in full on May 6, 2021.

On April 16, 2021, pursuant to the Synovus Loan Agreement, the Fund (i) increased the commitment of the existing lender by $20,000,000 from $100,000,000 to $120,000,000 and (ii) added WebBank as an additional lender with a commitment of $30,000,000.

 

50


Table of Contents
Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report on Form 10-Q (this “Quarterly Report”) contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about the Fund, its current and prospective portfolio investments, its industry, its beliefs and opinions, and its assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the Fund’s control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

 

   

an economic downturn could impair the Fund’s portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of the Fund’s investments in such portfolio companies;

 

   

such an economic downturn could disproportionately impact the companies that the Fund intends to target for investment, potentially causing the Fund to experience a decrease in investment opportunities and diminished demand for capital from these companies;

 

   

pandemics or other serious public health events, such as the recent global outbreak of a novel strain of the coronavirus, commonly known as “COVID-19”;

 

   

a contraction of available credit and/or an inability to access the equity markets could impair the Fund’s lending and investment activities;

 

   

interest rate volatility could adversely affect the Fund’s results, particularly if the Fund elects to use leverage as part of its investment strategy;

 

   

the Fund’s future operating results;

 

   

the Fund’s business prospects and the prospects of its portfolio companies;

 

   

the Fund’s contractual arrangements and relationships with third parties;

 

   

the ability of the Fund’s portfolio companies to achieve their objectives;

 

   

competition with other entities and the Fund’s affiliates for investment opportunities;

 

   

the speculative and illiquid nature of the Fund’s investments;

 

   

the use of borrowed money to finance a portion of the Fund’s investments;

 

   

the adequacy of the Fund’s financing sources and working capital;

 

   

the loss of key personnel;

 

   

the timing of cash flows, if any, from the operations of the Fund’s portfolio companies;

 

   

the ability of the Adviser to locate suitable investments for the Fund and to monitor and administer the Fund’s investments;

 

   

the ability of the Adviser to attract and retain highly talented professionals;

 

   

the Fund’s ability to qualify and maintain its qualification as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), and as a business development company (“BDC”);

 

   

the effect of legal, tax and regulatory changes; and

 

   

the other risks, uncertainties and other factors the Fund identifies under “Risk Factors” of its Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

Although the Fund believes that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this report should not be regarded as a representation by the Fund that its plans and objectives will be achieved. These risks and uncertainties include

 

51


Table of Contents

those described or identified in the section entitled “Item 1A. Risk Factors” of the Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and elsewhere in this report. These forward-looking statements apply only as of the date of this report. Moreover, the Fund assumes no duty and does not undertake to update the forward-looking statements. The forward-looking statements and projections contained in this Quarterly Report are excluded from the safe harbor protection provided by Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) because the Fund is an investment company.

The following analysis of the Fund’s financial condition and results of operations should be read in conjunction with the Fund’s financial statements and the related notes thereto contained elsewhere in this Quarterly Report.

Overview

The Fund was formed on February 6, 2015 as a corporation under the laws of the State of Maryland. The Fund is structured as an externally managed, non-diversified, closed-end management investment company. The Fund was formed to invest primarily in primary-issue middle-market credit opportunities that are directly sourced and privately negotiated. The Fund commenced investment operations on November 15, 2017 (“Commencement”) by issuing its first Capital Call (as defined below) on December 1, 2017. The Fund is advised by AB Private Credit Investors LLC (the “Adviser”), which is registered with the Securities and Exchange Commission (“SEC”) under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). The Adviser is responsible for sourcing potential investments, conducting due diligence on prospective investments, analyzing investment opportunities, structuring investments and monitoring the Fund’s portfolio on an ongoing basis. State Street Bank and Trust Company (the “Administrator”) provides the administrative services necessary for the Fund to operate.

The Fund has elected to be treated as a BDC under the 1940 Act. The Fund has also elected to be treated and intends to qualify annually as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As a BDC and a RIC, respectively, the Fund is and will be required to comply with various regulatory requirements, such as the requirement to invest at least 70% of its assets in “qualifying assets,” source of income limitations, asset diversification requirements, and the requirement to distribute annually at least 90% of its taxable income and tax exempt interest.

The Fund is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The Fund will remain an emerging growth company for up to five years following its initial public offering, if any, although if the market value of its common stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, the Fund would cease to be an emerging growth company as of the following December 31. For so long as the Fund remains an emerging growth company under the JOBS Act, it will be subject to reduced public company reporting requirements.

Effects of COVID-19 on the Fund’s Results of Operations

The rapid spread of COVID-19, a novel strain of coronavirus causing respiratory illness (“COVID-19”) has resulted in temporary closures of many corporate offices, retail stores, and manufacturing facilities and factories around the world, which could materially disrupt the demand for the Fund’s portfolio companies’ products and services. The World Health Organization (“WHO”) declared COVID-19 a global pandemic, and the WHO and governments have recommended, and in some cases, mandated, containment and mitigation measures worldwide. The COVID-19 pandemic has had a significant impact on the U.S. economy and supply chains worldwide have been interrupted, slowed or rendered inoperable, with an increasing number of individuals becoming ill, subject to quarantine, or otherwise unable to work and/or travel due to health reasons or governmental restrictions. Governmental mandates to control an outbreak may require forced shutdown of the Fund’s portfolio companies’ facilities for extended or indefinite periods. The extent of the impact of the COVID-19 outbreak on the financial performance of the Fund’s current and future investments will depend on future developments, including the duration and spread of the virus, related advisories and restrictions, and the health of the financial markets and economy as a result of COVID-19, all of which are highly uncertain and cannot be predicted. Adverse impacts on the Fund’s investments may have a material adverse impact on the Fund’s future net investment income, the fair value of the Fund’s portfolio investments, the Fund’s financial condition and results of operations and the financial condition of the Fund’s portfolio companies.

As of March 31, 2021, the Fund was in compliance with its asset coverage requirements under the 1940 Act. In addition, the Fund was not in default of any of the covenants under the Revolving Credit Facilities as of March 31, 2021. However, any increase in unrealized depreciation of the Fund’s investment portfolio or further significant reductions in the Fund’s net asset value as a result of the effects of the COVID-19 pandemic or otherwise may increase the risk of breaching the relevant covenants and requirements.

The Fund will continue to monitor the rapidly evolving situation surrounding the COVID-19 pandemic and guidance from U.S. and international authorities, including federal, state and local public health authorities, and may take additional actions based on their recommendations. Given the dynamic nature of this situation, the Fund cannot reasonably estimate the impact of COVID-19 on its financial condition, results of operations or cash flows in the future.

 

52


Table of Contents

The Private Offering

The Fund enters into separate subscription agreements with investors providing for the private placement of Shares in reliance on exemptions from the registration requirements of the Securities Act. Each investor makes a capital commitment (a “Capital Commitment”) to purchase Shares pursuant to a subscription agreement. Investors are required to make capital contributions (“Capital Contributions”) to purchase Shares each time the Fund delivers a capital call notice (a “Capital Call”), which is issued based on the Fund’s anticipated investment activities and capital needs, delivered at least 10 business days prior to the required funding date, provided that investors may fund such requirements sooner than the deadline as agreed between the Fund and the investor. Generally, purchases of Shares are made pro rata in accordance with each investor’s Capital Commitment, in an amount not to exceed each investor’s remaining capital commitment (“Remaining Commitment”), at a per-Share price equal to the net asset value per Share subject to any adjustments. Pursuant to the Private Offering, the Fund’s initial closing of Capital Commitments occurred on September 29, 2017.

The Fund may accept additional Capital Commitments quarterly (“Subsequent Closings”) from new investors as well as existing investors that wish to increase their commitment and shareholding in the Fund. These Subsequent Closings are expected to occur on a calendar-quarter end based on investor interest as well as the state of the market and the Fund’s capacity to invest the additional capital in a reasonable period. Each Capital Commitment is for the life of the Fund or for a shorter period based on the investor’s liquidation election, subject to the Fund’s receipt of exemptive relief that would permit stockholders to liquidate their investments pursuant to transactions that are currently prohibited by the 1940 Act and would require an SEC order in order to be established.

Revenues

The Fund’s investment objective is to generate current income and prioritize capital preservation through a portfolio that primarily invests in directly-sourced, privately-negotiated, secured, middle market loans. The Fund intends to primarily invest in middle market businesses based in the United States. The Fund expects that the primary use of proceeds by the companies in which the Fund invests will be for leveraged buyouts, recapitalizations, mergers and acquisitions and growth capital.

The Fund will seek to build its portfolio in a defensive manner that minimizes cyclical and correlated risks across individual names and sector verticals by targeting companies with strong underlying business models and durable intrinsic value.

The Fund will primarily hold secured loans, which encompass traditional first lien, unitranche and second lien loans, but may also invest in mezzanine, structured preferred stock and non-control equity co-investment opportunities. The Fund will seek to deliver attractive risk adjusted returns with lower volatility and low correlation relative to the public credit markets. The Adviser believes the Fund’s flexibility to invest across the capital structure and liquidity spectrum will allow the Fund to optimize investor risk-adjusted returns.

Expenses

Under the Amended and Restated Advisory Agreement, the Fund’s primary operating expenses will include the payment of fees to the Adviser, the Fund’s allocable portion of overhead expenses under the Expense Reimbursement Agreement and other operating costs described below. The Fund bears all other out-of-pocket costs and expenses of the Fund’s operations and transactions, including those relating to:

 

   

reasonable and documented organization and offering expenses to the extent reimbursement of such expenses is included in any future agreement with the Adviser;

 

   

calculating the Fund’s net asset value (including the cost and expenses of any independent valuation firm);

 

   

fees and expenses payable to third parties, including agents, consultants or other advisers, in connection with monitoring financial (including advising with respect to the Fund’s financing strategy) and legal affairs for the Fund and in providing administrative services, monitoring the Fund’s investments and performing due diligence on the Fund’s prospective portfolio companies or otherwise relating to, or associated with, evaluating and making investments;

 

   

interest payable on debt, if any, incurred to finance the Fund’s investments;

 

   

sales and purchases of the Fund’s common stock and other securities;

 

53


Table of Contents
   

base management fees and incentive fees payable to the Adviser;

 

   

transfer agent and custodial fees;

 

   

federal and state registration fees;

 

   

all costs of registration and listing the Fund’s securities on any securities exchange;

 

   

U.S. federal, state and local taxes;

 

   

independent directors’ fees and expenses;

 

   

costs of preparing and filing reports or other documents required by the SEC, the Financial Industry Regulatory Authority or other regulators;

 

   

costs of any reports, proxy statements or other notices to stockholders, including printing costs;

 

   

the Fund’s allocable portion of any fidelity bond, directors’ and officers’ errors and omissions liability insurance, and any other insurance premiums;

 

   

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

   

all other expenses incurred by the Fund, the Administrator or the Adviser in connection with administering the Fund’s business, including payments under the Administration Agreement and payments under the Expense Reimbursement Agreement based on the Fund’s allocable portion of the Adviser’s overhead in performing its obligations under the Expense Reimbursement Agreement, including the allocable portion of the cost of the Fund’s Chief Compliance Officer and Chief Financial Officer and their respective staffs.

Portfolio and Investment Activity

During the three months ended March 31, 2021, the Fund invested $64,356,307 in 12 portfolio companies, $5,881,161 was drawn down against the revolvers and delayed draw term loans, and the Fund had $15,637,321 in aggregate amount of principal repayments, which includes $1,348,999 in revolver and delayed draw term loan paydowns, and $7,921,954 in sales, resulting in net investments of $46,678,193 for the period. During the three months ended March 31, 2021, the Fund had $375,483 in PIK interest.

During the three months ended March 31, 2020, the Fund invested $26,047,107 in 12 portfolio companies, $31,464,713 was drawn down against the revolvers and delayed draw term loans, and the Fund had $12,615,490 in aggregate amount of principal repayments, which includes $3,988,364 in revolver and delayed draw term loan paydowns, and $842,678 in sales, resulting in net investments of $44,053,652 for the period. During the three months ended March 31, 2020, the Fund had $206,351 in PIK interest.

 

54


Table of Contents

The following table shows the composition of the investment portfolio and associated yield data as of March 31, 2021:

 

     As of March 31, 2021  
     Cost      Percentage of
Total Portfolio
    Fair Value      Percentage of
Total Portfolio
    Weighted
Average
Yield(1)
 

First Lien Senior Secured Debt

   $ 564,952,955        96.22   $ 558,929,700        95.93     8.27

Second Lien Junior Secured Debt

   $ 11,322,032        1.93   $ 11,396,370        1.96     9.51  

Preferred Stock

   $ 6,993,227        1.19   $ 8,174,321        1.40     0  

Common Stock

   $ 2,906,350        0.50   $ 3,641,561        0.62     0  

Warrants

   $ 955,313        0.16   $ 548,104        0.09     0  
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total

   $ 587,129,877        100   $ 582,690,056        100  
  

 

 

    

 

 

   

 

 

    

 

 

   

 

(1) 

Based upon the par value of the Fund’s debt investments

The following table shows the composition of the investment portfolio and associated yield data as of December 31, 2020:

 

     As of December 31, 2020  
     Amortized Cost      Percentage of
Total Portfolio
    Fair Value      Percentage of
Total Portfolio
    Weighted
Average
Yield(1)
 

First Lien Senior Secured Debt

   $ 518,106,245        96.08   $ 511,197,686        95.90     8.50

Second Lien Junior Secured Debt

   $ 11,315,669        2.10   $ 11,396,369        2.14     10.04

Preferred Stock

   $ 6,993,227        1.30   $ 7,495,949        1.41     0  

Common Stock

   $ 2,076,055        0.38   $ 2,663,040        0.50     0  

Warrants

   $ 737,264        0.14   $ 281,986        0.05     0  
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total

   $ 539,228,460        100   $ 533,035,030        100  
  

 

 

    

 

 

   

 

 

    

 

 

   

 

(1) 

Based upon the par value of the Fund’s debt investments

The following table presents certain selected financial information regarding the debt investments in the Fund’s portfolio as of March 31, 2021 and December 31, 2020:

 

     As of
March 31, 2021
    As of
December 31, 2020
 

Number of portfolio companies

     116       123  

Percentage of debt bearing a floating rate(1)

     100     100

Percentage of debt bearing a fixed rate(1)

     0     0

 

(1) 

Measured on a fair value basis, and excludes equity securities.

The following table shows the amortized cost and fair value of the Fund’s performing and non-accrual debt investments as of March 31, 2021:

 

     As of March 31, 2021  
     Amortized Cost      Percentage at
Amortized Cost
    Fair Value      Percentage at
Fair Value
 

Performing

   $ 572,398,089        99.33   $ 568,531,009        99.69

Non-accrual

     3,876,899        0.67       1,795,060        0.31  
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 576,274,988        100   $ 570,326,069        100
  

 

 

    

 

 

   

 

 

    

 

 

 

 

55


Table of Contents

The following table shows the amortized cost and fair value of the Fund’s performing and non-accrual debt investments as of December 31, 2020:

 

     As of December 31, 2020  
     Amortized Cost      Percentage at
Amortized Cost
    Fair Value      Percentage at
Fair Value
 

Performing

   $ 529,421,914        100   $ 522,594,055        100

Non-accrual

     —          —         —          —    
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 529,421,914        100   $ 522,594,055        100
  

 

 

    

 

 

   

 

 

    

 

 

 

Generally, when interest and/or principal payments on a loan become past due, or if the Fund otherwise does not expect the borrower to be able to service its debt and other obligations, the Fund will place the loan on non-accrual status and will cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to restructuring such that the interest income is deemed to be collectible. The Fund generally restores non-accrual loans to accrual status when past due principal and interest is paid and, in the management’s judgment, is likely to remain current.

The following table shows the amortized cost and fair value of the investment portfolio and cash and cash equivalents as of March 31, 2021:

 

     As of March 31, 2021  
     Amortized Cost      Percentage of
Total Portfolio
    Fair Value      Percentage of
Total Portfolio
 

First Lien Senior Secured Debt

   $ 564,952,955        88.54   $ 558,929,700        88.22

Second Lien Junior Secured Debt

   $ 11,322,032        1.77   $ 11,396,370        1.80

Preferred Stock

   $ 6,993,227        1.10   $ 8,174,321        1.29

Common Stock

   $ 2,906,350        0.46   $ 3,641,561        0.57

Warrants

   $ 955,313        0.15   $ 548,104        0.09

Cash and cash equivalents

   $ 50,890,483        7.98   $ 50,890,483        8.03
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 638,020,360        100.00   $ 633,580,539        100.00
  

 

 

    

 

 

   

 

 

    

 

 

 

The following table shows the amortized cost and fair value of the investment portfolio and cash and cash equivalents as of December 31, 2020:

 

     As of December 31, 2020  
     Amortized Cost      Percentage of
Total
    Fair Value      Percentage of
Total
 

First Lien Senior Secured Debt

   $ 518,106,245        92.25   $ 511,197,686        92.03

Second Lien Junior Secured Debt

   $ 11,315,669        2.01   $ 11,396,369        2.05

Preferred Stock

   $ 6,993,227        1.25   $ 7,495,949        1.35

Common Stock

   $ 2,076,055        0.37   $ 2,663,040        0.48

Warrants

   $ 737,264        0.14   $ 281,986        0.05

Cash and cash equivalents

   $ 22,410,622        3.98   $ 22,410,622        4.04
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 561,639,082        100   $ 555,445,652        100
  

 

 

    

 

 

   

 

 

    

 

 

 

 

56


Table of Contents

The following table shows the composition of the investment portfolio by industry, at amortized cost and fair value as of March 31, 2021 (with corresponding percentage of total portfolio investments):

 

     As of March 31, 2021  
   Amortized Cost      Percentage of
Total Portfolio
    Fair Value      Percentage of
Total Portfolio
 

Business Services

   $ 56,758,487        9.67   $ 56,759,502        9.74

Consumer Non-Cyclical

   $ 15,649,149        2.67   $ 15,341,080        2.63

Digital Infrastructure & Services

   $ 49,079,782        8.36   $ 48,661,140        8.35

Consumer Discretionary

   $ 9,163,585        1.56   $ 9,095,309        1.56

Energy

   $ 20,000,394        3.41   $ 18,548,469        3.18

Financials

   $ 8,069,290        1.37   $ 8,035,913        1.38

Healthcare & HCIT

   $ 180,187,359        30.69   $ 178,035,056        30.56

Software & Tech Services

   $ 239,143,970        40.72   $ 241,281,565        41.41

Transport & Logistics

   $ 9,077,861        1.55   $ 6,932,022        1.19
  

 

 

    

 

 

   

 

 

    

 

 

 
     587,129,877        100   $ 582,690,056        100
  

 

 

    

 

 

   

 

 

    

 

 

 

The following table shows the composition of the investment portfolio by industry, at amortized cost and fair value as of December 31, 2020 (with corresponding percentage of total portfolio investments):

 

     As of December 31, 2020  
   Amortized Cost      Percentage of
Total
    Fair Value      Percentage of
Total
 

Business Services

   $ 39,299,593        7.29   $ 38,887,140        7.30

Consumer Non-Cyclical

   $ 10,215,267        1.89   $ 9,866,617        1.85

Digital Infrastructure & Services

   $ 28,828,092        5.35   $ 28,732,616        5.39

Education

   $ 9,177,391        1.70   $ 9,108,599        1.71

Energy

   $ 21,301,663        3.95   $ 19,283,664        3.62

Financial Services

   $ 8,525,237        1.58   $ 8,527,428        1.60

Healthcare & HCIT

   $ 157,164,560        29.15   $ 154,546,234        28.99

Software & Tech Services

   $ 255,942,203        47.46   $ 257,378,914        48.28

Transport & Logistics

   $ 8,774,454        1.63   $ 6,703,818        1.26
  

 

 

    

 

 

   

 

 

    

 

 

 
   $ 539,228,460        100   $ 533,035,030        100
  

 

 

    

 

 

   

 

 

    

 

 

 

The Adviser monitors the Fund’s portfolio companies on an ongoing basis. It monitors the financial trends of each portfolio company to determine if they are meeting their respective business plans and to assess the appropriate course of action for each company. The Adviser has several methods of evaluating and monitoring the performance and fair value of the Fund’s investments, which may include the following:

 

   

assessment of success in adhering to the portfolio company’s business plan and compliance with covenants;

 

   

periodic or regular contact with portfolio company management and, if appropriate, the financial or strategic sponsor to discuss financial position, requirements and accomplishments;

 

   

comparisons to the Fund’s other portfolio companies in the industry, if any;

 

   

attendance at and participation in board meetings or presentations by portfolio companies; and

 

   

review of monthly and quarterly consolidated financial statements and financial projections of portfolio companies.

 

57


Table of Contents

Results of Operations

The following is a summary of the Fund’s operating results for the quarters ended March 31, 2021 and March 31, 2020:

 

     For the Three Months Ended
March 31,
2021
     For the Three Months Ended
March 31,
2020
 

Total investment income

   $ 10,859,760      $ 7,441,251  

Total expenses

     6,858,084        6,151,628  
  

 

 

    

 

 

 

Reimbursement payments to Adviser

     280,779        —    

Expense Reimbursement from Adviser

     —          (89,757

Waived Collateral Management Fee

     (454,343      (459,059

Waived Management Fee

     (183,001      (1,227,046

Waived Incentive Fees

     —          (486,784
  

 

 

    

 

 

 

Net investment income

     4,358,241        3,552,269  

Net realized and change in unrealized appreciation (depreciation) on investments

     1,813,079        (19,049,597

Net increase (decrease) in net assets resulting from operations

   $ 6,171,320      $ (15,497,328

Less: Net increase (decrease) in net assets resulting from operations related to Non-Controlling Interest in ABPCIC Equity Holdings, LLC

   $ (193    $ —    

Net increase (decrease) in net assets resulting from operations related to AB Private Credit Investors Corporation

   $ 6,171,513      $ (15,497,328
  

 

 

    

 

 

 

Investment Income

During the three months ended March 31, 2021, the Fund’s investment income was comprised of $10,377,184 of interest income, which includes $788,271 from the net amortization of premium and accretion of discounts, $375,483 of payment-in-kind interest and other fee income of $107,093.

During the three months ended March 31, 2020, the Fund’s investment income was comprised of $7,052,300 of interest income, which included $452,560 from the net amortization of premium and accretion of discounts, $206,351 of payment-in-kind interest and other fee income of $182,600.

Operating Expenses

The following is a summary of the Fund’s operating expenses for the quarters ended March 31, 2021 and March 31, 2020:

 

     For the Three
Months
Ended
March 31,
2021
     For the Three
Months
Ended
March 31,
2020
 

Interest and borrowing expenses

   $ 2,605,053      $ 2,568,667  

Management fees

     2,069,181        1,352,351  

Professional fees

     549,052        547,269  

Collateral management fees

     454,343        459,059  

Income-based incentive fee

     641,062        769,023  

Administration and custodian fees

     163,051        91,783  

Insurance expenses

     146,334        67,596  

Directors’ fees

     50,000        50,000  

Transfer agent fees

     16,386        10,758  

Other expenses

     163,622        235,122  
  

 

 

    

 

 

 

Total expenses

     6,858,084        6,151,628  

Reimbursement payments to Adviser

     280,779        —    

Expense reimbursement from Adviser

     —          (89,757

Waived collateral management fees

     (454,343      (459,059

Waived management fees

     (183,001      (1,227,046

Waived incentive fees

     —          (486,784
  

 

 

    

 

 

 

Net expenses

   $ 6,501,519      $ 3,888,982  
  

 

 

    

 

 

 

 

58


Table of Contents

Interest and Borrowing Expenses

Interest and borrowing expenses includes interest, amortization of debt issuance and deferred financing costs, upfront commitment fees and unused fees on the unused portion of the Revolving Credit Facilities, Secured Borrowings and the Notes issued in the CLO Transaction. The Fund first drew on the HSBC Credit Facility on November 15, 2017, the Synovus Credit Facility on October 15, 2020 and the Natixis Credit Facility on March 24, 2021. As of March 31, 2021, there were outstanding balances of $89,700,000 and $59,800,000 on the Synovus Credit Facility and the Natixis Credit Facility, respectively. As of December 31, 2020, there were outstanding balances of $46,000,000 and $84,700,000 on the HSBC Credit Facility and Synovus Credit Facility, respectively, and an outstanding balance of $18,870,856 in Secured Borrowings. The outstanding amount on the Notes is $211,612,948, net of unamortized discount and debt issuance costs as of March 31, 2021. The outstanding amount on the Notes was $211,337,498, net of unamortized discount and debt issuance costs as of December 31, 2020.

Interest and borrowing expenses for the three months ended March 31, 2021 and March 31, 2020 were $2,605,053 and $2,568,667, respectively. The weighted average interest rate (excluding deferred upfront financing costs and unused fees) on the Fund’s debt outstanding was 2.52% and 3.73% for the three months ended March 31, 2021 and March 31, 2020, respectively.

Management Fee

The gross management fee expenses for the three months ended March 31, 2021 and March 31, 2020 were $2,069,181 and $1,352,351, respectively. The increase in the management fee for the three months ended March 31, 2021 was a result of the increase in average gross assets during the period, which are the basis used to calculate management fees. For the three months ended March 31, 2021 and March 31, 2020, the Adviser waived management fees of $183,001 and $1,227,046, respectively.

Fund Expenses

For the three months ended March 31, 2021, the Fund incurred $6,858,084 of expenses in relation to professional fees, directors’ fees, collateral management fees, management fees, incentive fees, insurance expenses, interest and borrowing expenses, transfer agent fees, other fees, and administration and custodian fees. Additionally, $280,779 was reimbursed by the Fund to the Adviser and its affiliates. Further, $183,001 of management fees and $454,343 of collateral management fees were waived by the Adviser.

For the three months ended March 31, 2020, the Fund incurred $6,151,628 of expenses in relation to professional fees, directors’ fees, collateral management fees, management fees, incentive fees, insurance expenses, interest and borrowing expenses, transfer agent fees, other fees, and administration and custodian fees. The Fund was reimbursed by the Adviser and its affiliates fees in the amount of $89,757. Further, $1,227,046 of management fees, $486,784 of incentive fees and $459,059 of collateral management fees were waived by the Adviser.

Net Realized Gain (Loss) on Investments

During the three months ended March 31, 2021, the Fund had principal repayments of $15,637,321, which included $1,348,999 of revolver and delayed draw term loan paydowns, and $7,921,954 in sales, resulting in $59,470 of net realized gain.

During the three months ended March 31, 2020, the Fund had principal repayments of $12,615,490, which included $3,988,364 of revolver and delayed draw term loan paydowns, and $842,678 in sales, resulting in $13,369 of net realized loss.

 

59


Table of Contents

Net Change in Unrealized Appreciation (Depreciation) on Investments

During the three months ended March 31, 2021, the Fund had $1,753,609 in net change in unrealized appreciation on $587,129,877 of investments in 121 portfolio companies. Unrealized appreciation for the three months ended March 31, 2021 resulted from an increase in fair value, primarily due to positive valuation adjustments on level 3 securities.

During the three months ended March 31, 2020, the Fund had $19,036,228 in net change in unrealized depreciation on $391,572,934 of investments in 90 portfolio companies. Unrealized depreciation for the three months ended March 31, 2020 was primarily due to the negative economic impact and the increased uncertainty caused by COVID-19.

Net Increase (Decrease) in Net Assets Resulting from Operations

For the three months ended March 31, 2021 and March 31, 2020, the net increase and decrease in net assets resulting from operations was $6,171,320 and $(15,497,328), respectively. Based on the weighted average Shares outstanding for the three months ended March 31, 2021 and March 31, 2020, the Fund’s per Share net increase and decrease in net assets resulting from operations was $0.23 and $(1.06), respectively.

Cash Flows

For the three months ended March 31, 2021, cash increased by $28,479,861. During the same period, the Fund used $39,889,032 in operating activities, primarily as a result of net purchases of investments. During the three months ended March 31, 2021, the Fund generated $68,363,893 from financing activities, primarily from net borrowings on the Natixis Credit Facility and issuance of Shares.

For the three months ended March 31, 2020, cash increased by $1,319,834. During the same period, the Fund used $41,095,861 in operating activities, primarily as a result of net purchases of investments. During the three months ended March 31, 2020, the Fund generated $42,415,695 from financing activities, primarily from issuance of common stock and net borrowings on the HSBC Credit Facility.

Hedging

The Fund may enter into currency hedging contracts, interest rate hedging agreements such as futures, options, swaps and forward contracts, and credit hedging contracts, such as credit default swaps. However, no assurance can be given that such hedging transactions will be entered into or, if they are, that they will be effective. For the three months ended March 31, 2021 and March 31, 2020, the Fund did not enter into any hedging contracts.

Financial Condition, Liquidity and Capital Resources

At March 31, 2021, and December 31, 2020, the Fund had $50,890,483 and $22,410,622 in cash and cash equivalents, respectively. The Fund expects to generate cash primarily from (i) the net proceeds of the Private Offering, (ii) cash flows from the Fund’s operations, (iii) any financing arrangements now existing or that the Fund may enter into in the future and (iv) any future offerings of the Fund’s equity or debt securities. The Fund may fund a portion of its investments through borrowings from banks, or other large global institutions such as insurance companies, and issuances of senior securities.

The Fund’s primary use of funds from a credit facility will be investments in portfolio companies, cash distributions to holders of its common stock and the payment of operating expenses.

In the future, the Fund may also securitize or finance a portion of its investments with a special purpose vehicle. If the Fund undertakes a securitization transaction, the Fund will consolidate its allocable portion of the debt of any securitization subsidiary on its financial statements, and include such debt in the Fund’s calculation of the asset coverage test, if and to the extent required pursuant to the guidance of the staff of the SEC.

Cash and cash equivalents as of the three months ended March 31, 2021, taken together with the Fund’s uncalled Capital Commitments of $202,341,994, $50,000,000 undrawn amount on the HSBC Credit Facility, $10,300,000 undrawn amount on the Synovus Credit Facility and $40,200,000 undrawn amount on the Natixis Credit Facility, is expected to be sufficient for the Fund’s investing activities and to conduct the Fund’s operations for at least the next twelve months. As of March 31, 2021, the Fund had $50,890,483 in cash and cash equivalents. During the three months ended March 31, 2021, the Fund used $39,889,032 for operating activities. This “Financial Condition, Liquidity and Capital Resources” section should be read in conjunction with “Effects of COVID-19 on the Fund’s Results of Operations” above.

 

60


Table of Contents

Equity Activity

The Fund has the authority to issue 200,000,000 Shares.

The Fund has entered into Subscription Agreements with investors providing for the private placement of Shares. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase Shares up to the amount of their respective Capital Commitments on an as-needed basis upon the issuance of a capital draw down notice. As of March 31, 2021, the Fund received Capital Commitments of $456,870,158. Inception to March 31, 2021, the Fund received Capital Contributions to the Fund of $254,528,164. Proceeds from the issuances of Shares in respect of drawdown notices described below were used for investing activities and for other general corporate purposes.

For the three months ended March 31, 2021, the Fund received total Capital Commitments of $18,824,108, had $2,167,568 of dividend reinvestments and issued 229,904 Shares to investors that opted into the Fund’s dividend reinvestment plan, issued capital drawdown notices to its investors for an aggregate amount of $37,708,999 and issued 4,001,981 Shares to investors in respect of such capital drawdowns. In addition, during the three months ended March 31, 2021, the Fund launched the Q1 2021 Tender Offer, which expired on April 16, 2021, and in which Shares with a value of $11,061,881 were purchased by the Fund upon expiration. For the three months ended March 31, 2020, the Fund received total Capital Commitments of $20,827,965, had $1,931,666 of dividend reinvestments and issued 225,117 Shares to investors that opted into the Fund’s dividend reinvestment plan, issued capital drawdown notices to its investors for an aggregate amount of $41,844,852 and issued 4,876,625 Shares to investors in respect of such capital drawdowns.

Distributions

Distributions to stockholders are recorded on the record date. To the extent that the Fund has income available, the Fund intends to distribute quarterly distributions to its stockholders. The Fund’s quarterly distributions, if any, will be determined by the Board. Any distributions to the Fund’s stockholders will be declared out of assets legally available for distribution.

The following table summarizes distributions declared during the three months ended March 31, 2021:

 

Date Declared

   Record Date      Payment Date      Amount Per Share    Total Distributions

March 29, 2021

     March 29, 2021        April 28, 2021      $0.16    $4,358,022
        

 

  

 

Total distributions declared

         $0.16    $4,358,022
        

 

  

 

The following table summarizes distributions declared during the three months ended March 31, 2020:

 

Date Declared

   Record Date      Payment Date      Amount Per Share    Total Distributions

March 27, 2020

     March 27, 2020        April 29, 2020      $0.24    $3,551,533
        

 

  

 

Total distributions declared

         $0.24    $3,551,533
        

 

  

 

The federal income tax characterization of distributions declared and paid for the fiscal year will be determined at fiscal year-end based upon the Fund’s investment company taxable income for the full fiscal year and distributions paid during the full year. For the three months ended March 31, 2021, the Fund distributed $4,358,022 to stockholders, all of which was attributable to ordinary income. The character of distributions for federal income tax purposes are determined in accordance with income tax regulations which may differ from GAAP. Stockholders should read any written disclosure accompanying a distribution payment carefully and should not assume that the source of any distribution is only ordinary income or gains.

To the extent the Fund’s taxable earnings fall below the total amount of its distributions paid for that fiscal year, a portion of those distributions may be deemed a return of capital to the Fund’s stockholders for U.S. federal income tax purposes. Thus, the source of a distribution to stockholders may be the original capital invested by the stockholder rather than the Fund’s income or gains.

 

61


Table of Contents

For the three months ended March 31, 2020, the Fund distributed $3,551,533 to stockholders, all of which was attributable to ordinary income. The character of distributions for federal income tax purposes are determined in accordance with income tax regulations which may differ from GAAP. Stockholders should read any written disclosure accompanying a distribution payment carefully and should not assume that the source of any distribution is only ordinary income or gains.

General Tender Program

Beginning with the quarter ended March 31, 2021, the Fund began to conduct quarterly General Tenders, at the Board’s discretion, in accordance with the requirements of Rule 13e-4 under the Exchange Act and the 1940 Act, to allow each of its stockholders to tender Shares at a specific Purchase Price based on the Fund’s net asset value as of the last date of the quarter in which the General Tender is conducted. The Fund intends to conduct each General Tender on approximately 2.5% of the weighted average of the number of Shares outstanding during the three-month period prior to the quarter in which the General Tender is conducted. The General Tender Program includes numerous restrictions that limit stockholders’ ability to sell their Shares.

On February 26, 2021, the Fund commenced the Q1 2021 Tender Offer” for up to 502,190.45 Shares tendered prior to March 31, 2021. As a result of the number of Shares tendered to the Fund prior to the Initial Expiration Date, the Fund extended the Q1 2021 Tender Offer and increased the Q1 2021 Tender Offer Cap to 2,083,220 Shares. Stockholders who tendered Shares in the Q1 2021 Tender Offer received a non-interest bearing, non-transferable promissory note entitling such stockholders to an amount in cash equal to the number of Shares accepted for purchase multiplied by the Purchase Price. The Purchase Price for the Q1 2021 Tender Offer was $9.43 per Share and the Q1 2021 Tender Offer expired on April 16, 2021. The following table summarizes Shares purchased during the Q1 2021 Tender Offer:

 

Payment Date

   Shares      Dollar
Amount
 

May 6, 2021

     1,173,288      $ 11,061,881  

Contractual Obligations

The Fund has entered into certain contracts under which it has future commitments. Payments under the Amended and Restated Advisory Agreement with the Adviser consist of (i) a base management fee equal to a percentage of the average outstanding assets of the Fund (which equals the gross value of equity and debt instruments, including investments made utilizing leverage), excluding cash and cash equivalents, during such fiscal quarter and (ii) an incentive fee based on the Fund’s performance. The cost of both the base management fee and the incentive fee will ultimately be borne by the Fund’s stockholders. Under the Administration Agreement, the Fund will reimburse the Adviser an amount equal to the Fund’s allocable portion (subject to the review of the Fund’s Board) of its overhead resulting from its obligations under the Expense Reimbursement Agreement. Stockholder approval is not required to amend the Administration Agreement or Expense Reimbursement Agreement. Any new investment advisory agreement would be subject to approval by the Fund’s stockholders.

The following table shows the Fund’s contractual obligations as of March 31, 2021:

 

     Payments Due by Period (Millions)  
     Total      Less Than
1 Year
     1 –3 Years      3 – 5 Years      More Than
5 Years
 

HSBC Credit Facility

   $ —        $ —        $ —        $ —        $ —    

Synovus Credit Facility

   $ 89.7      $ —        $ —        $ 89.7      $ —    

Natixis Credit Facility

   $ 59.8      $ —        $ —        $ 59.8      $ —    

Class A-1 Senior Secured Floating Rate Note

   $ 178.2      $ —        $ —        $ —        $ 178.2  

Class A-2A Senior Secured Floating Rate Note

   $ 25.0      $ —        $ —        $ —        $ 25.0  

Class A-2B Senior Secured Floating Rate Note

   $ 9.95      $ —        $ —        $ —        $ 9.95  

 

62


Table of Contents

The following table shows the Fund’s contractual obligations as of December 31, 2020:

 

     Payments Due by Period (Millions)  
     Total      Less Than
1 Year
     1 –3 Years      3 – 5 Years      More Than
5 Years
 

HSBC Credit Facility

   $ 46.0      $ 46.0      $ —        $ —        $ —    

Synovus Credit Facility

   $ 84.7      $ —        $ —        $ 84.7      $ —    

Secured borrowings

   $ 18.9      $ 18.9      $ —        $ —        $ —    

Class A-1 Senior Secured Floating Rate Note

   $ 178.2      $ —        $ —        $ —        $ 178.2  

Class A-2A Senior Secured Floating Rate Note

   $ 25.0      $ —        $ —        $ —        $ 25.0  

Class A-2B Senior Secured Floating Rate Note

   $ 9.95      $ —        $ —        $ —        $ 9.95  

See Notes to Financial Statements – Note 4. Borrowings,” for a discussion of the terms of the Revolving Credit Facilities and Notes.

Off-Balance Sheet Arrangements

As of March 31, 2021 and December 31, 2020, the Fund had unfunded Capital Commitments related to Subscription Agreements of $202,341,994 and $231,023,885, respectively.

The Fund may become a party to financial instruments with off-balance sheet risk in the normal course of the Fund’s business to fund investments and to meet the financial needs of the Fund’s portfolio companies. These instruments may include commitments to extend credit and involve, to varying degrees, elements of liquidity and credit risk in excess of the amount recognized in the consolidated statements of assets and liabilities. As of March 31, 2021, the Fund believed that it had adequate financial resources to satisfy its unfunded commitments. The Fund’s unfunded commitments to provide funds to portfolio companies were as follows:

 

     As of  
Unfunded Commitments    March 31, 2021      December 31, 2020  

1st Lien/Senior Secured Debt

     86,412,651        76,225,252  

2nd Lien/Senior Secured Debt

     1,256,896        1,256,896  
  

 

 

    

 

 

 

Total

   $ 87,669,547      $ 77,482,148  
  

 

 

    

 

 

 

 

63


Table of Contents

Co-investment Exemptive Order

On August 6, 2018, the SEC granted the Fund relief sought in a new exemptive application that expands the co-investment exemptive relief previously granted to the Fund in October 2016 to allow the Fund to co-invest in portfolio companies with Affiliated Funds in a manner consistent with its investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, subject to compliance with the Order. Pursuant to the Order, the Fund is permitted to co-invest with Affiliated Funds, which the new exemptive relief defines to include affiliated managed accounts, if, among other things, a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Fund’s independent directors make certain conclusions in connection with a co-investment transaction, including that (1) the terms of the transactions, including the consideration to be paid, are reasonable and fair to the Fund and the Fund’s stockholders and do not involve overreaching in respect of the Fund or the Fund’s stockholders on the part of any person concerned, and (2) the transaction is consistent with the interests of the Fund’s stockholders and is consistent with the Fund’s investment objective and strategies. The Fund intends to co-invest with Affiliated Funds, subject to the conditions included in the Order.

Credit Facilities

HSBC Credit Facility

On November 15, 2017, the Fund entered into the HSBC Credit Agreement to establish the HSBC Credit Facility with the HSBC Administrative Agent and any other lender that becomes a party to the HSBC Credit Agreement in accordance with the terms of the HSBC Credit Agreement, as lenders.

The initial HSBC Maximum Commitment was $30 million. The HSBC Maximum Commitment may be increased upon request of the Fund to an amount agreed upon by the Fund and the HSBC Administrative Agent. Such increase may be done in one or more requested increases, each in a minimum amount of $10 million and in $5 million increments thereof, or such lesser amount to be determined by the HSBC Administrative Agent, subject to certain terms and conditions. So long as no request for borrowing is outstanding, the Fund may terminate the Lenders’ (as defined in the HSBC Credit Agreement) commitments (the “HSBC Commitments”) or reduce the HSBC Maximum Commitment by giving prior irrevocable written notice to the HSBC Administrative Agent. Any reduction of the HSBC Maximum Commitment shall be in an amount equal to $10 million or multiples thereof; and in no event shall a reduction by the Fund reduce the Commitments to $35 million or less (in each case, except for a termination of all the HSBC Commitments). Proceeds under the HSBC Credit Facility may be used for any purpose permitted under the Fund’s organizational documents, including general corporate purposes such as the making of investments.

Borrowings under the HSBC Credit Facility bear interest, at the Fund’s election at the time of drawdown, at a rate per annum equal to (i) with respect to LIBOR Rate Loans (as defined in the HSBC Credit Agreement), Adjusted LIBOR (as defined in the HSBC Credit Agreement) for the applicable Interest Period (as defined in the HSBC Credit Agreement); and (ii) with respect to Reference Rate Loans (as defined in the HSBC Credit Agreement), the greatest of: (x) the rate of interest per annum publicly announced from time to time by the HSBC Administrative Agent as its prime rate, (y) the rate per annum equal to the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers on such day, plus two hundred basis points (2.00%), provided that if such rate is not so published for any day that is a Business Day (as defined in the HSBC Credit Agreement), the average of the quotation for such day on such transactions received by the HSBC Administrative Agent from three (3) Federal funds brokers of recognized standing selected by the HSBC Administrative Agent and, upon request of Borrowers, with notice of such quotations to the Borrowers (as defined in the HSBC Credit Agreement) and (z) except during any period of time during which LIBOR is unavailable, one-month Adjusted LIBOR plus one hundred ninety basis points (1.90%). The Fund will also pay an unused commitment fee of 35 basis points (0.35%) on any unused commitments.

On January 31, 2019, the Fund reduced its maximum available borrowings under the HSBC Credit Facility from $125 million to $50 million by giving notice to the HSBC Administrative Agent. Effective November 13, 2019, the Fund exercised its option to extend the maturity date of the HSBC Credit Facility to November 11, 2020. On November 10, 2020, the Fund entered into the HSBC Credit Agreement Amendment. The HSBC Credit Agreement Amendment (i) extended the maturity date of the HSBC Credit Facility from November 11, 2020 to November 9, 2021, and (ii) inserted a provision permitting the Fund and the HSBC Administrative Agent to, upon the occurrence of certain conditions, amend the HSBC Credit Agreement to replace references to LIBOR with references to an alternate benchmark rate that may include a forward-looking rate based on the secured overnight financing rate or another alternate benchmark rate subject to certain conditions.

The Fund has an option to extend the maturity date for up to one additional term not longer than 364 days, subject to the following conditions: (i) each of the Lenders and the HSBC Administrative Agent consents to the extension in their sole discretion, (ii) the Fund has paid an extension fee to the HSBC Administrative Agent for the benefit of the extending Lenders consenting to such extension in an amount agreed to by the HSBC Administrative Agent and the Borrowers at the time of the extension and as set forth in

 

64


Table of Contents

the applicable extension request, (iii) no potential default or event of default has occurred and is continuing on the date on which notice is given in accordance with the following clause (iv) or on November 9, 2021; and (iv) the Fund has delivered an extension request to the HSBC Administrative Agent not more than one hundred twenty (120) days or less than forty-five (45) days prior to November 9, 2021.

Subject to certain terms and conditions, the HSBC Credit Facility is secured by a first priority, exclusive, perfected security interest and lien in and on all of the Fund’s right, title and interest, in, to and under, whether now existing or hereafter acquired or arising and wherever located (i) all of the Fund’s rights, titles, interests and privileges in and to the Capital Commitments, and the Capital Contributions made by its Investors, and all other rights, titles, interests, powers and privileges related to, appurtenant to or arising out of the Capital Commitments, (ii) all of the Fund’s rights, titles, interests, remedies, and privileges under the Constituent Documents (as defined in the HSBC Credit Agreement) (x) to issue and enforce Capital Calls and pending Capital Calls, (y) to receive and enforce Capital Contributions and (z) relating to Capital Calls, pending Capital Calls, Capital Commitments or Capital Contributions, and (iii) all proceeds of any and all of the foregoing.

The HSBC Credit Facility contains customary covenants and events of default (with customary cure and notice provisions).

As of March 31, 2021, the Fund had $0 outstanding on the HSBC Credit Facility and the Fund was in compliance with the terms of the HSBC Credit Facility. As of December 31, 2020, the Fund had $46,000,000 outstanding on the HSBC Credit Facility and the Fund was in compliance with the terms of the HSBC Credit Facility. The Fund intends to continue to utilize the HSBC Credit Facility on a revolving basis to fund investments and for other general corporate purposes.

For the three months ended March 31, 2021 and March 31, 2020, the components of interest expense related to the HSBC Credit Facility were as follows:

 

     For the Three Months Ended March 31,  
     2021      2020  

Interest and borrowing expenses

   $ 154,133      $ 145,023  

Unused facility fee

     21,486        —    

Amortization of deferred financing costs and upfront commitment fees

     36,885        46,904  
  

 

 

    

 

 

 

Total interest and borrowing expenses

   $ 212,504      $ 191,927  
  

 

 

    

 

 

 

Synovus Credit Facility

On October 15, 2020, ABPCIC Funding II entered into the Synovus Credit Facility. In connection with the Synovus Credit Facility, ABPCIC Funding II entered into, among other agreements, (i) the loan financing and servicing agreement (the “Synovus Loan Agreement”) with the Fund, as equityholder, the Adviser, as servicer (in such capacity, the “Synovus Servicer”), the lenders referred to therein, Synovus, as facility agent, and U.S. Bank, as collateral agent, collateral custodian and securities intermediary, (ii) the securities account control agreement (the “Synovus Control Agreement”), by and among ABPCIC Funding II, the Synovus Collateral Agent and the Synovus Securities Intermediary and (iii) the amended and restated sale and contribution agreement (the “Synovus Transfer Agreement”) by and between the Fund, as seller, and ABPCIC Funding II, as purchaser.

The Synovus Credit Facility provides for borrowings in an aggregate amount up to $100,000,000. Borrowings under the Synovus Loan Agreement bear interest based on an annual adjusted LIBOR for the relevant interest period or the applicable replacement thereto provided in the Synovus Loan Agreement, in each case, plus an applicable spread. Interest is payable quarterly in arrears. Any amounts borrowed under the Synovus Loan Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) October 15, 2025 (or such later date mutually agreed to by ABPCIC Funding II and Synovus) or (ii) upon certain events which result in accelerated maturity under the Synovus Credit Facility. Borrowing under the Synovus Credit Facility is subject to certain restrictions contained in the 1940 Act.

Borrowings under the Synovus Loan Agreement are secured by all of the assets held by ABPCIC Funding II. Pursuant to the Synovus Loan Agreement, the Adviser will perform certain duties with respect to the purchase and management of the assets securing the Synovus Credit Facility. The Adviser will not receive a fee under the Synovus Loan Agreement so long as the Adviser or an affiliate thereof remains the Synovus Servicer. ABPCIC Funding II will reimburse all reasonable expenses, disbursements and advances incurred or made by the Synovus Servicer in the performance of its obligations under the Synovus Loan Agreement. ABPCIC Funding II has made customary representations and warranties under the Synovus Loan Agreement and is required to comply with various covenants, reporting requirements and other customary requirements for similar credit facilities.

 

65


Table of Contents

All of the collateral pledged to the lenders by ABPCIC Funding II under the Synovus Loan Agreement is held in the custody of the Synovus Collateral Custodian or the Synovus Securities Intermediary under the Synovus Control Agreement. The Synovus Collateral Custodian will maintain and perform certain custodial services with respect to the collateral pursuant to the Synovus Loan Agreement. As compensation for the services rendered by U.S. Bank in its capacities as Synovus Collateral Custodian and Synovus Collateral Agent, ABPCIC Funding II will pay U.S. Bank, on a quarterly basis, customary fee amounts and reimburse U.S. Bank for its reasonable out-of-pocket expenses.

On or prior to the closing of the Synovus Credit Facility, the Fund contributed and/or sold certain assets to ABPCIC Funding II pursuant to the Synovus Transfer Agreement, and the Fund expects to continue to contribute and/or sell assets to ABPCIC Funding II pursuant to the Synovus Transfer Agreement in the future. The Fund may, but shall not be required to, repurchase and/or substitute certain assets previously transferred to ABPCIC Funding II subject to the conditions specified in the Synovus Transfer Agreement and the Synovus Loan Agreement. As of March 31, 2021, the Fund had drawn $89,700,000 from the Synovus Credit Facility and the Fund was in compliance with the terms of the Synovus Credit Facility. As of December 31, 2020, the Fund had drawn $84,700,000 from the Synovus Credit Facility and the Fund was in compliance with the terms of the Synovus Credit Facility. The Fund intends to continue to utilize the Synovus Credit Facility on a revolving basis to fund investments and for other general corporate purposes

For the three months ended March 31, 2021 and March 31, 2020, the components of interest expense related to the Synovus Credit Facility were as follows:

 

     For the Three Months Ended March 31,  
     2021      2020  

Interest and borrowing expenses

   $ 703,535      $ —    

Unused facility fee

     16,764        —    

Amortization of deferred financing costs and upfront commitment fees

     129,626        —    
  

 

 

    

 

 

 

Total interest and borrowing expenses

   $ 849,925      $ —    
  

 

 

    

 

 

 

Natixis Credit Facility

On March 24, 2021, ABPCIC Funding III entered into the Natixis Credit Facility. In connection with the Natixis Credit Facility, ABPCIC Funding III entered into, among other agreements, (i) the Natixis Credit Agreement, (ii) the Natixis Account Control Agreement, (iii) the Natixis Collateral Management Agreement, (iv) the Natixis Collateral Administration Agreement and (v) the Natixis Transfer Agreement.

The Natixis Credit Agreement provides for borrowings in an aggregate amount up to $100,000,000. Borrowings under the Natixis Credit Agreement bear interest based on an annual adjusted LIBOR for the relevant interest period or the applicable replacement thereto provided for in the Natixis Credit Agreement, in each case, plus an applicable spread. Interest is payable quarterly in arrears. Any amounts borrowed under the Natixis Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) March 24, 2031 (or such later date mutually agreed to by ABPCIC Funding III and the Natixis Administrative Agent) or (ii) upon certain other events which result in accelerated maturity under the Natixis Credit Facility. Borrowing under the Natixis Credit Facility is subject to certain restrictions contained in the 1940 Act.

Borrowings under the Natixis Credit Agreement are secured by all of the assets held by ABPCIC Funding III. Pursuant to the Natixis Collateral Management Agreement, the Natixis Collateral Manager will perform certain duties with respect to the purchase and management of the assets securing the Natixis Credit Facility. The Natixis Collateral Manager has elected to waive any fees that would otherwise be payable under the Natixis Credit Agreement and the Natixis Collateral Management Agreement. ABPCIC Funding III will reimburse the expenses incurred by the Natixis Collateral Manager in the performance of its obligations under the Natixis Collateral Management Agreement other than any ordinary overhead expenses, which shall not be reimbursed. ABPCIC Funding III has made customary representations and warranties under the Natixis Collateral Management Agreement and is required to comply with various covenants, reporting requirements and other customary requirements for similar credit facilities.

All of the collateral pledged to the lenders by ABPCIC Funding III under the Natixis Credit Agreement is held in the custody of the Natixis Custodian under the Natixis Account Control Agreement. The Natixis Collateral Administrator will maintain and perform certain collateral administration services with respect to the collateral pursuant to the Natixis Collateral Administration Agreement. As compensation for the services rendered by the Natixis Collateral Administrator, ABPCIC Funding III will pay the Natixis Collateral Administrator, on a quarterly basis, customary fee amounts and reimburse the Natixis Collateral Administrator for its reasonable out-of-pocket expenses. The Natixis Collateral Administration Agreement and the obligations of the Natixis Collateral Administrator will continue until the earlier of (i) the liquidation of the collateral and the final distribution of the proceeds of such liquidation, (ii) the date on which all obligations have been paid in full or (iii) the termination of the Natixis Collateral Management Agreement.

 

66


Table of Contents

Concurrently with the closing of the Natixis Credit Facility, the Fund contributed and/or sold certain assets to ABPCIC Funding III pursuant to the Natixis Transfer Agreement, and the Fund expects to continue to contribute and/or sell assets to ABPCIC Funding III pursuant to the Natixis Transfer Agreement in the future. The Fund may, but shall not be required to, repurchase and/or substitute certain assets previously transferred to ABPCIC Funding III subject to the conditions specified in the Natixis Transfer Agreement and the Natixis Credit Agreement. As of March 31, 2021, the Fund had drawn $59,800,000 from the Natixis Credit Facility and the Fund was in compliance with the terms of the Natixis Credit Facility. The Fund intends to continue to utilize the Natixis Credit Facility on a revolving basis to fund investments and for other general corporate purposes.

For the three months ended March 31, 2021 and March 31, 2020, the components of interest expense related to the Natixis Credit Facility were as follows:

 

     For the Three Months Ended March 31,  
     2021      2020  

Interest and borrowing expenses

   $ 29,900      $ —    

Unused facility fee

     4,467        —    

Amortization of deferred financing costs and upfront commitment fees

     12,393        —    
  

 

 

    

 

 

 

Total interest and borrowing expenses

   $ 46,760      $ —    
  

 

 

    

 

 

 

Secured Borrowings

From time to time, the Fund may engage in sale/buy-back agreements, which are a type of secured borrowing. The amount, interest rate and terms of these agreements will be individually negotiated on a transaction-by-transaction basis. Each borrowing is secured by an interest in an underlying asset which is participated or assigned to the sale/buy-back counterparty for the duration of the agreement.

On September 29, 2020, the Fund entered into the Macquarie Sale/Buy-Back. The Macquarie Sale/Buy-Back had a funding cost of 1.25 bps per day and was not subject to any additional fees. On January 14, 2021, the Fund repurchased the assets it assigned to Macquarie pursuant to the Macquarie Sale/Buy-Back. As of March 31, 2021, Secured Borrowings pursuant to the Macquarie Sale/Buy-Back were $0. As of December 31, 2020, Secured Borrowings pursuant to the Macquarie Sale/Buy-Back were $18,870,856, with a maturity of less than thirty days. Interest expense and amortization of deferred financing costs on Secured Borrowings for the three months ended March 31, 2021 were $30,665 and $15,421, respectively.

There were no Secured Borrowings outstanding as of March 31, 2021.

Secured Borrowings outstanding as of December 31, 2020 with Macquarie were as follows:

 

Loan Name

   Trade Date     

Maturity Date

   bps Daily Rate      Amount  

Businessolver.com, Inc.

     12/23/2020      60 days or less from trade date      1.25      $ 5,312,058  

Medbridge Holdings, LLC

     12/23/2020      60 days or less from trade date      1.25        7,710,514  

Higginbotham Insurance Agency, Inc.

     12/23/2020      60 days or less from trade date      1.25        5,848,284  
           

 

 

 
            $ 18,870,856  

Debt Securitization

On August 9, 2019, the Issuer and the Co-Issuer, each a newly formed special purpose vehicle, completed the CLO Transaction. The Notes offered by the Co-Issuers in the CLO Transaction are secured by a diversified portfolio of the Co-Issuers consisting primarily of middle market loans and participation interests in middle market loans and may also include some broadly syndicated loans. The CLO Transaction was executed through a private placement of: (i) $178,200,000 of Class A-1 Senior Secured Floating Rate Notes, which bear interest at three-months LIBOR plus 1.73% per annum; (ii) $25,000,000 of Class A-2A Senior Secured Floating Rate Notes, which bear interest at LIBOR plus 2.45% per annum; (iii) $9,950,000 of Class A-2B Senior Secured Fixed Rate Notes, which bear interest at 4.23% per annum; (iv) $16,400,000 of Class B Secured Deferrable Floating Rate Notes, which bear interest at LIBOR plus 3.40% per annum; and (v) $17,350,000 of Class C Secured Deferrable Floating Rate Notes, which bear interest at LIBOR plus 4.40% per annum. The Notes are scheduled to mature on August 9, 2030.

 

67


Table of Contents

The Notes are the secured obligations of the Co-Issuers, and the indenture governing the Notes includes customary covenants and events of default. The Notes have not been, and will not be, registered under the Securities Act, as amended, or any state securities or “blue sky” laws and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from registration.

The Adviser serves as collateral manager to the Issuer pursuant to the Collateral Management Agreement. For so long as the Adviser serves as collateral manager to the Issuer, the Adviser will elect to irrevocably waive any base management fee or subordinated interest to which it may be entitled under the Collateral Management Agreement. For the period ended March 31, 2021, the Fund incurred a collateral management fee of $454,343, which was voluntarily waived by the Adviser.

The interest rate and outstanding borrowings under the Notes as of March 31, 2021 were as follows:

 

Notes

   Principal Amount      Interest rate at March 31, 2021   Carrying Value      Fair Value  

Class A-1

   $ 178,200,000      L+1.73%   $ 176,935,979      $ 179,488,921  

Class A-2A

     25,000,000      L+2.45%     24,822,668        25,586,325  

Class A-2B

     9,950,000      4.23%     9,854,301        10,469,639  

Class B

     16,400,000      L+3.40%     0        0

Class C

     17,350,000      L+4.40%     0        0

Subordinated Notes

     53,600,000      N/A     0        0
  

 

 

      

 

 

    

 

 

 

Total

   $ 300,500,000        $ 211,612,948      $ 215,544,885  
  

 

 

      

 

 

    

 

 

 

 

*

Class B, Class C and Subordinated Notes have been eliminated in consolidation.

The interest rate and outstanding borrowings under the Notes as of December 31, 2020 were as follows:

 

Notes

   Principal Amount      Interest rate at December 31, 2020   Carrying Value      Fair Value  

Class A-1

   $ 178,200,000      L+1.73%   $ 176,706,612        178,352,361  

Class A-2A

     25,000,000      L+2.45%     24,790,490        25,361,000  

Class A-2B

     9,950,000      4.23%     9,840,396        10,639,316  

Class B

     16,400,000      L+3.40%     0        0

Class C

     17,350,000      L+4.40%     0        0

Subordinated Notes

     53,600,000      N/A     0        0
  

 

 

      

 

 

    

 

 

 

Total

   $ 300,500,000        $ 211,337,498      $ 214,352,677  
  

 

 

      

 

 

    

 

 

 

 

*

Class B, Class C and Subordinated Notes have been eliminated in consolidation.

For the three months ended March 31, 2021 and March 31, 2020, the components of interest expense related to the Notes were as follows:

 

     For the three Months Ended
March 31
 
     2021      2020  

Interest and borrowing expenses

   $ 1,151,318      $ 1,999,072  

Amortization of debt issuance costs

     298,460        377,668  
  

 

 

    

 

 

 

Total interest and borrowing expenses

   $ 1,449,778      $ 2,376,740  
  

 

 

    

 

 

 

Asset Coverage

In accordance with the 1940 Act, the Fund has historically only been allowed to borrow amounts such that its “asset coverage,” as defined in the 1940 Act, is at least 200% after such borrowing, permitting the Fund to borrow up to one dollar for investment purposes for every one dollar of investor equity. “Asset coverage” generally refers to a company’s total assets, less all liabilities and indebtedness not represented by “senior securities,” as defined in the 1940 Act, divided by total senior securities representing indebtedness and, if applicable, preferred stock. “Senior securities” for this purpose includes borrowings from banks or other lenders, debt securities and preferred stock.

 

68


Table of Contents

On March 23, 2018, the Small Business Credit Availability Act (the “SBCAA”) was signed into law. The SBCAA, among other things, modifies the applicable provisions of the 1940 Act to reduce the required asset coverage ratio applicable to BDCs from 200% to 150% subject to certain approval, time and disclosure requirements (including either stockholder approval or approval of a majority of the directors who are not interested persons of the BDC and who have no financial interest in the proposal). On July 5, 2018, the Board voted to approve the adoption of the reduced asset coverage ratio and separately recommended that Investors approve the reduced asset coverage requirements at the 2018 annual meeting of stockholders. On September 26, 2018, at the Fund’s 2018 annual meeting of stockholders, the Fund’s stockholders approved the reduction of the required minimum asset coverage ratio applicable to the Fund from 200% to 150%, which took effect on September 27, 2018. This reduction in the required minimum asset coverage ratio increases the amount of debt that the Fund is permitted to incur, permitting the Fund to borrow up to two dollars for investment purposes for every one dollar of investor equity.

As of March 31, 2021, and December 31, 2020, the Fund had total senior securities of $361,112,948 and $360,908,354, respectively, consisting of borrowings under the Revolving Credit Facilities and Notes, and had asset coverage ratios of 170% and 162%, respectively.

Critical Accounting Policies

Valuation of Investments

The Fund measures the value of its investments at fair value accordance with Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosure, or “ASC Topic 820,” issued by the Financial Accounting Standards Board, or “FASB.” Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

The audit committee of the Board (the “Audit Committee”) is also responsible for assisting the Board in valuing investments that are not publicly traded or for which current market values are not readily available. Investments for which market quotations are readily available are valued using market quotations, which are generally obtained from independent pricing services, broker-dealers or market makers. With respect to portfolio investments for which market quotations are not readily available, the Board, with the assistance of the Adviser and its senior investment team and independent valuation firms, is responsible for determining in good faith the fair value in accordance with the valuation policy approved by the Board. If more than one valuation method is used to measure fair value, the results are evaluated and weighted, as appropriate, considering the reasonableness of the range indicated by those results. The Fund considers a range of fair values based upon the valuation techniques utilized and selects the value within that range that was most representative of fair value based on current market conditions as well as other factors the Adviser’s senior investment team considers relevant.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

 

   

Level 1 – Quoted prices in active markets for identical investments.

 

   

Level 2 – Other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

 

   

Level 3 – Significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments at the reporting date).

The level in the fair value hierarchy within which the fair value measurement is categorized in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. If a fair value measurement uses price data vendors or observable market price quotations, that measurement is a Level 2 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgment, considering factors specific to the asset or liability.

 

69


Table of Contents

The determination of what constitutes “observable” requires significant judgment by the Fund. The Fund considers observable data to be that market data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market.

Because of the inherent uncertainty of valuation for all fair value investments and interests, the Board’s determination of fair value may differ from the values that would have been used had a ready market existed, or that could have been (or will be) realized in an actual sale, and such differences could be material.

The value of any investment on any valuation date is intended to represent the fair value of such investment on such date based upon the amount at which the investment could be exchanged between willing parties, other than in a forced liquidation sale, and reflects the Board’s determination of fair value using the methodology described herein. Any valuation of an investment may not reflect the actual amount received by the Fund upon the liquidation of such investment.

The Fund’s investments will be primarily loans made to middle-market companies. These investments are mostly considered Level 3 assets under ASC Topic 820 because there is not usually a known or accessible market or market indices for these types of debt instruments and, thus, the Adviser’s senior investment team must estimate the fair value of these investment securities based on models utilizing unobservable inputs.

Investment Transactions, Realized/Unrealized Gains or Losses, and Income Recognition

Investment transactions are recorded on a trade-date basis. The Fund measures realized gains or losses from the repayment or sale of investments using the identified cost method. The amortized cost basis of investments represents the original cost adjusted for the accretion/amortization of discounts and premiums and upfront loan origination fees. The Fund reports changes in fair value of investments that are measured at fair value as a component of net change in unrealized appreciation (depreciation) on investments in the consolidated statement of operations.

Interest income, adjusted for amortization of market premium and accretion of market discount, is recorded on an accrual basis to the extent that the Fund expects to collect such amounts. Interest income on debt instruments is accrued and recognized for those issuers who are currently paying in full or expected to pay in full. For those issuers who are in default or expected to default, interest is not accrued and is only recognized when received. Interest or dividend payments received on these non-accrual investments may be recognized as income or applied to principal depending upon management’s judgment. Nonaccrual investments are restored to accrual status when past due principal and interest or dividends are paid and, in management’s judgment, principal and interest or dividend payments are likely to remain current. The Fund may make exceptions to this treatment if an investment has sufficient collateral value and is in the process of collection. Interest income and expense include discounts accreted and premiums amortized on certain debt instruments as determined in good faith by the Adviser and calculated using the effective interest method. Loan origination fees, original issue discounts and market discounts or premiums are capitalized as part of the underlying cost of the investments and accreted or amortized over the life of the investment as interest income.

Management and Incentive Fees

The Fund will accrue for the base management fee and incentive fee. The accrual for the incentive fee includes the recognition of the incentive fee on unrealized capital gains, even though such incentive fee is neither earned nor payable to the Adviser until the gains are both realized and in excess of unrealized depreciation on investments. The amount of capital gains incentive fee expense related to the hypothetical liquidation of the portfolio (and assuming no other changes in realized or unrealized gains and losses) would only become payable to the Adviser in the event of a complete liquidation of the Fund’s portfolio as of period end and the termination of the Amended and Restated Advisory Agreement on such date. Also, it should be noted that the capital gains incentive fee expense fluctuates with the Fund’s overall investment results.

Federal Income Taxes

The Fund has elected to be treated, and to qualify annually, as a RIC under Subchapter M of the Code. Generally, a RIC is not subject to federal income taxes on distributed income and gains if it distributes at least 90% of its net ordinary income and net short-term capital gains in excess of its net long-term capital losses, if any, to its stockholders. The Fund intends to distribute sufficient dividends to maintain its RIC status each year and the Fund does not anticipate paying any material federal income taxes in the future.

 

70


Table of Contents
Item 3.

Quantitative and Qualitative Disclosures About Market Risk

The Fund is subject to financial market risks, including changes in interest rates. To the extent that the Fund borrows money to make investments, the Fund’s net investment income is dependent upon the difference between the rate at which the Fund borrows funds and the rate at which the Fund invests these funds. In periods of rising interest rates, the Fund’s cost of funds would increase, which may reduce the Fund’s net investment income. Because the Fund expects that most of its investments will bear interest at floating rates, the Fund anticipates that an increase in interest rates would have a corresponding increase in the Fund’s interest income that would likely offset any increase in the Fund’s cost of funds and, thus, net investment income would not be reduced. However, there can be no assurance that a significant change in market interest rates will not have an adverse effect on the Fund’s net investment income. In addition, U.S. and global capital markets and credit markets have experienced a higher level of stress due to the global COVID-19 pandemic, which has resulted in an increase in the level of volatility across such markets and a general decline in the value of the securities held by the Fund.

The Fund will generally invest in illiquid loans and securities including debt and equity securities of middle-market companies. Because the Fund expects that there will not be a readily available market for many of the investments in the Fund’s portfolio, the Fund expects to value many of its portfolio investments at fair value as determined in good faith by the Board using a documented valuation policy and a consistently applied valuation process. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Fund’s investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material.

In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. A prolonged reduction in interest rates will reduce the Fund’s gross investment income and could result in a decrease in the Fund’s net investment income if such decreases in LIBOR are not offset by a corresponding increase in the spread over LIBOR that the Fund earns on any portfolio investments, a decrease in the Fund’s operating expenses, including with respect to the Fund’s income incentive fee, or a decrease in the interest rate of the Fund’s floating interest rate liabilities tied to LIBOR.

Assuming that the consolidated statement of assets and liabilities as of March 31, 2021, were to remain constant and that the Fund took no actions to alter its existing interest rate sensitivity, the following table shows the annualized impact of hypothetical base rate changes in interest rates.

 

Change in Interest Rates

   Increase (Decrease) in
Interest Income
     Increase (Decrease) in
Interest Expense
     Net Increase (Decrease) in
Net Investment Income
 

Down 25 basis points

   $ (38,102    $ (1,064,390    $ (1,026,288

Up 100 basis points

     444,946        3,317,700        (2,872,754

Up 200 basis points

     5,749,188        6,844,700        (1,095,512

Up 300 basis points

     10,697,554        10,371,700        325,854  

In addition, although the Fund does not currently intend to make investments that are denominated in a foreign currency, to the extent it does, the Fund will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved.

The Fund may hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate the Fund against adverse changes in interest rates, they may also limit the Fund’s ability to participate in benefits of lower interest rates with respect to the Fund’s portfolio of investments with fixed interest rates.

 

Item 4.

Controls and Procedures

As of the end of the period covered by this report, the Fund carried out an evaluation, under the supervision and with the participation of the Fund’s management, including the Fund’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Fund’s disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, the Fund’s Chief Executive Officer and Chief Financial Officer have concluded that the Fund’s current disclosure controls and procedures are effective in timely alerting them to material information relating to the Fund that is required to be disclosed by the Fund in the reports it files or submits under the Exchange Act.

 

71


Table of Contents

There have been no changes in the Fund’s internal control over financial reporting that occurred during the Fund’s most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Fund’s internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

The Fund is not currently subject to any material legal proceedings, nor, to the Fund’s knowledge, is any material legal proceeding threatened against the Fund. From time to time, the Fund may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of the Fund’s rights under contracts with its portfolio companies. The Fund’s business is also subject to extensive regulation, which may result in regulatory proceedings against the Fund. While the outcome of these legal proceedings cannot be predicted with certainty, the Fund does not expect that these proceedings will have a material effect upon its financial condition or results of operations.

 

Item 1A.

Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in the Fund’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which could materially affect the Fund’s business, financial condition and/or operating results. The risks described in the Fund’s Annual Report on Form 10-K are not the only risks the Fund faces. Additional risks and uncertainties are not currently known to the Fund or that the Fund currently deems to be immaterial also may materially adversely affect the Fund’s business, financial condition and/or operating results. During the three months ended March 31, 2021, there have been no material changes from the risk factors set forth in the Fund’s Annual Report on Form 10-K for the year ended December 31, 2020 except for the following.

The Small Business Credit Availability Act allows the Fund to incur additional leverage, which may increase the risk of investing with the Fund.

On March 23, 2018, the SBCAA was signed into law. The SBCAA, among other things, modifies the applicable provisions of the 1940 Act to reduce the required asset coverage ratio applicable to BDCs from 200% to 150% subject to certain approval, time and disclosure requirements (including either stockholder approval or approval of a majority of the directors who are not interested persons of the BDC and who have no financial interest in the proposal). On July 5, 2018, the Board voted to approve the adoption of the reduced asset coverage ratio and separately recommended that Investors approve the reduced asset coverage requirements at the 2018 annual meeting of stockholders. On September 26, 2018, the Fund’s stockholders voted to approve the adoption of the reduced asset coverage ratio, effective September 27, 2018.

Increased leverage could increase the risks associated with investing in the Fund. For example, if the value of the Fund’s assets decreases, although the asset base and expected revenues would be larger because increased leverage would permit the Fund to acquire additional assets, leverage will cause the Fund’s net asset value to decline more sharply than it otherwise would have without leverage or with lower leverage. Similarly, any decrease in the Fund’s revenue would cause its net income to decline more sharply, on a relative basis, than it would have if the Fund had not borrowed or had borrowed less (although, as noted above, the Fund’s asset base and expected revenues would likely be larger). However, since the Fund already uses leverage in optimizing its investment portfolio, there are no material new risks associated with increased leverage other than the amount of the leverage.

If the Fund’s asset coverage ratio falls below the required limit, the Fund will not be able to incur additional debt until it is able to comply with the asset coverage ratio. This could have a material adverse effect on the Fund’s operations, and the Fund may not be able to make distributions to stockholders. The actual amount of leverage that the Fund employs will depend on the Board’s and the Adviser’s assessment of market and other factors at the time of any proposed borrowing. The Fund currently anticipates being able to obtain sufficient credit on acceptable terms, although the Fund can make no assurance that this will be the case or that it will remain such in the future.

The following table illustrates the effect of leverage on returns from an investment in Shares assuming that the Fund employs leverage such that the Fund’s asset coverage equals (1) the Fund’s actual asset coverage as of March 31, 2021 and (2) 150%, each at various annual returns, net of expenses and as of March 31, 2021.

The calculations in the tables below are hypothetical, and are provided for illustrative purposes only. Actual returns may be higher or lower than those appearing below.

 

72


Table of Contents

Assumed Return on the Fund’s Portfolio (net of expenses)

     (10.00 )%      (5.00 )%      0.00     5.00     10.00
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Corresponding net return to holders of common stock assuming actual asset coverage as of March 31, 2021(1)

     (30 )%      (17.4 )%      (4.8 )%      7.8     20.5

Corresponding net return to holders of common stock assuming 150% asset coverage(2)

     (36.3 )%      (21.3 )%      (6.3 )%      8.7     23.7
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) 

Assumes $638.6 million in total portfolio assets, $385.6 million in debt outstanding, $253 million in net assets, and an average cost of funds of 3.1%. Actual interest payments may be different.

(2) 

Assumes $638.6 million in total portfolio assets, $425.7 million in debt outstanding, $212.9 million in net assets, and an average cost of funds of 3.1%. Actual interest payments may be different.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Except as previously reported by the Fund on its current reports on Form 8-K, the Fund did not sell any securities during the period covered by this Quarterly Report that were not registered under the Securities Act.

 

Item 3.

Defaults Upon Senior Securities

None.

 

Item 4.

Mine Safety Disclosure

Not applicable.

 

Item 5.

Other Information

None.

 

Item 6.

Exhibits

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

 

31.1    Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*
31.2    Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*
32.1    Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended*

 

*

Filed herewith

 

73


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

      AB PRIVATE CREDIT INVESTORS CORPORATION
Date: May 14, 2021     By:  

/s/ J. Brent Humphries

      J. Brent Humphries
      President and Chief Executive Officer
      (Principal Executive Officer)
Date: May 14, 2021     By:  

/s/ Wesley Raper

      Wesley Raper
      Chief Financial Officer and Treasurer
      (Principal Financial and Accounting Officer)